Semantic interoperability of large complex health datasets

requires an ontological approach : a mixed method study. by Liyanage, Harshana
Semantic interoperability of large complex health datasets
requires an ontological approach: a mixed method study
Harshana Liyanage
Department of Computing
University of Surrey
A thesis submitted for the degree of
Doctor of Philosophy
January 2015
Abstract
The “connected world” forces us to think about “interoperability” as
a primary requirement when building health care databases in the
present day. Whilst semantic interoperability has made a major con-
tribution to data utilisation between systems it often has not been
able to integrate some large heterogeneous datasets required for re-
search. As health data gets “bigger” and complex, we are required to
shift to rapid and flexible ways of resolving problems related to seman-
tic interoperability. Ontological approaches accelerate implementing
interoperability due to the availability of robust tools and technology
frameworks that promote reuse.
This thesis reports the results of a mixed methods study that proposes
a pragmatic methodology that maximises the use of ontologies across
a multilayered research readiness model which can be used in data-
driven health care research projects. The research examined evidence
for the use of ontologies across a majority of layers in the reference
model. The first part of the thesis examines the methods used for
assessing readiness to participate in research across six dimensions of
health care. It reports on existing ontological elements that boosts
research readiness and also proposes ontological extensions for mod-
elling the semantics of data sources and research study requirements.
The second part of the thesis presents an ontology toolkit that sup-
ports rapid development of ontologies that can be used in health care
research projects. It provides details of how an ontology toolkit for
creating health care ontologies was developed through the consensus
of a panel of informatics experts and clinicians. This toolkit evolved
further to include a series of ontological building blocks that assist
clinicians to rapidly build ontologies.
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Chapter 1
Introduction
1.1 Background
In 2008, The International Medical Informatics Association (IMIA) presented
a strategic plan, “Towards IMIA 2015”, to develop a world-wide systems ap-
proach for health care that will incorporate and integrate research, clinical care
and public health [Murray, 2008]. The plan envisioned clinicians, researchers,
patients and people in general to be supported by effective informatics tools ,
processes and behaviors that allow them to take informed and timely decisions
in order to improve health care for all. In 2015, achieving interoperability among
health systems continues to be a major challenge in health care. Organisations
are increasingly relying on their proprietary methods for interoperability as inter-
nationally accepted standards such as HL7(version 3)1 are time consuming and
costly to implement.
Interoperability at semantic level is significantly important in health care since
we are consistently dealing with the same concepts represented as different in-
formation structures across a variety of data sources. This heterogeneity of data
is largely due shifting from single coding systems to complex data sources over
the years (Figure 1.1). The deluge of “big data” has dramatically changed the
landscape of health data re-defining challenges of data acquisition for health care
delivery and research. Utilising the continuous stream of data generated from so-
1Health Level 7 is the ISO standard for health information exchange.
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Figure 1.1: Increasing proportion of heterogeneous data sources
cial media and pervasive devices ( connected as a part of the Internet of Things)
is no longer an option, but a necessity to ensure efficient health care delivery
and high quality research. As health data gets bigger and complex, we are re-
quired to shift to rapid and flexible ways of resolving problems related to semantic
interoperability.
Ontologies allow concepts and relationships within a domain to be represented
in a format which is machine processable. They have proven to provide a flexible
approach to integrating data and sharing meaning and may be better able to
assist in inferring meaning in complex situations. HL7 recently published a draft
of its next generation standard known as the “Fast Healthcare Interoperability
Resources (FHIR) specification” which supports solid ontology-based analysis.
Furthermore, ontologies have received wide-spread adoption in the biomedical
research community and has become a de-facto standard for conceptualising data
in research projects.
During the initial period of my PhD, I was focused on developing ontological
methods for integrating heterogeneous data sources in health care. Experiences
in research projects showed that there was a great divide on how existing methods
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engaged informaticians and clinicians to conduct research. Additionally, I also
observed that semantic representation in research projects was limited to clinical
data and associated concepts despite of having clear opportunities for semanti-
cally representing other aspects such as to meta-data, study requirements, gover-
nance and business processes. As a result, I was motivated to develop boundary
spanning methods that broadens utilisation of ontologies in health care research
projects.
1.1.1 Scope of the thesis
This research aimed to develop a more pragmatic methodology that would allow
to maximise the use of ontologies across multiple dimensions of a health care
research project. The thesis examines the current state of readiness to support
ontology driven research in these multiple dimensions through a number of pub-
lished literature reviews. It suggests a series of elements that promote the use
of ontologies and validates them through their use in several real-world health
research projects. The ontological elements are complemented by an ontology
tool kit which can be used to develop boundary spanning ontologies that are
comprehended by both informaticians and clinicians alike.
1.2 Introduction to the research domain
The term boundary spanning describes the role of individuals who work in groups
but who have ties across boundaries that divide their colleagues [Ehrlich & Hor-
vath, 1999]. Real-world health projects often include “boundary spanning roles”
due to the complexity of the research problems they address (e.g. clinicians,
information technology practitioners, legal experts, academics). Methodologies
that are not capable of equal engagement of these multiple roles usually results
in project outputs that are not sustainable or sub-optimal. Building “boundary
spanning methods” that promote better engagement is challenging as they cannot
be validated through a single proof-of-concept project. The “boundary spanning
method” presented in this thesis has therefore been validated by testing its indi-
vidual components in a series of real-world research projects that took place of a
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range of work streams. These works streams are briefly introduced next.
1.2.1 Quality improvement research in primary care
Part of the research work has been produced as outputs of project undertaken
by the Clinical Informatics & Health Outcomes research group of the University
of Surrey. The projects carried out are mostly related to quality improvement of
primary care in the United Kingdom. During the past few years the group has
had a strategic focus on using ontologically rich approaches for case finding and
measuring quality and health outcomes from routine data.
1.2.2 Primary care informatics working groups
During the period of my PhD, I have been a active member of the Primary Health
Care Informatics - Working Group (PHCI-WG) of the International Medical In-
formatics Assocation and the Primary Care Informatics - Working Group (PCI-
WG) of the European Federation of Medical Informatics (EFMI).1 These working
groups have been actively working towards incorporating ontological approaches
in to areas of the Chronic Care Model (CCM). Outputs of the collaborative work
have been disseminated through key conferences and publications in medical in-
formatics. Parts of this thesis have been featured in three consecutive editions of
the Yearbook of Medical Informatics published by the IMIA.2
1.2.3 Monitoring benefit and risks of vaccines in Europe
The last year of my PhD was funded by the IMI (Innovative Medicines Initia-
tive) funded ADVANCE project (Accelerated development of vaccine benefit-risk
collaboration in Europe).3 This is a 5-year project which commenced in October
2013 and the University of Surrey is leading Work Package-3 (Data sources for
rapid and integrated benefit-risk monitoring). I have applied and validated sev-
eral components of my research methodology within the deliverables of the work
package.
1http://clininf.eu/about/imiaphciwg.html
2http://www.imia-medinfo.org/new2/node/110
3http://www.advance-vaccines.eu
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1.3 Rationale and background to the research
The “connect world” forces us to think about “interoperability” as a primary re-
quirement when building health care databases of the present day. While frame-
works such as HL7 that facilitate interoperability are fit for purpose, building
compliant systems is costly and time consuming [Dixon et al., 2014b; Sujansky
et al., 2009]. Ontological approaches accelerate implementing interoperability
due to the availability of robust tools and technology frameworks that promote
reuse. Whilst semantic interoperability has made a major contribution to data
utilisation between systems it often has not been able to integrate some large het-
erogeneous datasets required for research. Ontologies, however, provide a flexible
approach to integrating data and sharing meaning and may be better able to
assist in inferring meaning in complex situations. Semantic interoperability will
always have a place, but has not realised benefits in all circumstances; and as
health data get more complex so it becomes more challenging to make systems
interoperable. Nevertheless, ontological approach enables the best possible use of
data.
Ontologies can be used to:
• Maximise the meaning that can be inferred from coded data;
• Handle different granularity of data (of words & coding);
• Cope with temporal change in definitions, clinical practice, and fluctuation;
and
• Conduct structural system studies (e.g. encounters, health professionals,
governance, privacy etc.).
The comparison between semantic interoperability and ontological approach is
illustrated in Figure 1.2
Big data, or more precisely the mining of massive datasets potentially provides
insight into patterns and hence about process and behaviours. Much of the
work thus far into interoperability has focused on the linkage of data; perhaps
rightly as this is held in various formats, with differing levels of data quality.
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Figure 1.2: Comparison between semantic interoperability and ontological ap-
proaches
When examining health care literature, it is evident that the use of ontologies
is prevalent mostly within the context of clinical concept modelling and health
data linkage. Furthermore, harmonising of ontological work (often referred to as
ontology alignment [Puri et al., 2011]) is mostly carried out for ontologies that
formally represent clinical data.
In order to reap the true benefits of ontologies we need to extend the use of
ontologies to other elements of research studies. For example, ontologies need
to include actors and processes that can limit the capability to access data. In
health care ethics and privacy, different ways that data are stored create enor-
mous barriers to data mining on the same scale. Also, the legal access to health
data is largely controlled within individual jurisdictions, with data controllers
often existing at individual organisational level. Ontological extensions such as
HL7 privacy and ethics address issues related data access, privacy and ethics.
Further more, to have a more comprehensive support at semantic level, we need
to ontologically model the business processes that engage health professionals,
patients and other stake holders that participates in operationalising health care
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work flows.
1.4 Research aims and objectives
Research Aim
To develop boundary spanning ontological approach that facilitates research in-
volving large complex health datasets.
Research Objectives
1. To model aspects of readiness to participate in health care research projects.
2. To develop methods and tools to assess readiness of different aspects of
health care research.
3. To develop a toolkit for building ontologies that can be used in data-driven
health care research projects.
4. Develop informatics methods and tools that can be readily comprehended
by non-technical health care professionals.
1.5 Research outputs
The thesis predominantly advocates broadening the use of ontologies in real-world
health care research projects. A proposition of this nature is generally difficult
to validate within a single research project. Due to this reason, elements of this
larger framework were tested in several different research setting. Furthermore,
certain dimensions of the proposed research readiness model were not subjected
to the complete research process (i.e. from reviewing evidence to support to
development of new ontological extensions) due to time frame constraints of the
PhD study. Table 1.1 provides an overview on the extent of original research
contribution for each dimension of the model (the research readiness model is
discussed in detail in Chapter 2).
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Table 1.1: Extent of original research contributions across different dimensions
of the proposed research readiness model
Examine evidence
for use of ontologies
to support readiness
Conceptual
models
Methods and
tools to assess
research readiness
Ontological
extensions
Data readiness X X X X
Record system readiness X X X X
Organisational readiness X X
Governance readiness X X
Study-specific readiness X X
Business process readiness
Patient readiness X
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1.7 A guide to the thesis
Chapter 1 introduces the research background and the motivation for conduct-
ing this research. It defines the key concepts related to the problem domain and
the corresponding issues. It presents the three different settings in which various
elements of the PhD has been validated.
The subsequent chapters are organised as two parts: Part-I which examines
the readiness for different dimensions of health care for adopting ontological ap-
proaches for conducting research and Part-II presents a toolkit that complements
the research outputs of Part-I.
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PART-I: Dimensions of Readiness
Chapter 2 describes a study involving development of the research readiness
model in the which has been used to frame the research outputs of this thesis. It
provides a literature review about readiness of participating research and analyses
the results. It then extends a 5-level model, previously developed in a European
research project, to a 7-level model based on the findings of this study.
Chapter 3 describes a series of instruments used for assessing data & record
system readiness. It is mainly focused on the development and piloting of re-
search readiness instrument for assessing European data source for participating
in monitoring of vaccine benefit risk studies. This chapter also presents an on-
tological extension of the research readiness instrument capture data & record
system readiness at a semantic level.
Chapter 4 discusses prevailing readiness issues in organisation level. The prob-
lems are discussed with particular focus how organisations need to adapt to the
new challenges introduced by big health data. The chapter reviews big data
health care that have been developed based on evidence found in literature. It
introduces a conceptual model for intermediate processing of health data increases
readiness for participating in big data research while satisfying information gover-
nance requirements. It also presents a data quality management and information
governance framework and associated ontological extensions that fits within the
readiness model.
Chapter 5 presents a methodology for conducting requirements analysis for re-
search studies. The narrative use cases described in this chapter facilitates health
care professionals to engage in this stage of research projects without having to
deal with technical methods generally used for requirements analysis in software
engineering. A example use case associated to requirements of vaccine coverage
studies is presented along with details of how it was validated by boundary span-
ning project members.
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Chapter 6 presents an study about how current state of informatics supports
patient readiness to participate in research and other health care activities. Dur-
ing the literature review of the study, we examine for any use of ontologies to
increase readiness in this dimension.
PART-II: Boundary Spanning Ontologies
Chapter 7 presents a toolkit for building boundary ontologies. A literature re-
view which led to the development of the toolkit is given in this chapter. It also
gives details of the consensus process that was carried out to develop the toolkit
that focuses on developing clinical ontologies that process routine data.
Chapter 8 presents an extension of the toolkit for building boundary ontolo-
gies. It proposes the use of generic ontologies that have been mapped to common
clinical terminologies and also provides a method for validating the ontologies de-
veloped using routine data. A use case of utilising these ontologies in the vaccine
domain is also presented.
Chapter 9 concludes the thesis by presenting principle findings, their implica-
tions and conclusions of the research conducted. It discusses the strengths and
limitations of the research methods used in the thesis and provides recommenda-
tions about how this work can be extended further.
Figure 1.3 illustrates the organisation of the thesis with respect to the research
readiness model.
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Figure 1.3: Organisation of the thesis
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1.8 Source code
The source code for the ontologies featured in this thesis are published online in
the following github repository.
https://github.com/harshanal/ontologies
1.9 Summary
This chapter described the background of this PhD thesis, the context within with
the research was conducted, aims and objectives of the research and the contri-
butions made through the research activities. Ontological approaches provide
more flexibility than standard semantic interoperability methods for conducting
data-driven health care research projects. This chapter also provides list of pub-
lications related to the research work featured in this thesis and and an overview
of how the thesis is organised.
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Part I
Dimensions of readiness
15
Chapter 2
Models for research readiness
2.1 Introduction
This chapter introduces a multilayer model for assessing research readiness. We
define the term “research readiness” as the ability to participate in research.
The model will be used to organise the the research findings presented in PART-I
of this thesis.
Development of primary care research
Historically, most clinical research studies and expenditure on research were
in secondary care settings rather than in primary care. A decade ago primary
care research was described as a “lost cause,” although this was contested at
the time [Douglas, 2003; Hillman & Macnab, 2010; Howe, 2003]. However, since
then Primary Care Research Networks (PCRNs) have developed and encour-
aged and supported more research taking place in primary care [McAvoy, 2005;
Mold, 2012; Sullivan et al., 2007]. Plausibly, these network have contributed to
quality improvement [Peckham & Hutchison, 2012a]. There is some bibliomet-
ric evidence that primary care research is on the increase [Ovhed et al., 2005].
In England around a third of patients recruited into the National Institute for
Health Research (NIHR) portfolio were for primary care-led studies. 129,000 pa-
tients participated in primary care led studies; with a total of 206,716 patients
recruited into studies of all types from primary care [NIHR, 2014].
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UK primary care as a research setting
UK general practice should be an ideal location for a wide range of research be-
cause most general practices are computerised, with a vast quantity of routine
patient data recorded and potentially usable for research [de Lusignan & van
Weel, 2006]. The UK has a registration-based system, where individual patients
are registered with specific general practitioners (GPs) often for many years at
a time, if not their whole lives [de Lusignan & Chan, 2008; Schade et al., 2006].
Hence GPs have reasonably complete longitudinal records. A national identi-
fier, NHS number, makes it possible to link primary and secondary care data.
Linked data sources can add further value [Lyons et al., 2009], although there
are challenges in data validity, security and privacy[Dregan et al., 2012]. The
UK’s representative body for family practice the Royal College of General Prac-
titioners (RCGP) - set up a Research Readiness scheme to facilitate primary
care research. It saw governance as a barrier to practices delivering research and
sought to provide training to facilitate approval for its scheme [RSC, 2014].
Lessons from Primary Care research
Many investigators view UK general practice as difficult to access and re-
cruitment to studies as challenging. These barriers were summed up in a recent
English School of Primary Care Report [Ward E, 2014]:
• A number of publications have described the challenges associated with trial
recruitment in the United Kingdom and elsewhere, some of which have even
led to trials being abandoned. Up to 60% of trials need an extension or dont
recruit to target according to recent reviews, and concerns about this are
widespread in academia and industry. Although evidence is sparse, one
study of 114 UK trials in all health care contexts funded by the Medical
Research Council and Health Technology Assessment programme, found that
31% recruited successfully, and 45% recruited less than 80% of their target
[McDonald et al., 2006].
• Just over half of all trials required an extension. Similar findings from a
smaller survey of published primary care trials found that approximately
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one third recruited to timetable, one third required up to 50% more time
than planned and another third required over 50% extra time than originally
planned. [Bower et al., 2007].
The same picture is found internationally [Ngune et al., 2012].
Research Readiness
The concept of “research readiness” is not new; it has been described for nearly
thirty years [Clayden, 1986]. It aims to explore the gap between the resources
in primary care that could be used for research and what is ready and available
to be used. These resources include patients, who in the UK are registered with
a single practice, and their medical records. Quality improvement studies have
been suggested as a halfway house in which research concepts can be introduced
to health professionals and potentially lead to enhanced research readiness [Staj-
duhar et al., 2006]. There are probably many factors that contribute to whether
a primary care practice is ready and willing to participate in research and make
its patients and their data available to researchers. One factor may be that many
GPs in computerised practices are unaware of opportunities to become involved
in research projects; though others are aware but not interested [Supper et al.,
2011]. Part of the GP role can be as gatekeeper between primary and secondary
care [Nolte & McKee, 2003]; but also as gatekeeper between patients and re-
searchers, thus limiting the possibility of primary care patients being recruited to
studies.
However, much of what was written about research readiness predated the
computerisation of primary care, which makes searching for patients who meet
the criteria for inclusion in studies and the follow up of patients using the records
themselves much easier.11 We carried out this review to explore whether we could
use the learning from a European project to update the concept of “research readi-
ness” into a model that would help identify the key requirements for participation
in research. Such a model might help PCRNs identify practices ready to partici-
pate in research and reveal how others might be brought to a state of readiness.
Change in the state of readiness might also be utilised as a method of assessing
the effectiveness of PCRNs.
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2.2 Literature search
We conducted an evidence synthesis based on a literature review including ex-
ploration of the development of PCRNs in the UK. We focussed on identifying
dimensions of research readiness or initiatives that might affect data quality or
access; including the creation of national collections of primary care data. We
carried out our search using the search terms “readiness”,“research network” and
“family practice” on PubMed/Medline bibliographic database. We created a
PRISMA (Preferred Reporting Items for Systematic Reviews) flow diagram (Fig-
ure 2.1 to describe the search results. The searches identified papers between
April 1976 and March 2014 search was limited to the English language. The
publications from searches totalled 340. Screening process included removal of
duplicates, exclusion using title and exclusion by abstract. The screening pro-
cessed identified 27 relevant publications which were suitable for the synthesis.
These publications were categories based on four themes: national initiatives,
primary care research networks, primary care research databases and European
assessment of research readiness.
2.2.1 Analysis of search results
English national initiatives
a) Legislation and policy to promote research
A “top-down” approach has been used in England to improve participation in
research by primary care clinicians and their practices [Zachariadis et al., 2013].
In 2011, the Government announced funding to help develop the countrys science
and research base and secure England as a world leader in health research. There
is additional funding for biomedical research units to help develop medicines,
treatments and care for patients with diseases such as cancer, diabetes, heart
disease and dementia through a National Institute for Health Research (NIHR).
The Health and Social Care Act 2012 recognised that research is a core function
of the NHS and is vital to quality improvement. At primary care level, it has
made the promotion of innovation and research a core duty of the work of the
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Figure 2.1: Adapted PRISMA flow diagram research readiness literature review
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local NHS, with a requirement to participate in research and to promote patients’
recruitment to research. There is a strong focus on governance in the UK De-
partment of Health approach to primary care research [Boggon et al., 2013].
b) Primary Care Research Networks (PCRN)
To date, the principal national initiative to improve primary care research
capacity and capability has been the development of primary care research net-
works (PCRNs) [Clement et al., 2000], which have fulfilled many functions since
they were established in the 1980s. Over the years their emphasis has changed
from being locally-based networks which supported the research development,
resourcing and interaction of local primary care teams to the current state of a
more national network which encourages and supports practices to participate in
large-scale clinical trials allied with the research priorities of government. The
PCRN states that it
“Provides researchers with the practical support they need to make clinical studies
happen in a primary care setting in the NHS, so that more research takes place,
and more patients can take part” [CRN, 2014].
As the research conducted by PCRN-member practices includes clinical trials,
all practices working within the PCRN are encouraged to undertake Good Clinical
Practice (GCP) training. The EU Directive 2001/20/EC defines GCP as
“A set of internationally-recognised ethical and scientific quality requirements
which must be observed for designing, conducting, recording and reporting
clinical trials that involve the participation of human subjects. Compliance with
this good practice provides assurance that the rights, safety and well-being of
trial subjects are protected, and that the results of the clinical trials are credible
and accurate” .
PCRNs have also had other functions, including promoting research network-
ing events and developing research governance within primary care. In an age of
computerised medical records this includes information governance and data pro-
tection.This latter is important as the practice cannot delegate its responsibility
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to its patients and must safeguard their data; the practice is by data protection
statute the “Data controller” [de Lusignan et al., 2007].
Perhaps less well-documented is the value of the relationship capital and other
intangible resources built up between PCRNs and practices in their networks. We
only identified one review that considered intangible resources; it describes how
social and intellectual capital are the two key resources developed by PCRNs
[Fenton et al., 2001]. This was reinforced during discussions at a National Pri-
mary Care Research Networks conference at which there was recognition of the
extraordinary value of the social (i.e. relationship) capital, intellectual capital and
general know-how built up within the PCRN but acknowledgment that this was
not articulated through any particular intellectual frame. Whilst Fenton et al.
had reflected on organisational issues and recognised their importance [Fenton
et al., 2001]; they excluded microeconomics from their analysis. Other coun-
tries are at an earlier stage of developing primary care research networks, with
Practice Based Research Networks (PBRNs) in Australia [Zwar et al., 2006] and
the Canadian Primary Care Sentinel Surveillance Network being similar models
[Jones, 2006a; Peckham & Hutchison, 2012b].
c) Royal College of General Practitioners - Research Ready Scheme
“Research Ready” is an online tool developed for practices by the UK Royal
College of General Practitioners (RCGP) and the PCRN. It covers the basic prac-
ticalities for conducting research and describes five core competencies. The first
three describe the human resource, physical space and ability to run computer
searches to identify patients or extract data for research. The final two address the
minimum requirements of the Research Governance Framework for undertaking
primary care research in the UK [Thomas et al., 2013]. The RCGP, in collab-
oration with the National Institute for Health Research, is currently updating
and refining the way in which practices are accredited to the scheme, develop-
ing online training modules for practice staff with the aspiration of developing a
leadership role amongst other practices less experienced in research.
Research Ready is a streamlined, web-based self-assessment tool for all prac-
tices taking part in research or wishing to start. Designed to ensure awareness
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of relevant responsibilities, ability to fulfil them, patient safety and professional
protection based on 5 Core Competencies as well as information on practice de-
mographics and research interests(Table 2.1).
Table 2.1: Royal College of General Practitioners Research Readiness scheme
Core Competencies
1. Support within the practice for research activity.
2. Identified space and facilities to host research.
3. Database searches possible.
4. Awareness of research governance requirements for practice
and individual members of staff
5. Awareness of responsibilities to participating patients and staff
2. IT developments that facilitate primary care involvement in
research
a) Standardising primary care computer systems:
General practice has proved easier to computerise than hospital care. One of
the contributors to this in the UK was a Requirement for Accreditation of GP
computer systems, which ensured there was a degree of standardisation between
the systems. The standardisation included the coding system used to record
diagnoses, symptoms, investigation results and treatment [Benson, 2002]; Read
codes have been used in the NHS since 1985. The use of EPR systems combined
with standardised coding systems within them, is now almost universally used at
the point of care; computerised primary care EPR data have enormous potential
for research [de Lusignan et al., 2006].
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b) Making primary care health data accessible for research:
There are four primary ways that primary care computer system data have been
made more accessible for research:
• Search tools provided by the vendor allow case-finding within a practice
• In the UK a standard extraction tool was created, allowing the same search
to be run across different vendors systems. In the UK the first such tool
to be developed was Morbidity Information Query and Export Syntax
(MIQUEST) [Horsfield & Teasdale, 2003].
• Creation of research databases initially based on single computer systems.
These data also have shortcomings [de Lusignan et al., 2004]; and extraction
methods have imperfections but the types of errors can be classified to
enable a rational approach towards addressing them [Michalakidis et al.,
2010].
• Newer UK developments in 2013 such as the establishment of the Farr Insti-
tute of Health Informatics Research [FARR, 2014] which aims to link elec-
tronic health data with other forms of research and routinely collected data,
and the Scottish Primary Care Information Resource (SPIRE) [SPIRE,
2014] which will be a primary care data extraction scheme.
The oldest network or research database is that established by the Royal Col-
lege of General Practitioners (RCGP) to collect morbidity data and carry out
surveillance for infectious diseases and conduct research into vaccine effective-
ness [Fleming & Miles, 2010]. This is now known as the RCGP Research and
Surveillance Centre (RSC) [Fleming & Elliot, 2008]. Not all research databases
survive; the Doctors Independent Network Database (DIN) [Carey et al., 2004]
has now closed, as has the computer systems it was based upon. There have been
other systems established around single practice electronic patient record (EPR)
systems, for example:
• Clinical Practice Research Datalink (CPRD) which started in a single EPR
system but has now been extended to include other brands [Bhaskaran
et al., 2013; Mathur et al., 2014],
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• QResearch is based on the EMIS (Egton Medical Information System)
[Hippisley-Cox et al., 2004],
• The Health Improvement Network (THIN) [Blak et al., 2011; Bourke et al.,
2004],
• ResearchOne [ResearchOne, 2014].
The Clinical Practice Research Datalink (CPRD) is probably the most suc-
cessful database in terms of research output. It is an observational data and
interventional research service which has been built upon the General Practice
Research Database (GPRD) [Hollowell, 1996]. The GPRD contains anonymised
health data pertaining to consultations, prescriptions, referrals and health out-
comes. The data is collected from a particular GP computer system named Vision
and includes a built-in data collection component. When forming the CPRD, the
GPRD was combined with the Health Research Support Service (HRSS), a pro-
gram developed to help researchers access and analyse health care and relevant
data to support their research projects. CPRD has plans to expand further and
to have national coverage.
3. Learning from a European project which included an assessment of
research readiness
A European project (TRANSFoRm) aimed to facilitate research by linking
together data from primary care databases with either genetic or disease registry
data, and resulted in the development of a survey instrument named TIRRE
(TRANSFoRm International Research REadiness) designed to assess readiness to
participate in such linked research [de Lusignan et al., 2011f; Leppenwell et al.,
2012].
The TIRRE survey instrument from the TRANSFoRm project initially iden-
tified four main areas of readiness: data readiness, record readiness, organisa-
tional readiness (including health system structure and socio-cultural factors)
and study-specific readiness as follows.
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The 4-element research readiness model
1. Data Readiness (micro level)
This will assess the current state of data held within the practice.
(a) What data
i. Scope of data recorded
ii. How held (distributed or centralised)
iii. Single or multiple systems
(b) Interoperability
i. Denominator data, - demographics, - unique identifiers
ii. Coding system
iii. Data quality metadata Linkages lab
2. Record System Readiness (meso level)
(a) Type of record architecture encounter based, problem orientated
(b) Data extraction method (e.g. local or central)
(c) Extract type
(d) Health-system-wide initiatives for data extraction (e.g. CPRD, GPES)
3. Organisational Readiness (macro level)
(a) Legislative and regulatory compliance readiness
(b) Health system readiness
i. Organisational structure
ii. Local issues or service configuration that might inform data avail-
ability
iii. Other studies which may involve the target patients / subjects of
research
(c) Socio-cultural readiness
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i. Types of studies that the data provider finds acceptable/is allowed
to participate in
ii. Other factors that might influence local data
iii. Language within records
4. Study Readiness
(a) Quality of relevant data
(b) Demographic and other data including access to laboratory and imag-
ing results
Upon conducting further analysis it became clear that business process readiness
was also important [de Lusignan et al., 2012a]. We combined the learning from the
TIRRE project with the existing Royal College of General Practitioners (RCGP)
Research Ready scheme to develop a new readiness model which would assess
whether GP practices were truly research-ready, and would provide investigators
with a mechanism to assess research readiness in potential participants.
2.3 The 7-element research readiness model
Subsequent to the literature review,a schema for readiness based the following
was developed:
• The results of the literature review
• Lessons from the development of PCRNs to promote research in primary
care
• Technical and other advances that facilitated access to primary care data
• Incorporating the learning from a European project which included an as-
sessment of research readiness [de Lusignan et al., 2011c]
• Presentation and workshop at a National Primary Care meeting and the
subsequent discussion groups and feedback.
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The model was refined based on feedback recieved at a workshop held during
the National PCRN meeting. We explored feedback particularly from the perspec-
tive of adding value through the development of intangible resources or assets,
which we considered were an important part of becoming research ready. We
analysed intangible resources in three component areas: (1) Human capital: in-
dividuals knowledge and know-how about getting research done; (2) Relationship
capital: built up through personal contact and relationships between practices
and their research network; and (3) Structural capital: the training, information
systems, and other unified organisational structures provided to support primary
care research [Stewart, 2007].
The “dimensions of research readiness” model specifies seven perspectives
from which a practice might be assessed in order to determine its readiness to
participate in research (Figure 2.2 & Table 2.2). Including a “study specific”
requirement enables researchers to set out any research requirements not covered
elsewhere in the readiness model. The business process, including workload,
has to work if practices are to participate in studies; and whilst this aspect of
readiness is modulated by the type of study, in the end most practices require
reimbursement for the time taken to participate in research. Patients also need
to be “ready” to participate in research; the authors experiential learning is that
it is more difficult to recruit in research-naive practices than in those experienced
in research.
Initiatives such as Scottish Health Research Register (SHARE) [SHARE,
2014] in Scotland, which aims to establish a register of people interested in par-
ticipating in health research, aim to improve patient readiness. The other new
dimension is that of “governance readiness”. This has been moved out of its pre-
vious position within organisational readiness to be a dimension in its own right,
acknowledging the enormous increase in its prominence since development of the
original TIRRE model.
Current models of readiness are limited and there is scope for development.
Whilst the TIRRE instrument provided insight into the breadth and depth of re-
search readiness, we have had to develop the model further, formalising the need
to include business process modelling and identifying that intangible resources
are also important. We have added culture, ethos and track record (of research
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Figure 2.2: New model for dimensions of research readiness (Bold arrow TIRRE
model, shaded arrow extended model)
participation), and recognised there will often be additional study-specific require-
ments. We propose this seven-element model is used to explore research readiness
and to assess the suitability of projects to recruit successfully in primary care.
Research readiness models should be broad and multifaceted if they are to
fully address the requirements for effective involvement in research. This new
model could become the basis of the next iteration of TIRRE or another tool to
assess the readiness of practices to participate in primary care research. Areas for
further development are to optimise approaches that achieve the buy-in of busy
clinicians working in ordinary primary care settings without any formal links to
academic institutions. These areas represent important intangible assets that
need to be developed; particularly human and relationship capital [Bontis et al.,
1999].
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2.4 Comparison with literature
The report from the English School of Primary Care provides a comprehensive
list of strategies for researchers, but is written more from the perspective of over-
coming barriers to recruitment [Ward E, 2014]. A Cochrane review looked at
strategies to improve recruitment of participants to randomised controlled tri-
als. The review suggested that telephone reminders, opt-out rather than opt-in,
and open designs where patients know their treatment all help; however it did
not report evinces of organisational readiness being a key factor [Treweek et al.,
2013]. An Australian study around managing clinical data requirements for a
compulsory national performance system defined the key features of readiness as
staff skills, supportive management and a high level of trust from participating
practices [Kelly et al., 2009]. An American editorial commented that attempts
to define research capacity within primary care, let alone readiness, have been
incomplete although there is encouraging evidence of enthusiasm [James et al.,
2010]. Another American study found that the key incentives for primary care
doctors to collaborate with academic researchers were the potential to enact qual-
ity improvement, make a contribution to the body of knowledge, and intellectual
stimulation [Gibson et al., 2010]. An editorial focussed on the necessity of collab-
oration and sharing of expertise and resources [Mainous & Hueston, 2006]; and a
further Australian report argues that it is important that network are properly
resourced, based in academic departments, and that there is more interventional
research carried out on a larger scale [Zwar et al., 2006].
Finally, there is much written on the importance of intangible resources or
assets in industries that rely on relationships and communication to get thing
done, though relatively little in health care [Hamed H, 2013]. PCRNs have yet to
document the extent to which they have created social and intellectual capital,
which might soon be lost as they are amalgamated into comprehensive research
networks. The case for investment in structural capital, particularly better use
of informatics, has been made on the basis that this may be one of the biggest
bars to recruitment [de Lusignan, 2012]. A Canadian series on research networks
emphasises the central role of the EPR in research [Terry et al., 2012]. Developing
research in primary care is also seen as a tool for developing primary care per se
30
[Herbert, 2004; Jones, 2006b; Peckham & Hutchison, 2012a].
2.5 Publications associated with the chapter
This chapter is based on research published in Carr H, de Lusignan S, Liyanage
H, Liaw ST, Terry A, Rafi I. Defining dimensions of research readiness:
a conceptual model for primary care research networks. BMC Fam
Pract. 2014 Nov 26;15(1):169. I was involved with conducting interviews with
various stakeholders in primary care research that allowed to build the evidence
base for extending the 7-level research readiness model. In addition I carried
out thematic analysis of the interview transcripts and contributed in synthesising
research conclusions for publication.
2.6 Summary
This chapter presented details about how a 7-element research readiness model
was developed. The model is an extension of a 4-level model which was developed
as part of a European project studying the barriers for conducting international
research. The new dimensions identified included governance readiness, business
process readiness and patient readiness. The need for these additional dimensions
were recognised by issues currently prevailing in health care research project.
The remainder of this part of the thesis examines methods used for assessing
readiness across each level of the research readiness model. It also presents various
ontological elements that can be used to increase research readiness at each level.
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Table 2.2: New model of dimensions of readiness of practices to participate in
research
Dimension of
readiness
Key attribute(s)
Health System & Research network activity to
promote research readiness
Existing New activity required
1. Data
Coded data that identifies:
Denominator,
Cases (& controls),
Inclusion & exclusion
criteria
Pay-for-performance(P4P)
has improved (but also distorted)
data quality
Active engagement in
data quality (of cases &
likely controls)
2. Records Data are extractable
Networks that extract data
(research databases),
One-off (MIQUEST) extraction,
Practice searches (EPR vendor
search tool)
Validation of
extracts is required: these
can have errors and be
inconsistent.
3. Organisational
Health system readiness
Socio-cultural
Legislation (Health & Social Care
Act 2012),
Government/Health ministry,
Promotion of bioscience research,
Incentive schemes for practices
Engagement with local
primary care structures
(Health service localities;
Medical primary care societies
etc.)
4. Governance
Research
governance (RG)
Information (IG)
governance
RG emphasis of existing scheme,
Good Clinical Practice (for trials),
Some confusion about Opt out,
Practice has legal responsibility as
the Data Controller in the UK (Data
Protection Act)
Educational programme
New national guidance
about personal data is required.
5. Study
Impossible to cover
all eventualities
Data quality for the specific study,
Demographic data
Responsive support,
direct data collection from
patients may be possible
6. Business
Tipped in favour or
participation
Mechanism for funding research
(e.g. some practices reluctant to carry
out studies sponsored by pharmaceutical
industry)
Level of funding and whether provides
sufficient incentive to participants,
Feasibility of study being incorporated
into existing workload.
Any risk/perceived risk (e.g. new drug)
Standard payments
Use quality improvement
studies to promote research-
relevant activities
Develop intangible resources,
(social/relationship capital)
7. Patient
Information
Consent
Individual expectation to participate in
research / pre-consentmodels,
Volunteer patient cohorts,
Single disease (e.g. diabetes) where
there may be an associated primary
care clinic, Patient-practice culture &
ethos about participating in research,
Track record previous experience of
delivering projects - type,
clinical domain, number of,cases
Learn how to take consent,
Develop intangible resources
(relationships with practices)
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Chapter 3
Data & Record System Readiness
3.1 Introduction
This chapter presents two survey instruments developed for assessing data and
record system readiness for participating in international research projects. First
it introduces, the TRANSFoRm International Research Readiness (TIRRE) In-
strument used for identifying barriers for data sources to participate in research
and then the ADVANCE International Research Readiness (AIRR) Instrument,
which extended TIRRE to assess readiness of data sources to participate in vac-
cine benefit-risk studies. We also present a data source ontology which can be
used to formally representing the metadata captured by the survey instruments.
3.2 TRANSFoRm International Research Readi-
ness(TIRRE) Instrument
The Translation Research and Patient safety in Europe (TRANSFoRm) is a Eu-
ropean Union funded research project which explored interoperability between
different health systems in Europe. The project was particularly focused on link-
ing primary care databases with genetic and/or cancer registries for conducting
research studies. The main component of the project involved development of
three-dimensional use cases for type 2 diabetes and gastroesophageal reflux dis-
ease (GORD). These use cases were developed as an outcome of a requirement
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analysis exercise which will be discussed in detail in Chapter 5 as a part of study-
specific readiness.
The primary aim of the survey instrument was to determine if a database is
suitable for participating in linked data research projects specified in the use cases.
The requirement analysis was designed to identify micro-,meso- and macro-levels,
and study-specific requirements.
Table 3.1: Levels of requirement analysis in TIRRE
Level Description
Micro Potential study data quality and readiness to incorporate in to linked research.
Meso Technical readiness of the system and data exports.
Macro Governance and regulatory readiness of participating in research.
Study-specific Nature of the data held and the sample size required for a specific studies.
The project involved two phases: an initial phase involving development of the
survey instrument and a subsequent phase involving data collection and analysis.
The development of the survey instrument was based on the 4-element research
readiness model described in Section 2.1.2. The model ensured that the survey
data were collected at the requirement analysis levels described above. Due to
the heterogeneity of the data a comprehensive schema was developed and used
to model the survey questions. The complete schema is given in Appendix-A.
This survey instrument was further developed during the project and redeployed
under the name TIRRE2.
The TIRRE2 survey instrument was deployed on a online survey platform (i.e.
SurveyMonkey) and consisted of 160 questions.1 Skip logic was implemented to
ensure that only questions relevant to the respondents were presented.
3.3 ADVANCE International Research Readi-
ness (AIRR) Instrument
The Accelerated Development of VAccine beNefit-risk Collaboration in Europe
(ADVANCE) is a 5-year European project funded by the Innovative Medicines
Initiative (IMI).2 The project commenced in October 2013 and is executed by a
1http://www.surveymonkey.com/s/tirre2
2http://www.advance-vaccines.eu
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consortium of about 45 partners and associate partners organisations representing
academia, public health institutes, regulatory authorities and the pharmaceutical
industry. The primary aim of the project is to build an integrated and sustainable
framework for continuous vaccine monitoring to evaluate the benefit and risks of
vaccines. The key aims of the project include:
1. Rapid verification of safety issues (including monitoring for risk manage-
ment activities) with a prior hypothesis utilizing all available information
sources (e.g. clinical trial data, spontaneous reporting data, data from elec-
tronic health care records);
2. Thorough signal substantiation (hypothesis testing studies);
3. Effectiveness of vaccine utilizing available data sources (e.g. clinical trial
data, pathogen/vaccine targeted disease surveillance data and data from
electronic health care records);
4. Population impact monitoring of intended vaccine effect utilizing available
data sources (e.g. clinical trial data, pathogen/vaccine targeted disease
surveillance data, data from electronic health care records); and
5. Integrated vaccine benefit-risk monitoring with the option for cyclical up-
dates during the vaccine life cycle.
To achieve these objectives the projects tasks are organised in to 7 work
package (WPs):
1. WP1: Best practice and code of conduct for benefit-risk monitoring of
vaccines
2. WP2: Creation of synergies for benefit-risk monitoring in Europe
3. WP3: Data sources for rapid and integrated benefit-risk monitoring
4. WP4: Methods for burden of disease, vaccination coverage, vaccine safety
effectiveness, impact and benefit-risk monitoring
5. WP5: Proof-of-concept studies of a framework to perform vaccine benefit-
risk monitoring
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6. WP6: Project management and communication
7. WP7: Implementability analysis
The WP3 is being led by the University of Surrey (as academic co-leader)
and Sanofi-Pasteur (as pharmaceutical industry co-lead). A considerable portion
of the research work presented in the thesis (i.e research readiness instruments,
narrative use cases) have been developed as a part of the research conducted
within this work package. Further more, the aforementioned work builds upon
research outputs of the TRANSFoRm project. As a part of the ADVANCE
blueprint, the project intends to develop a catalogue of data sources suitable
for conducting vaccine benefit risk studies. These data sources will be used to
support the proof of concept studies (POCs) and mock-up studies (MOCs) of
this project. We now discuss details of methodology used for designing and
developing the AIRR survey instrument to assess the readiness of data sources
for participating in vaccine research studies.
Data capable of supporting vaccine studies can be obtained from a diverse
collection of data sources. Some are dedicated for recording data related to
vaccines (e.g. immunisation registers for recording administered vaccines), while
others are generic health care databases that contain certain information about
vaccines, related aspects (e.g. primary care databases) or data that can be mainly
used as background information (e.g. population statistics). Additionally, there
are surveillance databases that routinely gather data from other data data sources
that are used mainly for monitoring purposes. Thus, our approach for designing
the survey instrument was twofold: first, developing survey questions related
to generic health care data and second, developing survey questions which are
specifically related to vaccines use.
For developing survey questions related to generic health data, we analysed
previously developed surveys for assessing readiness to participate in research
studies. Furthermore, we also consulted a group of experts on privacy and ethics
to develop (or refine existing) questions related to the privacy and ethics of data
access. The vaccine specific questions were developed by consulting domain ex-
perts within the ADVANCE consortium. Certain questions were enriched by
utilising narrative use cases created during the initial technical requirement anal-
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ysis of the ADVANCE project. The technical requirement analysis and use cases
for understanding data requirements of various types of vaccine studies wil be
discussed further in Chapter 5.
3.3.1 Development of the AIRR Instrument
Survey questions relating to the readiness of data sources for conducting various
research projects in generic health data were developed using experiences from
previous / ongoing projects (e.g. TRANSFORM, ENCePP) exploring this area.
We were also able to leverage the knowledge of ADVANCE consortium members
who were also involved in similar ongoing projects conducting readiness assess-
ments at European level. The generic section of the survey was designed to collect
general metadata, administrative contact information, data access information
and specific details about the technical configuration. The survey instruments
evaluated for developing the AIRR survey are briefly described in Table 3.2.
The comprehensive draft survey developed consisted of 172 questions. This
survey was evaluated during the Work package 3 workshop held on June 13,
2014 at the University of Surrey, United Kingdom. The outcome of the meeting
was to develop a short survey by focusing mainly on prior experiences from the
TIRRE2 (developed as part of the 7th Framework project TRANSFoRm), and
GRIP surveys.
TIRRE (TRANSFoRm International Research Readiness) was a very detailed
and structured survey (160 questions) used within TRANSFoRm project. The
initial pilot telephone interview took 1.5 hours to complete the survey. Despite
a low response rate (17.7%) but TIRRE provided a comprehensive level of infor-
mation to perform an accurate assessment of research readiness. TIRRE divided
questions into micro (about the data itself); meso (about the extract format);
and macro (about permissions, ethic, confidentiality etc.). It also included study
specific questions to ensure compatibility with the investigators requirements.
The GRIP (Global Research in Paediatrics) survey was brief in comparison
to TIRRE2 (14 questions on 4 pages). In GRIP 50% response rate was achieved.
The main strategy for dissemination of the survey was to ensure the right person
received it (1/3 of contacts could be by phone and 2/3 electronically). It was
37
Table 3.2: Survey instruments evaluated during development of initial versions
of AIRR
Survey instrument Description
TIRRE2 (TRANSFoRm
International Research
Readiness instrument)
An online questionnaire instrument to assess capacity
and capability for international research linking primary care
data to genetic databases and disease registers (http://www.clininf.eu/
projects/project-archive/transform/ tirre.html)
Global Research in
Paediatrics (GRIP)
Survey for identifying and describing automated
population-based healthcare databases that can provide
medication and clinical information for paediatric
pharmacoepidemiological researches on a global scale.
(http://www.grip-network.org/)
European Medical
Information Framework
(EMIF)
Survey to identify data sources for the EMIF (who are
able to provide data for research are working together
towards an infrastructure to facilitate re-use of medical data.
(http://www.emif.eu/)
European Network of
Centres for
Pharmacoepidemiology and
Pharmacovigilance.
(ENCePP)
Data source questionnaire for registering databases
for profiling data sources applicable for
pharmacoepidemiology and pharmacovigilance
(http://www.encepp.eu)
Web survey Inventory of
Belgium databases
with health and health
care related information
Survey developed aiming the development of an online
metadata repository of all health related databases in
Belgium, the definition of common variables and the
development of specifications (by health profession
and by type of institute) for developers of medical
software. The survey is an action point of the Action
plan Roadmap to eHealth 2013-2018.
highlighted that for both surveys it may take multiple persons to answer the
survey. Two things were learnt during this process, firstly it was important to
make preliminary contact with the person (database custodian) by phone and
secondly, to have the survey readily available (send link by e-mail) so that the
contact person could complete it immediately. Therefore, to align with the aims
of the ADVANCE project, it was decided that the deployment of the survey would
be conducted in two phases.
• Phase 1 : The goal of this phase is to initially capture basic metadata of as
many databases as possible and contact information using a short survey.
The rationale of this approach was to increase the response rate in order
to deliver a comprehensive report of the landscape of databases that are
available for vaccine benefit-risk studies.
• Phase 2 : A longer survey will be used to collect micro/ meso/ macro levels
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of details from data sources. The survey will target data sources identified
(through the phase 1 survey) as suitable candidates for vaccine benefit-risk
studies.
In phase 1, the ADVANCE International Research Readiness (AIRR) survey
instrument, was developed. It was designed to consist of two components: the
AIRR A and AIRR B surveys. The AIRR-A targeted database users. The
aim of this short survey was to identify data sources that were potentially suited
for inclusion in the catalogue of data sources, which is the key outcome of work
package 3. The respondents were expected to provide information about their
vaccine data sources and relevant contact information for those involved. The
AIRR-B focused on database owners/ data custodians. The aim of this survey
was to capture essential metadata about the data source and additionally to
obtain a high-level understanding of the nature and extent of vaccine related
data stored in the data source. The interaction between surveys and responses
of these two surveys are illustrated in Figure 3.1. The response is sufficient for
ADVANCE to determine if the database is suitable for profiling further. The
generic flow adopted for developing, testing and deploying the two surveys is
given in Figure 3.2.
The AIRR- A survey allows the respondent to input details of up to five data
sources in a single attempt. The survey can be repeated if more details need to
be provided (Appendix I). The AIRR-B survey consists of approximately thirty
questions covering the following topics.
• Contact details
• Database overview
• Population
• Geographical coverage
• Publications
• Data access/ethics
• Vaccines
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Figure 3.1: Workflow of survey invitations and responses of AIRR-A and AIRR-B
Data sources identified through the AIRR survey will allow the work package 5
to determine the type of studies that can be conducted using ADVANCE partner
databases in the initial round of POC studies. It will also inform about the gap
in available data to conduct future studies according to the study types analysed
by work package 4. More details of the questions featured in AIRR-B are given
in Appendix-II.
3.3.2 AIRR survey testing and validation
Testing and validation of the survey was conducted in several phases in order to
ensure the effectiveness of the instrument being developed. Testing involved as-
sessing the validity of the questions, usability of the web-based survey instrument
and assessment of the usefulness of the information captured. This is described
in more detail below.
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Figure 3.2: Generic flow for developing, testing and deploying the AIRR survey
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3.3.3 Validation of survey instrument
During early stages of survey development the longer version of the survey, which
was compiled by using survey questions from previous projects (TIRRE3,4 and
GRIP, predominantly). These questions were circulated within the WT3.2 task
group for review (months 6 -8). The feedback received from the review was
incorporated into the revision of the survey. Revisions included amendments to
suit vaccine databases, merging of redundant/ similar questions and removal of
questions irrelevant to the project.
3.3.3.1 Pilot testing of draft survey instrument
The draft survey was implemented as an online survey on the web-based Survey-
Monkey platform and was tested by several partners. The main focus of these
pilot tests was to evaluate the usability of the survey instrument and the clarity
of the questions. The WP3 workshop focusing on the survey was held during this
time, the primary outcome of which was that the survey was redesigned into a
shorter 2-part survey and named AIRR.
3.3.3.2 Testing and validation of the AIRR instrument
As aforementioned, dissemination of the AIRR survey during the initial phase was
limited to the databases participating in the ADVANCE consortium. This was
aligned with the testing strategy, which aimed to validate the survey questions
through feedback from the database partners. The results of the survey are
presented in this report and will help validate the effectiveness of each question
included.. This phased testing approach will ensure development of a robust and
high quality survey instrument as an output of this work package. The usability
of the survey will be an essential factor for increasing the response rate when
disseminating to the wider audience (i.e. vaccine data sources in Europe).
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3.3.4 Results
3.3.4.1 Survey responses
An invitation to participate in the B survey was sent to 19 database data custo-
dians and we received 17 responses (89% response rate). All 12 ADVANCE part-
ners, one associate partner, and four external databases were represented. The
results presented here reflect only those of the ADVANCE partner databases.
Figure 3.3: Workflow of survey invitations and responses of AIRR-A and AIRR-B
Characteristics: Information about database population size and data col-
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lection start date was collected. Data collection start dates ranged from 1979 to
2013. Population size comprised close to 16 million persons (15 506 402) captured
over time. Pediatric population made up 16-24% of four database populations
and two databases collected solely pediatric data. Discrepancy in “Total number”
and “Active number” of population size demonstrate that there is a difference in
how these terms are considered. These figures require follow-up from respondents.
How often databases were updated was also captured. Eleven databases re-
sponded to this question, of which, 3 have “annual” updates while others classi-
fied their updates as “continuous”,“monthly” and “weekly” (each category had 2
responses).
Nature of data: When asked, “Which of the following does your database
capture?” two possible responses were possible; “Outpatient/inpatient through
medical records” or “Outpatient/inpatient through insurance claims”. Four out
of the 11 respondents chose “Inpatient through medical records”. When asked
about self-characterisation only one respondent characterised their database as
“inpatient electronic medical records”. None of the respondents selected “inpa-
tient or outpatient data through insurance claims”.
Geography: No multi-national databases were identified. Only national (8
of 11) and sub-national (3 of 11) databases were represented in this survey. These
databases covered the 7 countries shown in Figure 3.4.
Patient-based linkage: Linking clinical data to follow-up time was possible
in 8 of the 11 databases and clinical data to drug prescription linkage was possible
in 6 of 11 of the databases. The deterministic linkage method was used among
all respondents where linkage was available.
Vaccine-related data: Two specific vaccine-related questions were asked in
the survey. One question asked “if your database contains vaccine data, please
indicate the completeness of the recording in the target population with respect to
each vaccine”. Databases had full “completeness” in 13 of 18 vaccines but not for
BCG, influenza, rabies, Tick-borne encephalitis, and typhoid. “None” or “Don’t
know” level of completeness was selected for 8 and 18 vaccines respectively (Figure
3.5). The second vaccine-specific question was related to variables collected within
the databases. The variable that was the most commonly captured was “date
of vaccination” (10 of 10). The least commonly collected variables were “lot
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Figure 3.4: Geographic coverage of databases
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number” (2 of 10) and “body site of vaccination” (2 of 10) and “batch number”
(1 of 10).
Figure 3.5: Completeness of recording vaccine-related data in target population
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Data access: One of the survey questions concerned involvement in industry-
sponsored studies in the past five years. Four of 11 responded that they had “no
industry sponsored studies” while the other 6 databases had been involved in 1
to 8 industry sponsored studies. Additionally, respondents were asked if external
parties were allowed to audit the database. The answer options were “yes to
regulators”, “yes to companies for whom studies are done” or “No”. Most replied
“yes to allowing regulators” to audit the database (6 of 8) or “No” external parties
are allowed to audit database (2 of 8). There were zero responders who allowed
“companies for whom studies are done” to audit. In addition, job titles were
collected for those who the person can authorise access to the database, though
it should be of note, that also captured this may not be wholly relevant as a
broad range of job titles have this authority.
3.3.4.2 Opportunities and gaps
All 12 ADVANCE partners responded to part-B of the survey, which related to the
data custodian AIRR-B. However, a description of all available data sources still
needs to be completed, as there are data sources that have yet not been identified.
Over 15 million registered subjects and seven countries were represented, however
thus far no multinational databases among the ADVANCE partners responded.
Since most vaccines are administered among children, it is important to know
the representation of the pediatric population in these databases and currently
it would appear that it is somewhat limited. Another gap that was identified
was the incompleteness on vaccine exposure data, even among self-characterised
vaccine-immunisation registries, although this varies by vaccine type. Patient-
based clinical data linkage to follow-up time and to drug prescriptions is avail-
able using the deterministic method. Lastly, most databases allow manufacturer
sponsored studies.
The survey proved feasible given the overall 85% response rate and 100%
ADVANCE partner response rate. There is, however, a need to follow-up with
databases for consistency. The metadata captured by the survey is valuable for
cataloging databases, but defining terminology and harmonisation of classifica-
tions is necessary. An expansion of the survey to associate partners and other
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sources is next and this will be necessary for completeness. Additionally, it is
imperative to map the relationships of data sources and data users, so that we
properly identify the necessary sources to meet our objectives.
3.4 Data source ontologies
TIRRE and AIRR instruments presented earlier in this chapter, were primarily
developed to collect metadata about data sources. Traditionally, the term meta-
data was used for card catologs used for organising information about books in
libraries. In the digital world, metadata is used to describe and allow data to
be easily found. Metadata can be structural (i.e. describing how an information
object is composed), descriptive (i.e. description of the information object) or
administrative (i.e. information required for managing the information object)
[Hodge, 2001]. In health care, metadata is of critical importance due to the
dispersed nature of health care data that requires frequent integration efforts.
The increase of big data sources has made metadata volatile and forced us to
rethink how metadata is being managed in health care projects. In certain sec-
tors, advanced text analytics techniques has been used to address issues related
to volatility of metadata [Bose, 2009]. Nevertheless, the diversity of data sources
prevents us from decommissioning metadata approaches and calls for more ef-
fective methods of using metadata to be developed [Allison & Mookencherry,
2012].
Ontologies has been previously used support integration of data sources [Buc-
cella et al.; Poggi et al., 2008; Uzdanaviciute & Butleris, 2011]. There are three
main approaches for integrating data using ontologies: global ontology approach,
multiple ontology approach, hybrid approach (Figure 3.6). In general, these ap-
proaches provide good assistance for integration of data at a semantic level. How-
ever, they do not necessary flexibility and scalability to support work such as
readiness assessments.
The process of collecting metadata involves understanding requirements of the
project, conversion of requirements into a survey, dissemination and collection of
survey and corresponding responses, and analysing or storing collected metadata.
Despite being a rudimentary process, it is often highly customised to match the
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Table 3.3: Ontology approaches for data integration (based on [Gagnon, 2007])
Ontology Approach Description
Global Ontology Approach
An integration ontology describes data in all data sources.
A domain expert who knows all data sources is needed to
define this ontology.
Multiple Ontology Approach
Each data source is represented by an own local ontology.
Integration is through mapping across ontologies. Distributed
queries retrieve integrated data sets.
Hybrid Ontology Approach
Each data source is represented has a local ontology. A shared
vocabulary defines terminology used for the local ontologies height
Figure 3.6: Basic architectures in ontology integration approaches (reproduced
from [Wache et al., 2001])
needs of the specific project. As a result, the metadata collected in one project
is not readily reusable within the context of another project. Furthermore, once
submitted, the data owner is unable to amend the metadata to reflect any schema
change of the data source structure that may occurs at a later date. The metadata
repositories built in different projects cannot be linked despite having obvious
benefits of doing so. We believe that most of these issues can be resolved if the
metadata captured at the data source is represented at a semantic level.
A data source ontologies formally represent metadata obtained from the data
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source. Ontologies can be developed using standards such as OWL (Web On-
tology Language) while existing tools and methods can be used to manipulate
them.Using an ontology representation of metadata can have numerous advan-
tages such as:
• Providing a mechanism for sharing a metadata repository with other sys-
tems or projects through a semantic endpoint;
• Use of semantic queries to utilise the information to create larger virtual
knowledge bases.
• Facilitating controlled access to data owners to allow any changes in meta-
data to be reflected in the information stored in the repository.
• Having a common form of representation irrespective of how metadata is
collected (i.e. surveys, metadata extraction etc.)
. Such features will ensure reuse of metadata by similar initiatives that takes
place in the future.
3.4.1 Development of data source ontologies
For activities involving scoping database (which is a preliminary activity to in-
tegration), we have developed a novel method that translates the information
captured in the survey instrument in to a ontology describing the data source.
We have used the schema developed for the AIRR survey to ensure that domain
expertise captured during the survey development process is transferred to the
ontology. The ontology has been developed using the standard ontology visuali-
sation tool known as Prote´ge´, maintained by the Stanford Center for Biomedical
Informatics Research, USA1.
While modelling the data source as an ontology, we analysed the schema of
AIRR to identify entity hierarchies, data properties and their corresponding rela-
tionships. The entity hierarchy of the data source ontology developed is given in
Figure 3.7. It consists of two main entities representing the concepts data source
1http://protege.stanford.edu/
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and vaccine preventable diseases. Different variations of data sources are repre-
sented as sub classes while a range of vaccine are specified as sub classes of the
vaccine preventable disease class. Hierarchies of this nature can be used to rep-
resent relationships in the ”IS A” form. For example, “ an immunisation register
IS A data source” and “measles IS A vaccine preventable disease.
Figure 3.7: Entities in the data source ontology
We also defined data properties for represent an array of properties captured
according to the AIRR schema. The data properties have been logically grouped
to represent the structure of the survey questions (Figure 5.4. Each data property
can have a predefined data type to ensure validation of data (Validation can be
achieved by executing the reasoner associate with Prote´ge´.
To demonstrate the usage of the ontology we have created an individual
semantic representation to formally represent the metadata collected from the
RCGP research and surveillance database (RCGP RSC). The information was
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Figure 3.8: Data properties in the data source ontology
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this formal representation was captured from a survey response from an RCGP
RSC representative (Data capture was carried through the online survey instru-
ment). In the data source ontology each metadata item is represented in the
form of a property assertion. A graphic representation of the assertions for this
example is given in Figure 3.9 while the excerpt of the actual machine processable
is given in 3.10. The complete ontology is available at: The complete ontology is
available at: https://github.com/harshanal/ontologies
Figure 3.9: Property assertions for RCGP RSC individual representation in the
data source ontology
Once the data source ontology has been developed using the pilot data schema
there is also, the option to make the survey instrument to dynamically run us-
ing the ontology as a source information for the survey questions. This dynamic
approach will allow any future schema changes done to the ontology to be au-
tomatically reflected in the survey instrument without any manual modification.
This approach of using an ontology as a template for dynamic forms has been
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Figure 3.10: OWL/XML representation of RCGP RSC metadata as a data source
ontology
demonstrated previously [Zheng et al., 2011].
3.5 Reports associated with the chapter
The research outputs described in this chapter were published as a deliverable of
the ADVANCE project (D3.1 First report of data access, linkage and integration
for proof-of-concept studies - October 2014). As the lead researcher producing
this deliverable, I was leading the development of the survey instrument, dissem-
ination of the survey, data collection and authoring the methodological aspects
of the report.
3.6 Summary
Survey instruments are commonly used for capturing metadata from to data
sources. Shorter surveys have improved response rates and therefore, the design
of such surveys are specific to the research study that they are used for. This
results in limited reuse or sharing of captured data across projects. Furthermore,
a mechanism to update a submitted response is typically not considered in such
projects invalidating the information collected on completion of projects. The
proprietary tools used for implementing survey tools (i.e. mostly online survey
platforms) have not been designed with data sharing mind. The AIRR survey
instrument was developed to assess readiness for participate in vaccine benefit-risk
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research. We have also developed a data source ontologies to formally represent
the metadata collected through AIRR to facilitate the use of semantic queries and
to promote reuse of the data collected. As a proof-of-concept we have formally
represented the metadata captured from the RCGP RSC database to demonstrate
the usage of the ontology.
3.6.1 Clinical perspective
Metadata collection is significantly important to gain a comprehensive under-
standing of a clinical data source. Metadata useful to determine the provenance
and lineage of the data. Constrainsts specified in metadata related to data access,
privacy and ethics gives insight to whether a data source can be utilised for a
given research study. Ontological approaches for formally representing metadata
in data sources will allow clinicians to explore possible research designs using
semantic queries if sufficiently user friendly interfaces are given. Also, the possi-
bility of linking metadata repositories through ontologies will help design of more
complex research studies from the data sources available.
3.6.2 Informatics perspective
Survey instruments that are typically used for collecting metadata are labour
intensive to developed and cannot be reused due to the high specificity of project
requirements. Metadata collection is often carried our per project and resulting
metadata repositories become outdated at the end of projects as mechanisms for
updating metadata are typically not implemented or not used. The use of an
ontology for formal representation of metadata collected will increase the poten-
tial of the data beyond the lifetime of the repository hosting environment is kept
online and accessible. Exposing repositories through semantic endpoints will fa-
cilitate pooling of metadata through the use of semantic queries. Additionally,
the semantic interface for the metadata can be controlled by enforcing access
permissions in order to share only necessary metadata with external parties. If
robust security policies are implemented the ontologies could facilitate an meta-
data updating mechanism that could be potentially integrated with a third-party
system to enable automated updates.
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Chapter 4
Organisational & Governance
Readiness
4.1 Introduction
This chapter examines some of the key organisational & governance challenges
faced by modern organisations, particularly in relation to dealing with “Big data”.
Organisations require to increase their agility and adjust their organisational pro-
cedures to accommodate the complexity and scale of future datasets.
Big data has brought forward a new set of challenges that has called for
organisations to review how they need adapt to be produces and/or consumers
of large complex data sets. The challenges are typically associated to the variety,
velocity, volume and veracity of new types of data. The archaic governance
procedures that are still operational in most organisations that produce health
care data are struggling to cater to the rapid information requirements of data-
drive health care projects. In this chapter, we first examine the evidence based
for existing uses of big data in health care to understand the nature of the new
challenges that organisations have to face. We then present a conceptual model
that could be used to overcome the barriers of utilising large complex datasets
and to improve integration of data that promotes reuse of data. Finally, we
review existing frameworks and ontological elements that improve organisation
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and governance readiness to participate in research.
4.2 Big data in health care: a new challenge for
semantic interoperability
The rapidly reducing cost of data storage and increasing bandwidth of communi-
cation networks have enabled large volumes of data to be mobilised easily. Due to
the proliferation of social media and cloud computing, the collection, storage and
processing of data has become much easier allowing large datasets to be generated
and managed in a cost effective manner[Buyya et al., 2009]. This has extended
the boundaries of data processing by the introduction of a new perspective of data
called Big Data. It has been reported that the total data generated in the last
two years exceeds that amassed throughout the entire history of the digital age
[IBM, 2013]. A quantitative definition of Big Data is difficult as the big volume
is relative to the time of definition. Datasets considered to be Big Data now, may
not be considered so in the very near future, due to technological advancements
[Dong et al., 2013; Ward & Barker, 2013]. This is somewhat in contrast to our
conventional approaches to study design where the data requirements are set to
answer a specific research question.
In terms of the nature of data, big data consists of large bodies of unstructured
or raw data which cannot be processed using conventional, largely relational data
processing techniques. The complexity of the data is often important in char-
acterising datasets as big data. Big data is characterised by IBM according to
four dimensions: volume, velocity, variety and veracity (Table 4.1). The volume
and complexity of big data means that it cannot be processed using conventional
data processing methods. Big data processing methods address issues such as
data volume and heterogeneity in large datasets.
The literature suggests that cloud based processing of petabytes of data can
be achieved at a fraction of the time and cost when adopting big data processing
methods [de Lusignan et al., 2011a]. Whilst the wave of big-data technologies will
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Table 4.1: Four dimensions of big data
Volume
The scale of data. Represents the characteristic rapid rate that
data is growing. (e.g. 2.3 trillion gigabytes of data are generated
by computer systems each day)
Velocity
Data is delivered at an increased frequency (mostly in the form
of a continuous stream) (e.g. Social media, pervasive sensing
devices)
Variety
Data exists in a multiple format. Most of it is unstructured.
(e.g. free text in medical records, data streams from monitoring
devices, imaging data)
Veracity Big data can be uncertain and may contain erroneous data.
not resolve the plethora of data issues that exist in the health care information
ecosystem (the system of processing and filtering data between data recording and
utilisation)[Neff, 2013]; methods for harnessing big data are considered to offer
the potential to take a big step forward in improving the quality and efficiency
of health care delivery [Murdoch & Detsky, 2013].
4.2.1 Search strategy
The rapid literature review employed is more suited for conducting exploratory
reviews of emerging technologies in a given domain. It relied on the fact that
there are common usage patterns of techniques in the same domain. Therefore,
a sample of actual uses of big data in the domain of interest is sufficient for
determining the generic usage patterns ( known here as use cases).
We have searched PUBMED, Medline, Scopus, Web of Science, and the
Cochrane Database for publications related big data in health care. We have
focused on health care databases intentionally as big data is an emerging tech-
nology in health care research. Furthermore, we have not used complex search
strings due to the limited availability of big data applications in existence in
health care literature. An adapted PRISMA flow chart is shown in Fig. 4.1. The
inclusion criteria for papers where those which focused primarily on conceptual
or practical uses of big data in health care research. Papers that were excluded
were based on themes within the periphery of this concept. This includes in-
stances where big data has been used to highlight the volume of data. Electronic
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Figure 4.1: Adapted PRISMA flow diagram
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searches were performed retrospectively and commenced from the January 2005
to December 2013. In the absence of translation resources searches were limited
to the English language. The number of articles from all searches totalled 410,
with 165 being duplications. Due to big data being a relatively new concept, no
limits were set/ placed regarding type of paper. As such we included any review
and reports on this topic. The abstracts were reviewed for applications of big data
methods in health care. Key information from each publication was extracted to
form a summary (which we refer to as a use case instance). After the screening
process we grouped the use case instances that have common utilisation patterns
of big data. The groups were then analysed separately to build the generic use
cases we describe in the next section.
4.2.2 Results
The overall result of the review was that most studies looked at how big data
and associated methods can be leveraged to enhance standard data manipulation
methods in different areas of study in health care. A summary of the big data
methods discussed in the publications are highlighted in a word cloud Fig. 4.2. In
the word cloud, exploration of data (including data mining and pattern analysis)
was the most emphasised. This is a ubiquitous part of any work with big data
and is essentially the process of hypothesis generation or early hypothesis testing.
We have therefore not created a use case around this activity.
We have generalised the usage of big data and associated methods into three
main use cases.
4.2.2.1 Use case 1: Big data processing
Data generation in health care systems has now reached exabyte levels (1 exabyte
= 1 billion gigabytes) [Mu¨ller et al., 2012; Newman et al., 2003]. Big data tech-
nologists have a growing collection of big data processing techniques and we have
found evidence where some of these techniques have been used within health care
applications. We describe the more widely used big data processing methods.
Distributed big data Processing: Conventional data processing techniques do
not scale to meet processing requirements of big data. MapReduce is a distributed
60
Figure 4.2: Word cloud of big data methods represented by literature search
results
data processing method often used to process big data. This method adopts a
two-step approach where the problem is first split into many homogeneous sub-
problems (map step) and then outputs of sub-problems combined to generate the
overall output (reduce step) [Schadt et al., 2010]. A cloud based implementation
of MapReduce has been used to analyse electrophysiological data in epilepsy
clinical research [Sahoo et al., 2014]. The increased sensitivity of cardiac imaging
and radiology equipment resulted in multiple terabytes of data being produced
each year and frameworks such as MapReduce have been used for proof-of-concept
studies in this area [Narula, 2013]. This processing method is also commonly
used in complex biological data processing operations such as genome sequencing
which required large computation capabilities [Mudunuri et al., 2013]. Current
statistical methods may have limitations when handling the scale of data sets
associated with big data. Evidence exists that such optimisations have been
carried out on these conventional techniques to support the increased size of big
datasets [Simpson et al., 2013].
Predictive analytics: This method of analysis uses various statistical and data
mining techniques to analyse historical and present data in order to predict future
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Figure 4.3: Use case 1: Big data processing
outcomes. Predictive analytics is already demonstrating its usefulness by appli-
cations that enable smarter prediction of health care outcomes by combining
clinical, insurance and public data sets. It supports intelligent case management
which involves development of programs that can have a higher impact on patient
behaviour [Fox, 2011, 2012]. We have found evidence for the use of these methods
in secondary care for purposes ranging from reducing readmissions to predicting
outcome in patients admitted to surgical intensive care units [Celi et al., 2013;
Choi et al., 2013; de Lissovoy, 2013].
Crowdsourcing: This involves recruiting large numbers of people who collabo-
ratively collect, filter and analyse large amounts of data for a common purpose.
Using the internet as the medium of participation, thousands of people partic-
ipate in completing a small part of a problem (often offered in multiplicity for
the purposes of validation). Gamified approaches (i.e. regular tasks built as
computer games) have been developed for aiding the diagnosis or labelling of
biomedical images [Mavandadi et al., 2012]. In HIV research crowdsourcing has
been used to identify important genes using 500 billion subsets related to HIV
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Figure 4.4: Use case 2: Data integration of heterogeneous big data sources
biology [Bushman et al., 2013].
4.2.2.2 Use case 2: Data integration of heterogeneous big data sources
Health care data sources used for decision making are no longer restricted to clin-
ical databases [Liyanage et al., 2013b]. Accommodating this heterogeneity often
leads to better service improvements and policy development. It is important
that health care specific techniques such as record linkage, cohort creation are
adopted appropriately when using big data sources. The majority of the data
(80%) in these sources are unstructured and includes medical data such as ra-
diological images, clinic notes, operative reports, and pathologic slides [Green &
Rapp, 2013; Seth, 2008].The national cyber-infrastructure of the United States
has progressively improved to support integration of various big data sources,
particularly for biomedical research [LeDuc et al., 2014]. Also, there has been an
effort to integrate biomedical data sources in Japan [Morita et al., 2012]. There
is evidence of integrating big data sources in studies related to mental health
[Mohr et al., 2013]. Example data sources used include pervasive device usage
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data, patient workflows and sensor readings. The Cancer Genome Atlas is a pub-
licly accessible website which acts as a portal to multiple big data sources and
includes genomic data, tissue slide images and clinical outcomes data [Robbins
et al., 2013]. Evidence demonstrates a stream of work focusing on frameworks
developing service-models based on aggregating data from pervasive computing
devices (wearable body sensors, body function monitors), lifestyle data (diet,
sleep), mobility data (smart phones, tablets) and clinical data. Such aggrega-
tion helps build an understanding of the overall lifestyle and not only medical
conditions, thereby leading to better preventive care.
4.2.2.3 Use case 3: Real-time monitoring
Present day medical devices generate data at a rapid rate and this is challenging
especially when real-time responses are anticipated. Similarly, when decisions
need to be taken from aggregated data sources such as social media, the data
needs to processed in real-time in order to benefit from the relevance of insights
generated from the data. Evidence in our review demonstrates real-time monitor-
ing as a significant use case in health care. In pharmacovigilance, once drugs are
approved and available in the market, it is required to monitor for adverse events
to ensure that drugs are performing as expected. Any adverse events are gener-
ally captured by Adverse Event Reporting Systems and efforts are being made
to move towards real-time surveillance of these events. Spontaneous reporting
systems (SRS) are currently in use for drug safety monitoring [Shah, 2012].
We have also observed an increasing trend in incorporating social media as a
data source for supporting clinical data in health care applications and policy de-
velopment. The micro blogging service Twitter has so far been the most adopted
social media service [Bartlett & Wurtz, 2013; Denecke et al., 2013]. Social media
data has been proven to be more insightful in assessing patient satisfaction about
the quality of care than conventional methods for collecting feedback from forms
and surveys [Greaves et al., 2013]. The HealthMap application uses social media
data and other online web sources to perform infectious disease surveillance on
a global scale [Hay et al., 2013]. Twitter and similar micro blogging services are
increasingly used for public health analysis [Paul & Dredze, 2011].
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Figure 4.5: Use case 3: Real-time monitoring
4.2.2.4 Ethical aspects of using big data
while conducting this literature review we observed concerns of privacy and ethics
as a common theme on most publications. Privacy and security needs to be
considered as a primary consideration of any big data solution and the necessary
legislation needs to be adopted to ensure that big data is not misused. Effort
should be taken to keep individual identities from being identified during the
big data processing workflows. However, there is the possibility that this may
result in data duplication during the integration of big data sources and affect
the usefulness of big data.
Legislation in the USA such as HIPAA (Health Insurance Portability and
Accountability Act) do not cover data storage outside of health care systems.
Much of these big data will not be personal data and not subject to European
legislation and control may rest with the responsibility and professionalism of
system designers and owners [de Lusignan et al., 2007]. However, this is a criti-
cal concern of those looking to use big data generated and available from online
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sources. Community driven health data repositories may not be as private as
consumers assume [Steinbrook, 2008]. The ownership of data generated through
big data analytics is also constantly subjected to debate. Most online services
are free and the user agreements generally state that the owner of the service can
use the data collected from the application. It is necessary to regulate data (es-
pecially health related) online and perhaps intermediate processors that enforce
governance restrictions could be used for this purpose.
4.3 Intermediate Processors of Health Informa-
tion (IPHI)
Health care in common with many other industries is generating large amounts
of routine enterprise data, which can be mined and even combined with com-
ments, tweets and blogs. This mass of data is termed Big data. A challenge for
informatics is to make sense of these data, which can sit in numerous disparate
systems; and due to their sheer volume are hard to analyse, process and curate
en masse [de Lusignan et al., 2011c].
Sense making, of these data, offer opportunities for the surveillance of disease
[Thacker & Stroup, 1994], addressing complex public health issues, as well as for
running complex health care providers [Bain & Standing, 2009]. Ontologies that
support the use of heterogeneous data sources will provide part of the answer
[Liaw et al., 2013; Sahoo et al., 2008]; the use of ontological concepts can be used
as a means of improving the quality of complex research data [de Lusignan et al.,
2011d]. Additionally, there is a place for advanced data mining and data mod-
elling methods, including Mashups of data [Kamel Boulos et al., 2010], enhanced
use of metadata and semantic enhancement [Shotton et al., 2009]. However, the
best way to stimulate the development of these tools will be through the develop-
ment of safe intermediate processors of health information (IPHI) working within
a health ecosystem (Figure 4.6).
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Figure 4.6: Information Ecosystem
4.3.1 Information ecosystem
An information ecosystem is a complex environment in which data and informa-
tion providers, users and processors interact in a mutually interdependent and
transformational process.
The information ecosystem is made more dynamic by the diversity and effec-
tiveness of the information processors:
• Data mining, combining multiple information sources to produce new in-
formation (Meaningful Mashups)
• Multiple methods of data presentation and visualisation, some will be brief
and superficial
• Interactive processes involving linked data
• Sherpas are methods to guide users to the information they seek.
• Interactive databases
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Within the health environment these tools are what we refer to as the inter-
mediate processors of health information (IPHI), unlike other sectors they need
to ensure privacy.
IPHI will sit between the generators of health data and information, often the
providers of healthcare, and the users of this information. The users of informa-
tion are health service managers, commissioners, policy makers, researchers, and
the pharmaceutical and other healthcare industries. They will create a health
ecosystem, by processing data in a way that stimulates improved data quality
and potentially healthcare delivery by providers of healthcare and by providing
legitimate users of data greater insights.
4.3.2 Meaningful Mashups
The last decade introduced a new wave of information sources in the form of
Worldwide Web (WWW) based Mashups; a term invented for combining music
tracks became taken over as a term for combining multiple data sources. Mashups
are web applications that combine multiple sources of information to generate a
secondary source of information which gives a new perspective of the data involved
[Brownstein et al., 2009]. Mashups were the highlight of the Web 2.0 era of the
WWW [Giustini, 2007]. They have evolved from simple data mixing to platforms
that synthesise complex information structures. These Meaningful Mashup have
technological similarities to the IPHIs discussed here. They have been piloted for
looking at genes and clinical data, geographical data [Boulos et al., 2008], and
also been developed using ontologically rich processes [Sahoo et al., 2008].
Exemplar roles of an IPHI: unsafe use of alcohol and vaccine coverage,
benefits and risk. Exemplars are provided of how a health ecosystem might be
encouraged and developed to promote patient safety and more efficient health
care. These are in the areas of how to integrate data around unsafe use of alcohol
and to explore vaccine coverage, benefits and safety.
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4.3.3 Vaccine Effectiveness Monitoring
The 2009 pandemic influenza (H1N1) experience has demonstrated the presence
of a major gap in vaccine monitoring and benefit-risk assessment across Europe.
The key issue appears to be not in the absence of data for monitoring such public
health emergencies but the coordinated aggregation of such data within a realistic
time-frame. In theory, open standards are an idealistic approach for harmonious
collation of data across the health enterprise. However, the perception about
incorporating open data standards has changed in the recent years due to numer-
ous information systems projects failing to effectively adopt such standards in to
usable implementations.
Vaccine monitoring and benefit-risk assessment would be successful only if
the data generated from thousands of data sources can be orchestrated to form
a unified information flow within the health care ecosystem. Existing effort for
monitoring vaccine outcomes only utilise a fraction of the big data available from
the health care enterprise. An information architecture that could leverage a
wider coverage of the available health data would have to be flexible. We also
would have better results in these initiatives if our approach shifted from being
data collection centric to data processing centric. Recent advances in distributed
computing have made the latter approach more feasible than ever before.
The challenge for generating a unified information flow for vaccine monitoring
would also require overcoming information governance requirements which are
usually specific to the locality of the data sources. Therefore, an improved in-
formation flow would also need to be complemented by standardised governance
procedures that would allow flexibility while not affecting data integrity. One
of the key success factors about big data implementations so far have been the
abundant availability of open data. It will be interesting to see if big data would
be equally successful within data ecosystems with restrictive governance policies.
4.3.4 Monitoring Unsafe Use of Alcohol
Alcohol use among under-aged youth is a growing problem and a burden on
emergency departments. Despite having certain legislative frameworks in place,
there seems to be a clear increase in alcohol related violence and injuries [Newton
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et al., 2007]. Easy access to alcohol is mainly due to the ability to obtain fake
licenses online [Morleo et al., 2010]. Addressing such issues are complicated due to
the data involved being available at multiple granularities. Nevertheless, sharing
data related to alcohol related injuries with local partners to monitor local trends
and to take preventive action such as targeted policing and licensing enforcement
has been successful in the past [Quigg et al., 2012]. We need to examine novel
methods of generating information required specifically for this purpose. This
data may originate from crime records, ambulance logs [Martin et al., 2012],
emergency admissions and other related sources. An IPHI produced for this
purpose may serve as an information source for off-license renewals or alcohol
control for the beverage industry.
Alcohol consumption is a major risk factor for the global burden of disease.
Monitoring of alcohol consumption patterns on a global scale provides critical
insight for enforcing control through health care policies. The World Health
Organisations has developed a comprehensive information system that includes
data on more than 200 alcohol-related indicators, named the Global Information
System on Alcohol and Health (GISAH) [Organization et al., 2012]. This system
uses SDMX-HD (Statistical Data and Metadata Exchange Health Domain) data
exchange format for facilitating exchange of indicator definitions and data from
their data sources [Sundgren et al., 2006]. GISAH and its hierarchy of data
sources across various national health services in the world forms a specialised
ecosystem based on WHO proprietary standards. Additionally, this demonstrates
that implementing IPHIs in a controlled environment can be achieved at a large
scale.
4.3.5 Safe and private processing of health and other linked
data
A challenge for IPHI is how to ensure their processing of data is valid, safe and
maintains privacy. Information governance (IG) plays a key role in ensuring con-
trolled access at the source of data. The dynamics of IG can potentially be more
complicated in a setting where multiple IPHIs cascade information across the
healthcare ecosystem. Considering the nature of the data involved, it may be
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Figure 4.7: Traditional flows of data in a health system
more effective to achieve privacy at the data level. Recent advances in crypto-
graphic techniques such as homomorphic encryption allow data to be processed
while being encrypted [Naehrig et al., 2011].
Building isolated information ecosystems that guarantee the highest levels of
security can be expensive. Also, present day security attacks are highly sophis-
ticated and isolation is a weaker form of security compared to other types of
security. Therefore, the ideal case would be to use security mechanisms at every
level of the technology stack and working with data where the identifiers, if not
all the data elements, are “hashed” to reduce the risks of identification by the
people who work with the datasets.
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Figure 4.8: Role of intermediate processors of health information in a health
system
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4.3.6 Increasing “Governance Readiness” in the Big Data
era through IPHIs
Big data processing has now become a core-functionality of many information
systems, well tested big data technology stacks are freely available. The majority
of big data analytic applications are focused on secondary use of data, delivering
insights that were previously unattainable using traditional processing methods.
Frequently, this type of data usage gives rise to concerns related to privacy and
ethics. The potential of developing massive clinical datasets that can leverage big
data techniques are discussed frequently in literature. Nevertheless, translating
these conceptual ideas in to practice is not a trivial task primarily due to the socio-
technical boundaries within organisations that often resist fusion of disparate
clinical data sets. We also find that real world systems often do not align data
quality and information governance with the objectives of the information system.
4.3.6.1 Architecting IPHIs to resolve Big “Health Care” Data issues
Earlier in this chapter, we presented the evidence base suggests that there are
three main use cases of big “health care” data. The sensitivity of health care
data has prevented the use of standard methods of big data processing in this
domain. Adopting “confidentiality” as an intrinsic property of the algorithms
used for big data processing has been recognised as primary need for realising big
data applications in the health care domain.
Within the health care digital ecosystems, IPHIs are primarily used for to
managing data semantics and data privacy of health care data for consumers
that mainly implement the data integration use case (Figure 4.4). Maintaining the
quality of data while connecting data sources with different levels of granularity is
critical to successful implementations of IPHIs. These requirements are illustrated
in Figure 4.9. The parallel layers of data and privacy/ethics provides a foundation
for a robust architecture that caters to the needs of the health care domain.
4.3.6.2 Discovering and understanding health care data sources
The health care eco-systems is complex and a continuous inflow of data from a
range of sources. There is a need for efficient methods of locating web based re-
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Figure 4.9: Requirements model for an IPHI
sources (including data sources) within connected digital ecosystems. The ability
to be discovered is a primary requirement for data sources to participate in inte-
grated care. A potential method is to build on shared markup schemas that can
be interpreted by search engines. Schema.org, a community based collection of
vocabularies, provides conservative extensions namely a hierarchy of MedicalEn-
tity classes for improving the discoverability of health and medical web content.
1 The schemas are used for annotating web-enabled data sources by means of an
agreed hierarchy of domain specific terminology.
Ontologies, introduced previously, provide a standard of describing health
data semantics. The widespread adoption of biomedical ontologies has improved
interoperability among health care datasets. Shared markup schemas and ontolo-
gies should be embraced by the medical informatics community to handle veracity
issues in big health care data.
1http://schema.org/
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4.3.6.3 Integrating non-health care data to facilitate studies for gen-
eral wellbeing
Beyond health care, we are able to find certain databases that can provide vital
data that can be used for assessing life style choices. Consumer buying pattern
integrated with health care sets can provide a basis for improved demographic
studies. This is a use case where health datasets can be integrated with non-health
dataset to perform data analytics that will benefit the average consumer. In the
food industry, results of such data analytics can provide early alerts of distribution
of diseases in livestock with relation to human disease patterns. Similarly, there
is potential to conduct studies on health benefits of organic vs factory farmed
meats. Data integration patterns of this nature could also link dietary patterns to
common health conditions (for example, consuming high sugar content with tooth
decay or long term conditions such as diabetes mellitus). At present public health
institutes do not advocate this form of patient-level linkage due to governance
restrictions. We for see that, such organisations could improve their governance
readiness by utilising secure data hubs similar to IPHIs to facilitate secure linkage
between patient level databases and frequent buyer schemes in the consumer
industry based on opt-in of patients.
4.3.6.4 Safe Havens for maintaining privacy properties of linked data
IPHIs have the potential to act as safe havens for merging sensitive data sets.
Datasets can be marked up and data analysis of the integrated data sets could
be performed only to output summarised data. This will model will encourage
patients to opt-in for studies that link personal consumer data to health care data
as described above.
We can broadly classify two patterns of secure data integration that can be
facilitated by IPHIs.
• Sensitive-to-Sensitive data integration (i.e. merging primary care data with
vaccine registries for burden of disease studies).
• Sensitive-to-Non-sensitive (i.e. primary care data with food purchase pat-
terns)
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4.3.6.5 Implementing trust models within IPIHs to harness cross-
border research
Integration of patient level data is a significant barrier to international health
care research. IPHIs setup at national level have the potential to act as brokers
of cross-border research initiatives. Trust models specified at local level can al-
low researchers widen the geographic scope of health studies by connecting to
international datasets through a local governance control mechanism. The dis-
tributed governance policies will reduce the time required for granting clearance
to support time critical studies such as disease outbreaks. Such increase of gov-
ernance readiness could boost support policy implantation at international level
(for example, EU health care directives, Vaccine monitoring across EU etc.).
4.4 Ontological support for governance and or-
ganisational readiness
Ontologies related to governance and privacy are commonly found in computer
science literature with respect to web data access and data privacy [DAWN &
Bodorik, 2005; Hassan, 2008; Jutla & Xu, 2004]. However, such ontologies are
less prevelant in health care literature.
An ontology has been developed for terminology associate with Person-Oriented
Virtual Organization (POVO), in initiative based in Spain to integrate all the re-
sources related to each citizen’s health-related data. In this system, the subject
is capable of actively controll access to personal data such as demographic data,
health, well-being, social condtions etc. [Calvillo et al., 2013].
In the context of European healthgrids, a ontological mapping from high-level
legislation on privacy and data protection to operational-level privacy-aware con-
trols has been conceptualised. This has been conceptualised to address conflicting
conditions among different national frameworks and also between different legal
and ethical frameworks within a single state [Rahmouni et al., 2010].
The HL7 version 3 standard includes an ontology specification related to se-
curity and privacy. 1 The ontology, which is in its initial release, can be used
1http://www.hl7.org/documentcenter/private/standards/v3/HL7 V3 SECPRONT R1 2014MAY.zip
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to name, define, formally describe, and interrelate key security and privacy con-
cepts in health care. The concepts that it represent include security policies,
privacy policies, consent directives, and access control policies. This ontology
is well aligned with Services-Aware Interoperability Framework(SAIF) objectives
allows to derive SAIF-specific application ontologies. The SAIF is the principle
component in HL7 that enables interoperability.
4.5 Publications associated with the chapter
Sections 4.1 and 4.2 report a study conducted in association with the IMIA Pri-
mary Care Informatics Group. These contents were published as “Liyanage H, de
Lusignan S, Liaw ST, Kuziemsky CE, Mold F, Krause P, Fleming D, Jones S. Big
Data Usage Patterns in the Health Care Domain: A Use Case Driven
Approach Applied to the Assessment of Vaccination Benefits and Risks.
Contribution of the IMIA Primary Healthcare Working Group. Yearb Med In-
form, Germany: 9 (1), pp. 27-35.” In this study, I conducted the literature
review and development of resulting big data use cases. I drafted the manuscript
for publishing this study.
A version of section 4.3 was published as “Liyanage H, Liaw ST, de Lusig-
nan S. Accelerating the development of an information ecosystem in
health care, by stimulating the growth of safe intermediate processing
of health information (IPHI). Inform Prim Care. 2012;20(2):81-6”. I con-
tributed to the development of the conceptual model of an IPHI and drafted the
manuscript.
4.6 Summary
Big data has brought forth a new breed of semantic interoperability challenges
mainly due to their scale and heterogeneity. There are recurring patterns of how
big data is used in health care. Novel uses of big data can bring new insight to
health care data by integrating datasets that have contrasting privacy levels (i.e.
patient level linking between health data and consumer data). Nevertheless, there
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are barriers in current governance procedures set out by health data custodians
that act as a barrier to engage in these novel research initiatives. IPHIs could
potentially act as an intermediary between sensitive and non-sensitive data to
realise such data analytics projects.
The development of the health care ecosystem and its associated IPHI should
be actively encouraged internationally. Such developments could help tackle
complex health issues such as how to reduce risks associated with alcohol and
how to carry out vaccine effectiveness monitoring. Governments, regulators and
providers of health care should facilitate access to health data and the use of
national and international comparisons to monitor standards. However, most im-
portantly they should pilot new methods of improving quality and safety through
the intermediate processing of health data.
Not everything in a data and information ecosystem is good. The creation of
processed data will include inaccurate and misleading data, so called information
pollution.
“Expansive nature of information ecosystems would tend introduce pollution, which
is the gap between information-rich and information poor entities in the ecosys-
tem.”[Capurro, 1990]
Our primary source of information, the Internet, presents us with a Data Smog;
making identification of credible information sources a challenge.
A health ecosystem will maximise use of data, and create new knowledge
and insights. However, within a health ecosystem, information processing and
integration should be regulated to ensure data integrity and privacy is maintained
between the sources and destinations of the orchestrated information flows. There
may need to be tolerance of imperfect processing, but not of privacy breach. IPHIs
could be the key to achieving the vision of making better use of health data and
to increase “Governance Readiness” as well as “Organisational Readiness” in a
sustainable manner.
78
4.6.1 Clinical perspective
Big data has revolutionised how clinical data is being analysed. The large volumes
of data available for analysis enables clinicians to take more informed decisions
about their patients. In terms of research, the greatest challenge is to build
novel datasets by integrating diverse heterogeneous data. Unfortunately, barriers
due to organisation contrasts and governance procedures are much greater than
technical barriers related to data analytics. The IPHIs proposed in this chapter
opens many doors for clinicians to engage in new ways of conducting research.
Their ability to act as trusted data hubs that maintain certain levels of privacy
increases governance readiness and organisation readiness (although the change
may not be at the source of the data). The various suggestions for conducting
novel data analytics will support clinicians to seek answers to more complex
problems in at a more rapid pace.
4.6.2 Informatics perspective
Most technical solutions related to the data integration patterns suggested are
feasible and can be obtained in a fairly economical manner, due to the low cost
of computing power and storage space. Due to the service orientated nature
of computing commodities, we no longer need to have dedicated computing or
storage devices. Big data processing can be done by leasing computing power
for a limited time. Nevertheless, the governance restrictions generally constrain
the use of service oriented computing commodities due to security restrictions.
The situation can be changed by having trusted hubs such as IPHIs to securely
process the data within a common infrastructure. This would mean that there
will be governance and organisation readiness that is implemented via the trusted
IPHI infrastructure to promote these new types of research.
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Chapter 5
Study-specific readiness
5.1 Introduction
Study requirements are an essential component of a successful research workflow.
This chapter presents an effective methodology for capturing study requirements
and corresponding ontological extensions that increase the readiness of this di-
mension of the readiness model.
Study readiness can be achieved by having relevant data which is of high qual-
ity. Access to other data such as demographic, laboratory results and imaging
results is equally important to achieve this same goal. However, if the require-
ments of the study are poorly defined this would cause to deviate from the goals of
the study at the very early stages. Whilst requirements analysis has its origins in
software engineering, the usefulness of using these methods in data-driven health
care projects has been well acknowledged. Nevertheless, health care professionals
and scientists who have a limited technical knowledge, often struggle to elicit
requirements of large projects dealing with complex databases. As a part of the
objective to create boundary spanning methods, we have developed a narrative
approach to develop use case that can be easily comprehended by non-technical
members involved in studies.
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5.2 Evidence-based narrative use cases
“Use cases” have been originally used to model systems and their interactions
in the discipline of software engineering. They tell a story of how a system and
its actors (those who engage in various interactions with the system) collaborate
to achieve a specific goal. Generally in information systems science and software
engineering these are developed as a series of diagrams. At the initial stages of
ADVANCE we understood that using unified modelling language (UML) repre-
sentations of use cases in this manner was challenging for clinicians and scientists
involved in vaccine benefits and risk research. We therefore developed an alter-
native narrative method for capturing study requirements.
The use case development (requirement analysis) within ADVANCE WP3 has
followed an adaptation of the requirements analysis method used in the TRANS-
FoRm project. The purpose of the method is to develop high level use cases by
abstracting details of various scenarios related to monitoring vaccine benefit/risk.
In TRANSFoRm, requirements of research studies were captured through a series
of reference models which included elements such as rich pictures, data flow dia-
grams, use case diagrams (developed according to the unified modelling language)
and business processes (using Business Process Model Notation). This methodol-
ogy has been adapted to suit the needs of the ADVANCE project. In the process
of these changes, the methodology evolved from a diagrammatic approach to a
narrative method.
5.2.1 Literature search
The use case development process was initiated by conducting a literature search
which involved identification of specific examples in literature which describe
processes related to the use case being developed. This method of use case de-
velopment does not require an exhaustive search to be conducted as study de-
signs frequently recurr as patterns. However, it is helpful to select a variation
of contrasting examples for the process to be successful. In order to leverage
the expertise available in the project, the majority of the literature used for use
case development has been selected based on recommendations of methodological
experts in work package dealing with methods in the ADVANCE project. The
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Figure 5.1: Evidence based approach for narrative developing use cases
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methodological experts were requested to recommend a diverse range (from a
data and study perspective) of literature. This enabled the team building use
cases to identify a comprehensive set of data and study requirements across a
series of vaccine study types: vaccine coverage, vaccine benefit, vaccine risk and
burden of vaccine preventable disease.
5.2.2 Development of use case instances
During this step, information from each publication identified during the litera-
ture search were used to develop a single use case instance description. A Use
case instance would therefore capture specific details about one of the four study
types mentioned earlier in to a document template. An example of a use case
instance is given in Figure 5.1.
A use case instance is an abstract representation of a specific study
that features data and methodological requirements. A collection of
use case instances will provide input for developing the generalised use
cases
5.2.3 Generalisation of use case instances
The use case instances developed contained sufficient information to highlight
generic scenarios encountered in the four types of vaccine studies. During the
generalisation process, study specific details are removed and the remaining in-
formation was used to generate a generic description of the area of focus. A
common template was utilised for creating the generalised use case to ensure that
the outputs are in a common format. The generalised use cases also included a
matrix containing elements of vaccine studies for the specific study type.
An inability to generalise a use case instance into a single pillar would suggest
it is misclassified or it is a new type of study (e.g. vaccine studies utilising big
data).
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Table 5.1: Example use case instance - Collection of routine national seasonal
influenza vaccine coverage data from GP practices in England
Use case instance ID UC-x.x (Example use case instance)
Use case
instance title
Gates P, Noakes K, Begum F, Pebody R, Salisbury D. Collection of routine
national seasonal influenza vaccine coverage data from GP practices in England
using a web-based collection system. Vaccine. 2009 Nov 12;27(48):6669-77.
Context GP Practices in the UK
Key methods Data survey, Web-based data collection,(ImmForm website),
Study description
Study focuses on a web-based system
for near real time data on influenza vaccine uptake in England. Data submitted
weekly by GP practices participating in the immunisation programme on a monthly
basis. Manual automated and semi-automated methods for submitting data is made
available.
Population includes all those aged 65
years and over and those under 65 belonging to a risk group (identified by
clinical codes on GP system)
Identified risk groups chronic heart disease, chronic respiratory disease, chronic renal
disease, chronic liver disease, diabetes, immunosuppression, stroke/TIA, chronic
degenerative neurological disease including MS
Data sources
GP Databases: (n=7980),(population=52,217,430),(duration= 5 months),Geographic
coverage: England
Actors
GP Practice, Primary care trusts, Strategic,health authority,
NHS England, Department of Health, Chief Medical Officer
(CMO) Health ministers and senior,policy officials
*
Stakeholder
interests
Timeliness (Real time monitoring)
Weekly or Monthly data uploads from GP practices,Data
available for reporting several days after being submitted.
Quality
Typically 50 % of 8315 practices
responded.,95%
of practices provide responses for each risk group specified
Support,input from study
design from manufacturers
No information
Auditability Data,is auditable and can be verified at practice level.
Trust,in data sources Data,is captured from the source and therefore accurate.
Data,governance
Data,governance policies control which data can be viewed at
specific levels of,the health care organisation (i.e. National Health
Services) e.g. Primary,care trusts can only view data of practices
managed under them.
Heterogeneous,data sources
There,are several types of GP systems in use. (EMIS,TPP etc.)
but provides a common,method of extraction across different systems.
Avoidance of conflict of
interest
-
Data,Security Data,is anonymised and uploaded.
6*
Research
questions
RQ-A-1,(Patient related )
Risk Groups(Yes- 8 risk groups defined: coronary heart
disease, chronic respiratory disease, chronic kidney disease,
chronic liver disease, diabetes, immunosuppression, stroke
/TIA, chronic degenerative neurological disease including MS)
/ Gender(Yes)/ Age(Yes- Age groups: 6 months 2 yrs;
2 16 yrs; 16 65yrs)
RQ-A-2,(Prog.
related )
Administrator Type (GP)
RQ-A-3,(Vaccine
exposure)
Brand of vaccine (No)/Type of vaccine (No)/
Batch/lot number(No)
RQ-A-4,(Time
related)
Calendar time of vaccination
RQ-B-1,(Patient
level data)
Data retrieval (Anonymised patient level data is available)
RQ-B-2(Aggregated data) Aggregated data is available.
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5.2.4 Elements of vaccines studies matrix
The elements of vaccine studies matrix conceptualises data requirements by pop-
ulation, exposure and outcome or equivalent for the other study types. This
division of grouping data is based on standard used in epidemiological study
designs. It considered a defined range of data elements per category (e.g. Pop-
ulation age, gender, ethnicity, etc. Exposure- vaccine provider, product quality,
etc. Outcome seriousness, frequency, etc.). For each use case the matrix was
completed with respect to the following questions.
(a) What elements should be captured in a database?
(b) What elements help identify data sources?
Question (a) related to the data requirements, while question (b) related to
data source selection. The elements considered in the matrix are given in Table
5.2.
5.2.5 Final specification of generalised use cases
The use case development can be an iterative process that will executed during
the life time of the project. From the context of vaccine studies, subsequent
iterations could consider the following additions based on high-level scoping of
literature.
• Repeated rapid literature review to add additional information to gener-
alised use cases
• Additional information obtained through synergies created with external
projects.
• Additional use cases:
– Use case for benefit-risk; and
– Use case for leveraging big data.
• New methods that are developed in methodological experts during the
course of the project
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Table 5.2: Elements of vaccine studies
Category Elements
Population
Age group
Gender
Ethnicity
Location (Country/Postal code)
SE status
Special population,
- Host immunity (e,g, pregnant, immunocompromised)
- Risk groups (e.g. traveller, prisoner, migrant, refugee,
military, health care provider)
Exposure
Program (Routine, seasonal, outbreak)
Provider (primary care, public health clinics)
Substance (single vs combination),or brand name
Date of administration
Product ID (Lot, expiry date)
Vial (monodose/multidose/pre-filled syringe)
Dose (high/low)
Dose in series (1st, 2nd, booster)
Application device (needle, needle free injection, spray)
Route of Application (intramuscular/ subcutaneous/
intravenous/ intradermal)
If injected, injection site
Live killed
Adj-nonadjuvanted
Construct
Previous vaccinations
Current/other medications
Outcome
Diagnoses
Date of diagnoses
Diagnosing Health Care Professionals (generalist v specialist)
Signs & Symptoms
Diagnostics (labs, other)
Extent (local/systemic)
Organ involvement (System Organ Class)
Frequency (rare, common)
Seriousness (death, life threatening, hospitalisation,
persistent, sequelae)
Severity (grade, scale)
Mechanism (immunologic, toxic)
Early/late- onset
Treatment for outcome
Pre-existing medical conditions
Concurrent illnesses/ treatment
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Figure 5.2: Process of building use cases
Figure 5.2 illustrates how the final use case specification is gradually built
starting from the initial extraction of study specific information from vaccine
studies.
Where a prototypical study (i.e. a use case instance) fits in to an existing
pillar (i.e. generalised use case) this will be where it is classified. Where they
do not, we would consider developing additional pillars. New pillars defined will
need to be validated through expert opinion. Benefit-risk studies may be a new
pillar- but it is also conceivable that we may create an aggregated studies pillar
to include data chosen from two or more pillars (e.g. burden of disease from
populations with partial vaccine coverage).
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5.2.6 Instrument for critical appraisal of narrative use
cases
The development of use cases is an iterative process and therefore, receiving feed-
back through critical appraisal, during each iteration use case development, is
important for optimising the output. We developed an instrument for evaluating
use cases and referred to it as the “Use Case Score Sheet”. This was developed
based on the “AGREE II (APPRAISAL OF GUIDELINES FOR RESEARCH
EVALUATION II)”, a tool for assessing the quality and reporting of practice
guidelines. The changes done during the adaptation of this instrument are spec-
ified in Table 5.3.
The critical appraisal of use cases was carried out by representatives of each
stakeholder group including health professionals, academia, regulatory authorities
and pharmaceutical industry representatives. This allowed the use cases to be
reviewed from a different perspectives of the vaccines domain. Each reviewer
reviewed each use case and indicated their score from a scale of 1 to 7 which
corresponds to strongly disagree to strongly agree respectively. In addition to the
rating, an additional column was added to this scoring sheet to capture optional
comments regarding each item. When analysing results, a domain score was
calculated by totaling the value of the rating given by each reviewer.
5.2.6.1 Calculating domain scores to assess quality
The domain scores for a use case will be calculated by summing the score given
by each appraiser for each domain. The final score is given as a percentage of the
maximum score possible for each domain.
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Table 5.3: Adaptation of AGREE II to use case appraisal method (“Use Case
Score Sheet”)
Adapted AGREE
II Domain
Domains and items implemented in
Use Case Appraisal Method
Scope
and purpose
Scope and purpose
1.The overall objective(s) of the use case is well defined.
2.Related actors in the use case has been identified.
3.The scenarios and variations in the use case are well defined.
4.Methods used for the use case have been identified.
5.Outcomes of the use case have been identified.
6.Exposures of the use case have been identified.
7.Populations relevant to the use case have been well defined.
8.Stake holder interests have been clearly expressed.
9.Use case diagram represents the use case well.
10.Elements of vaccine studies matrix,for the given use
case clearly represent the specific data requirements.
Stakeholder
involvement
Not implemented
Rigor of
development
Rigor of development
11.Systematic methods have been used for developing the
use case.
12.Evidence selected has comprehensive coverage of the use case.
13.The strengths and limitations of the body of evidence are clearly
described.
Clarity of
presentation
Clarity of presentation
14.Use case has been documented in sufficient detail.
15.All aspects of the use case have been considered.
16.Data related to the use case have been clearly identified.
Applicability Not implemented
Editorial
independence
Not implemented
Overall Guideline
Assessment
Overall Guideline Assessment
17.Rate the overall quality of this use case.
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Table 5.5: Example calculation of total score for use case
Domain 1 Domain 2 Domain 3 Domain Total
Appraiser 1 6 7 6 19
Appraiser 2 7 6 5 18
Appraiser 3 5 4 6 15
Total 18 17 17 52
Example calculation:
Assuming that the quality assessment was conducted across 3 domains by 3 ap-
praisers:
Maximum possible score = 7(strongly agree)× 3(domains)× 3(appraisers) = 63
Minimum possible score = 1(strongly disagree)× 3(domains)× 3(appraisers) = 9
Quality score =
(Obtained score−Minimum possible score)
(Maximum possible score−Minimum possible score) × 100
Quality score =
(52− 9)
(63− 9) × 100 = 79%
(5.1)
The initial technical requirements analysis resulted in the development of four
generalised use cases. In addition, to developing the methodology for building
narrative use cases, I followed the described process to build use cases for vaccine
coverage studies and burden of vaccine preventable studies. To demonstrate the
nature of the output of this development process, the generalised use case for
vaccine coverage is given next.
5.3 Generalised Use Case for Vaccine Coverage
Immunisation programmes across the EU demonstrates a variation in terms of the
vaccines offered, number of doses given and the timing of vaccine administration.
This variation makes monitoring of vaccine coverage complex beyond national
level. This document intends to generalise the different aspects of vaccine cov-
erage and uptake based on a selection of evidence from published literature. We
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have extracted the salient features of these studies and presented the generic fea-
tures to build a basis for developing an instrument for identifying vaccine data
sources.
5.3.1 Literature selection used for generating the use case
1. Annunziata K, Rak A, Del Buono H, DiBonaventura M, Krishnarajah G
(2012) Vaccination Rates among the General Adult Population and High-
Risk Groups in the United States. PLoS ONE 7(11): e50553. [Context:General
adult population and High risk groups in the United States][Methods
used:Internet based survey]
2. Bonanni P, Bechini A, Boccalini S, Peruzzi M, Tiscione E, Boncompagni
G, Mannelli F, Salmaso S, Filia A, Ciofi degli Atti M. Progress in Italy
in control and elimination of measles and congenital rubella. Vaccine.
2007 Apr 20;25(16):3105-10. [Context:Child and women population in
Italy][Methods used:Surveillance data analysis]
3. Borrs E, Domnguez A, Batalla J, Torner N, Cardeosa N, Nebot M, Plasen-
cia A, Salleras L. Vaccination coverage in indigenous and immigrant children
under 3 years of age in Catalonia (Spain). Vaccine. 2007 Apr 20;25(16):3240-
3. [Context:Child population (indigenous and immigrant) in Catalonia][Methods
used: Retrospective cross-sectional descriptive study, telephone survey]
4. Braeckman T, Lernout T, Top G, Paeps A, Roelants M, Hoppenbrouwers
K, Van Damme P, Theeten H. Assessing vaccination coverage in infants,
survey studies versus the Flemish immunisation register: Achieving the
best of both worlds. Vaccine. 2014 Jan 9;32(3):345-9.[Context:Infant im-
munisation coverage in Flanders, Belgium][Methods used:Corhort study,
Comparison of coverage rates estimates generated from web based system
vs surveys]
5. Stampi S, Ricci R, Ruffilli I, Zanetti F. Compulsory and recommended vac-
cination in Italy: evaluation of coverage and non-compliance between 1998-
2002 in Northern Italy. BMC Public Health. 2005 Apr 21;5:42.[Context:Infant
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immunisation coverage in Bolognia, Italy]
6. de Melker HE, van den Hof S, Berbers GA, Conyn-van Spaendonck MA.
Evaluation of the national immunisation programme in the Netherlands:
immunity to diphtheria, tetanus, poliomyelitis, measles, mumps, rubella
and Haemophilus influenzae type b. Vaccine. 2003 Jan 30;21(7-8):716-
20.[Context:Immunisation of national population of Netherlands][Methods
used:Serological surveillance]
7. Wright JA, Polack C. Understanding variation in measles-mumps-rubella
immunization coverage-a population-based study. Eur J Public Health.
2006 Apr;16(2):137-42.[Context:Population of United Kingdom][Methods
used:Stepwise regression, spatial autocorrelation]
8. Rondy M, van Lier A, van de Kassteele J, Rust L, de Melker H. Deter-
minants for HPV vaccine uptake in the Netherlands: A multilevel study.
Vaccine. 2010 Feb 25;28(9):2070-5.[Context:Specific female population in
Netherlands][Methods used:Descriptive analyses, multilevel, logistic re-
gression model ]
9. Theeten H, Hens N, Vandermeulen C, Depoorter AM, Roelants M, Aerts M,
Hoppenbrouwers K, Van Damme P. Infant vaccination coverage in 2005 and
predictive factors for complete or valid vaccination in Flanders, Belgium:
an EPI-survey. Vaccine. 2007 Jun 21;25(26):4940-8.[Context:Infant vac-
cination coverage in Flanders, Belgium][Methods used:EPI-survey, Face-
to-face interviews, Logistic regression, Non-parametric analysis]
5.3.2 Description of Actors
We have identified key actors (Table 5.6) it is important that these groups and
categories are used as defined and distinct new groups are created in a controlled
manner.
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Table 5.6: Actors participating in the vaccination coverage use case
Actor Category Actors (examples)
Public health authorities
National Health Services, Disease control and prevention organisations,
National advisory committees on immunisation, Health Authorities,
Ministry of Health, Schools, Primary Care Organisations, Vaccine Register,
Regulatory
agencies
European,Medicines Agency, National Competent Authorities (NCA)
Health care professionals General practitioners , Nurse
Industry Pharmaceutical Company, Health insurance providers
Academia Research group, Researcher
Consumers Children , Parent/Carer
5.3.3 Scenarios
The information produced/consumed in vaccine studies vary based on a number
of factors.
5.3.3.1 Variations based on geographical setting (e.g. Regional, mul-
tiple countries etc.)
Vaccine Coverage at Regional Level
• Dynamics of data acquisition and exploration are less complex at regional
level. The data available generally falls under a single health administrative
authority. This would result in less restriction in terms of information
governance.
• A possible consideration at a regional setting is the effect of the population
that can move across regions. This needs to be addressed in a case by case
basis.
Vaccine Coverage at National Level
• Data acquisition may be more complex than at regional level based on the
administration structure of the health authorities (unless national registers
exists). If data is not integrated across the country, this may include addi-
tional information governance permission to be taken based on the sources.
• Registers for immunisation are generally maintained at a national level. In
addition, other statistics are obtained at national statistics institutes.
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Vaccine Coverage at Multinational Level
• Data acquisition across borders is complex due data sharing legislations
that have been specified at a national level.
5.3.3.2 Data collection methods and data sources
Data for vaccine coverage studies are either obtained specifically for studies or
obtained by extracting exiting databases/data sources.
Data collection specifically for studies
• Face to face or telephone interviews of vaccinees/ parents
• Obtaining data from vaccination records held by vaccinees
• Online surveys
Data extracted from existing databases/ data sources
• National birth and immunisation registers
• Primary care database Integrated
• Primary care databases Extracting data from individual practices
• Secondary care databases
• Infant clinics/ Outpatient clinics
5.3.4 Methods
5.3.4.1 Administrative methods
Immunisation coverage can be assessed through reporting of the number of doses
administered to a target population. The target population can vary depending
on the immunisation schedules defined by the countries health policy. Adminis-
trative methods involve the use of databases and immunisation registers as data
sources. Coverage estimated using the administrative method can be biased due
to under estimated numerators due to reporting inaccuracies. Furthermore, this
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type of assessment is affected by movement in population and inaccurate census
estimates. National immunisation programmes mainly target children and special
risk groups. Administrative method examples:
• Aggregate number of vaccines administered
• Aggregate collection of number of vaccines distributed
• School or day care records
• The number of subjects vaccinated
5.3.4.2 Immunisation coverage surveys
Surveys provide a method of verification of coverage rates with respect to rates
determined by administrative methods. Surveys have the added benefit of being
a mechanism to collect additional data in order to conduct extensive analysis of
coverage (e.g. socio-economic indicators). The frequency of data collection varies
from quarterly to 5 years in different EU countries. Key methods used for
surveys
• EPI cluster surveys
• Multiple Indicator Cluster Surveys (MICS)
Examples of survey types:
• Household surveys
• Telephone interviews
• Mail surveys
• Face to face interviews
• Focus groups
• School surveys
• Internet surveys
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5.3.5 Outcomes
Vital parts of any such research are the outcomes relevant to the vaccine benefits-
risk pillar being investigated. For example, vaccine preventable disease may only
have a descriptive outcome; vaccine uptake may have descriptive and process out-
comes. Research into benefits or risks may have outcomes which are descriptive,
related to process, or of interventional studies with true or surrogate outcome
measures.
5.3.6 Exposure
The main type of exposure are individual vaccination and vaccination programmes.
In addition details such as vaccine schedule, age at vaccination, vaccine batch in-
formation, vaccine provide details can be considered. Such data may be complete
(with full details) or partial records; based on health care professional or vaccine
consumer information.
5.3.7 Population
Obtaining the denominator of the study population is important for vaccine cov-
erage studies. This may not be found in the data source used for the study. In
such cases it is necessary to utilise other data sources that have the denominator
data (i.e. census statistics).
Vaccination coverage data for special risk groups
• Clinical risk groups (e.g. patients with autoimmune disorders)
• Health care workers
• Migrants
• Refugees
• Ethnic minorities
• Population sub groups
• Homeless
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• Socially and economically disadvantaged
• Elderly
• Children
• Pregnant women
Factors such as age and gender are also essential for coverage studies.
5.3.8 Stakeholder interests
5.3.8.1 Public health authorities
Coverage rates of immunisation are of primary interest of public health authori-
ties. They are also interested in tools for proactive and long-term evaluation of
vaccine benefit/risks during its life-cycle. Data allowing to estimate/demonstrate
impact and economic benefit of vaccination and possibly pharmacogenetic studies
to guide vaccination of special populations are also relevant to PH authorities.
5.3.8.2 Regulatory agencies
Vaccine coverage data is essential for regulatory authorities for conducting phar-
mocovigilance. Stratification by age and sex is useful for these monitoring activ-
ities.
5.3.8.3 Patients and health care professionals
These stakeholders are interested in vaccine coverage in general population and
benefit/risk of vaccination with the intention of improving public trust.
5.3.8.4 Industry
Stakeholders from the industry are interested in vaccination coverage to under-
stand the uptake of vaccine products. They are interested in exploring additional
data sources and methods that will enhance coverage assessment and vaccine
utilisation patterns and pharmocovigilance.
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5.3.8.5 Academia
This stakeholder group is interested in the following aspects.
• Measurement of vaccine uptake by relevant variables such as age groups
• Development of use cases and requirements analysis to assess data sources
ability to participate in project, in particular for vaccine coverage/uptake,
vaccine benefits and vaccine safety.
• Rapid access to data
• Identification of sustainable resources for collaborative studies, incl. infras-
tructures and training personnel in each centre, quality control, fingerprint-
ing and mapping of data
• Mechanisms to access updated data from registers and databases.
5.4 Using ontologies to improve study-specific
readiness
The importance of having ontological extensions for formally representing study
requirements can only be understood when considering the bigger picture that
includes interactions between ontologies across different dimension of the research
readiness model. In this case we specifically, focus on possible interactions be-
tween the data source ontology and an ontology representing study requirements.
From a knowledge engineering perspective, the collection of metadata rep-
resented in the data source acts as a knowledge base for the study require-
ments ontology which acts as a query object having a compound set of query
parameters. Following a similar approach used for developing the data source
ontology, we created a study-requirement ontology to formally represent study-
requirements. Since these ontologies are being developed with reference to the
ADVANCE project, we have named the formal representation as a POC Study
ontology (Proof of Concept). The entity hierarchy of the POC Study ontology is
given in Figure 5.3.
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Figure 5.3: Entities in the POC Study ontology
Figure 5.4: Data properties of the POC Study ontology
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Figure 5.5: Property associations of the individual POC Study: InfluenzaPOC
The data properties are given in Figure 5.4. As an example we have demon-
strated representation of an individual POC study (i.e. InfleunzaPOC) through
data property assertions (Figure 5.5).
The complete ontology is available at: https://github.com/harshanal/ontologies
5.5 Reports associated with the chapter
The use cases presented in this chapter were a part of Deliverable 3.1 of the
ADVANCE project titled -“Technical Requirements & Use Cases”. I was
responsible for developing the methodology for developing narrative use cases
and the critical appraisal tool used for validating use cases. I also developed the
vaccine coverage use case which is featured in this chapter.
5.6 Summary
Understanding study-requirements is essential for conducting successful research
projects. This chapter presented an evidence-based methodology for building
narrative use cases. The use case development process has been simplified and
does not involve any technical diagrams to represent use case. The new approach
was well received by vaccine experts and clinicians in the ADVANCE project and
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there was a high-level of engagement from them during the technical requirement
process. Furthermore, we ensured that the use cases developed were practically
useful for informing the subsequent research activities. The appraisal tool devel-
oped provided a method of formally evaluating the use cases by representatives
from different stake holder groups involved in the project. This ensured that the
quality of the use cases were acceptable for all stakeholders in general.
5.6.1 Clinical perspective
The use case methodology presented in this chapter is easier to work with than
more technical UML artifacts proposed in the earlier stages of the project. Start-
ing the development process from a literature review ensured that use cases had a
robust foundation to build upon. The critical appraisal tool provided mechanism
to get feedback from people from diverse background in order to clearly validate
the suitability of the research outputs.
5.6.2 Informatics perspective
Despite being useable for the non-technical users, due to narrative nature the use
cases developed did not provide the ideal foundation for conducting a technical
requirement analysis. However, the elements of vaccine studies matrix was able
to compensate for this lack of structure by giving a well defined set of data re-
quirements based on principles of the vaccine domain. The study-requirement
ontology allowed linking the knowledge captured by the data source ontologies
with requirements of specific studies. The ontology development will be followed
by developmemt of semantic queries (using SPARQL semantic query language)
to automate the process of selecting the best data sources that match the require-
ments of a given study.
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Chapter 6
Patient Readiness
6.1 Introduction
Better patient engagement in research leads to robust research outcomes. This
chapter explores informatics factors that improves readiness for patients to par-
ticipate in research. It also examines the evidence for the ontological approaches
for enhancing patient involvement in research.
Most technology we frequently use as individuals (i.e. smart phones, web
browsers) are personalised to cater to our specific information needs. The growth
of Internet services, the infrastructure that hosts them, and the associated tech-
nologies have enabled us to transmit and store virtually all data being produced
in our personal lives. This has led to a paradigm shift on how information is
processed and utilised in most information domains including health care.
The US Institute of Medicine has highlighted well-designed information sys-
tems as key supports in the delivery of patient-centred care [Bloom, 2002]. The
availability of patient electronic data has revolutionised health care in many posi-
tive ways, although it can also be seen as an obstacle for the personalised approach
necessary in patient-centred care [Finkelstein et al., 2012]. Big data technologies
have now matured and laid a platform for patient centred care to be taken to the
next level. Nevertheless, harnessing novel informatics techniques should be done
strategically without impeding the relationship between the health care provider
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and the patient [Martin & Felix-Bortolotti, 2014].
6.2 Methods
This paper will explore the question of whether informatics enables or inhibits
the delivery of patient-centred, coordinated, and quality-assured care. This study
involved a literature review followed by a thematic analysis of literature and a
three-round consensus panel involving a group of international experts in the
subject.
6.2.1 Literature review
We carried out a literature review to identify published research work related
to patient-centred care. We have searched PUBMED/Medline, Scopus, Web
of Science, CINAHL and the Cochrane Database for publications related to
this topic. The search terms used included ”patient-centred care” (or ”patient-
centered care”) and ”informatics”.
An overview of the literature review is given in the adapted PRISMA flow
chart shown in Figure 6.1. Research papers published between January 2000 and
November 2014 were taken into consideration. We limited the literature search
to publications written in the English language.
The initial search results yielded 817 publications, which was then reduced to
128 for the final in-depth review. The literature was mapped to the four themes
identified during the consensus development process described in the next section.
Certain publications were mapped to multiple themes. We identified the health
care setting and technical focus for each of the papers reviewed. The Primary Care
Health Informatics Working Group has been researching on ontological methods
to improve semantic interoperability in various health care settings [Liyanage
et al., 2013b]. Therefore, we also searched for evidence for using ontological
approaches for enhancing patient centred care.
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Figure 6.1: Adapted PRISMA flow diagram
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6.2.2 Consensus exercise
We engaged the Primary Care Health Informatics Working Groups of the Euro-
pean Federation of Medical Informatics (EFMI) and the International Medical
Informatics Association (IMIA) by conducting a three-round consensus develop-
ment process. The process involved consulting an international panel of five clin-
icians and 15 informatics experts from six countries including Australia, Canada,
Croatia, Spain, South Africa and United Kingdom.
a. Round 1: Identifying informatics factors enabling/inhibiting patient-
centred, coordinated and quality-assured care
The initial round intended to explore how the use of computerised medical
record systems at the point of care (i.e. using a computer in a doctors office con-
sultation) changes the delivery of patient-centred care. We invited the panel
to list enablers and inhibitors of delivering patient-centred, coordinated, and
quality-assured care. This round was conducted in the form of an online sur-
vey instrument. It was an inclusive round seeking to identify key issues related to
the research topic. When analysing the responses from this round we were able
to distinguish issues across four distinct themes (Figure 6.2)
1. Computerised medical record (CMR) systems: Factors focusing on
the functionality and clinical decision making tools available to the clinician
within the computerised medical record system. Similar terminology for
this theme includes Electronic Health Record (EHR), Electronic Medical
Record (EMR) or Electronic Patient Record (EPR).
2. Patient communication and engagement:Factors focusing on the en-
gagement of patients with their online medical record, and on the limitations
or advantages of communicating clinical concepts to patients effectively via
an electronic medium.
3. Health care provider communication and information sharing:
Factors focusing on the integration of workflows and safe sharing of data
across different health care providers, for the purpose of providing coordi-
nated care to patients.
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4. Standards and quality: Factors focusing on the use of informatics for
surveillance and other quality monitoring activities in health care, and on
the necessary training and support for clinicians to use informatics effec-
tively.
Figure 6.2: Four themes of informatics factors affecting patient-centred coordi-
nated care
The suggested issues were then used to develop consensus statements for
Round 2.
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b. Round 2: Rating of statements using the RAND/UCLA appropri-
ateness method
The second round of the study was focused on achieving consensus about the
appropriateness of the issues identified in the initial round. We enquired about
the appropriateness of each statement developed using the responses of Round 1.
Twenty-seven statements across the four themes were included in this round. We
achieved 75% response rate from the panel for this round. The list of statements
is given in Box 2; this round was also conducted using an online survey instru-
ment. We replaced the standard terms used in the UCLA/RAND appropriateness
scale, Highly inappropriate and Highly appropriate, with Strongly disagree and
Strongly agree to improve the usability of the instrument.
Statements used for Round 2
A. Computerised medical record (CMR) systems
Enabling factors
1. Accurate and complete data on patient circumstances, health, and health
care is available in the CMR to aid the clinical decision making process.
2. Use of electronic clinical decision support, with strong international, con-
temporary evidence base.
3. Easy access to relevant and appropriate health care delivery using the CMR.
4. User friendly and functional information systems/ CMR are essential in the
delivery of patient-centred quality-assured care.
Inhibiting factors
6. Paper based communication between medical carers is still commonly used.
7. CMR systems that are not user friendly, or which have poor functionality,
that detract from efficient care delivery.
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8. Looking up clinical terminological terms for recording patient details is
inefficient when using a CMR system.
9. CMR systems are in constant change, and it is difficult for clinicians to keep
up-to-date on how to use them.
B. Patient communication and engagement
Enabling factors
10. The use of technology allows the engagement of patients in the clinical
decision-making process.
11. Individualised advice and education for the patient is facilitated by a com-
prehensive and structured electronic medical record.
12. Providing patients with access to their own computerised medical record
(CMR) online can help with engagement and effective communication.
13. The CMR system can facilitate communication, by using accessible lan-
guage in explaining clinical concepts.
Inhibiting factors
14. Low health literacy in patients could result in online access to their com-
puterised medical record being irrelevant or even detract from care. Low
patient engagement often poses an obstacle in involving patients in the
clinical decision-making process.
15. The interruptions in the consultation resulting from recording data in the
CMR system can detract from effective communication with patients.
C. Health care provider communication and information sharing
Enabling factors
17. The sharing of the CMR across health care providers can enable integrated
patient-centred care.
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18. The interoperability of CMR systems allows for the coordination of care
across multiple health care providers.
19. The safe sharing of electronic patient data to ensure patient confidentiality
is maintained is a priority in patient-centred care.
20. The CMR system allows informational continuity, which in turn is key in
ensuring the best quality of care is provide.
Inhibiting factors
21. It is difficult to merge different workflows from various health care providers
into a single integrated workflow for clinical decision making.
22. There may be resource conflicts between health care providers, which im-
pede the coordination of care.
23. Different CMR systems often result in silo working across health care providers,
rather than coordinated care.
D. Standards and quality
Enabling factors
24. The use of the CMR system can lead to clear standards for coding of key
clinical data, and these data can be used to ensure quality-assured care.
25. Where patient data are readily available this facilitates regular audits of
indicators of quality of non-communicable diseases (especially long term
conditions).
Inhibiting factors
26. The use of the CMR systems requires clinician competence and this is dif-
ficult to achieve.
27. Health professionals are time poor, and the use of CMR system requires a
large time investment in training and education .
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28. There are low levels of investment in the equipment and education needed
to ensure that CMR systems are used routinely .
c. Round 3: Discussion of findings by expert panel
The final round of the consensus process was conducted in the form of an
online panel discussion. Two separate online meetings were organised, in order
to engage panel members in different time zones. The results of the two initial
rounds were communicated to the expert panel, and this acted as a basis for these
discussions. The feedback received was incorporated to the discussion section of
this paper.
6.3 Results
The results of the literature review were mapped on to the four themes (results
shown on Figure 6.3). Although some papers referred to multiple themes, the ma-
jority of the papers focused on CMR systems, particularly on studies evaluating
the effectiveness of using a clinical decision support tool on the health outcomes of
patients [Chawla & Davis, 2013; Klinkman & van Weel, 2011; Ruland & Bakken,
2002; Ruland et al., 2007]. The second most common theme across the literature
was that of patient engagement and communication; a common topic within was
the use of online patient portals to communicate complex clinical information to
patients clearly and succinctly and engage them in self-management [Archam-
bault, 2011; Ricciardi et al., 2013; Weiss et al., 2013].
Papers focusing on health care provider communication and information shar-
ing were less common, and their focus tended to be across building effective health
care models to support coordinated workflows across different providers [Samal
et al., 2013; Velianoff, 2014]. Finally, the least common papers were those on
standards and quality, and the focus tended to be on clinician education and
training to use informatics appropriately [Brown et al., 2011; Wald et al., 2014].
The health care setting varied, but primary care and nursing were emphasised
as informatics provides essential supports to general practitioners and nurses
[Krist et al., 2014]. Further, patient-centred medical homes, which will be ex-
panded on in a later section, were a setting often studied in the papers reviewed
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Figure 6.3: Number of publications mapped to the four identified themes (Note:
certain results map to multiple themes)
(Figure 6.4). The technical focus of the papers was mostly on building the or-
ganisational infrastructure necessary for integration (Figure 6.5).
The degree of consensus for the statements is summarised in Figure 6.6. The
panel of experts strongly agreed on 15 statements, while 9 statements were con-
sidered to be equivocal. There were 3 statements with which they disagreed.
Within the RAND/UCLA method non-agreement does not denote that the ex-
perts considered the statements inappropriate, but rather that opinions differed.
The panel tended to agree on the technical advantages and limitations of the
CMR system itself. The equivocal statements mostly focused on the level of
patient engagement and the improved access to information. Finally, the state-
ments where the panel disagreed on referred mostly to the clinician-computer
interaction.
The key messages found on both the literature review and the consensus
exercise, divided across all four themes and ontological approaches, are described
next.
6.3.1 Information systems/computerised medical records
The nature of the CMR system and any associated clinical decision-making sup-
port tools are essential in the delivery of effective patient-centred care. Poor
112
Figure 6.4: Word cloud for health care setting mentioned in publications anal-
ysed)
Figure 6.5: Word cloud for technological focus mentioned in publications anal-
ysed)
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Figure 6.6: Word cloud for technological focus mentioned in publications anal-
ysed)
functionality of the CMR system has been cited as a key obstacle in usability
by health care providers[Finkelstein et al., 2012]. Conversely, the availability of
strong evidence-based clinical decision-making support tools allows clinicians to
enhance the quality of patient-centred care [Chawla & Davis, 2013].
These support tools have an increasingly high relevance in a context where
the patient to health professional ratio becomes larger, which may lead to poor
decisions where less time has been spent with the patients, and not all of the
necessary information has been obtained. The use of informatics embedded into
clinical decision-making support tools can summarise key patient data and make
recommendations to the health professional using a strong evidence base.
6.3.2 Patient communication and engagement
A key consideration in the use of a CMR system in medical consultations is
the communication and engagement with the patient. The use of the electronic
tool might deter from effective communication with the patient [Gonzales et al.,
2013], although the various online channels can encourage the patient to engage
in self-management [Krist et al., 2014; LeRouge & Wickramasinghe, 2013]. This
is, of course, highly dependent on the computer literacy of the patients and their
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willingness to engage with self-management tools outside of the traditional health
care channels [Adler-Milstein & Cohen, 2013].
A key health care setting found in the literature was the patient-centred medi-
cal home (PCMH), since this is a realm where the enabling force of informatics in
delivering patient-centred care is most evident [Kraschnewski & Gabbay, 2013].
This is a key reform of the primary care system, which has occurred mostly in the
United States, and which has a number of core principle around providing inte-
grated and well-planned care, as well as engaging the patient in self-management.
Although informatics is seen as vital for the functioning of these settings, it is
thought that many of the currently available technologies do not fully provide the
high level of integration and coordination necessary for the aims of the PCMH
[Adler-Milstein & Cohen, 2013].
6.3.3 Health care provider communication and informa-
tion sharing
The sharing of patient data across health care providers allows the opportunity
to approach health care from the patient perspective. As the person-centred
approach suggests, the spheres of care surrounding the patient should be jointly
involved in the management of the patients health [Kraschnewski & Gabbay,
2013]. Although the data across providers may be integrated, there may be
difficulties in the integration of the differing work flows [Ozkaynak et al., 2013;
Saleem et al., 2013].
As mentioned before, the PCMH is a setting that most appropriately harnesses
informatics in delivering patient-centred care. The key advantage of the PCMH
is that there is a high degree of integration and coordination across the health
care providers that surround the patient. While informatics is unable to generate
an integrated workflow, once this organisational reform occurs, it becomes an
essential support tool that facilitates the integration [Daaleman et al., 2014].
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6.3.4 Standards and quality
Electronic patient records allow for key data that can be used in the monitoring
of chronic conditions [Chawla & Davis, 2013], drug adherence and adverse effects
[Dixon et al., 2014a], among others. Data quality presents itself as a major issue
[Finkelstein et al., 2012]; further education and training of health care profession-
als and their support staff is needed, in order to ensure that data quality and
use meet the necessary standards to deliver effective patient-centred care [Brown
et al., 2011; Wald et al., 2014].
The field of nursing informatics has been developed around the need of bring-
ing informatics closer to a profession which involve a high degree of patient-
centred care [Staggers & Thompson, 2002]. Especially in an acute care setting,
where a high degree of monitoring patients with complex conditions is required,
real-time and easy to use informatics tools become an essential support. Emerg-
ing technology has been viewed as a solution to compensate for the globally trend
of increasing nurse to patient ratio [Duffield et al., 2011]. Furthermore, nurses will
need to develop new skills to ensure that emerging technologies are use effectively
without compromising patient safety [Huston, 2013].
6.3.5 Ontological approaches to support patient centred
care
In a previous article produced by the Working Group, we reviewed evidence
for the use of ontologies and other semantic integration methods to achieve se-
mantic level interoperability across disparate health systems [Liyanage et al.,
2013b]. However, from the perspective of patient-centred care, we found only few
instances where ontological approaches have been leveraged. A review on im-
plementation challenges for process-oriented, patient-centred health information
systems found a general trend of adopting formal, clinical, and organisational
ontologies, and the use of workflow management systems [Gooch & Roudsari,
2011]. There is also evidence for using ontological approaches for representing or-
ganisational and situation-specific work patterns and practices to facilitate cross-
boundary decision support [Tawfik et al., 2012]. Despite the limited number of
ontological applications, we recognise that there is widened scope for the use of
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ontologies to link the big data generated by wearable devices and other sensors
attached to patients with other health care systems [Liyanage et al., 2014].
6.4 Discussion
Though the key messages by theme were rather varied, most of them supported
the role of informatics in the delivery of patient-centred care. It is acknowledged
that informatics merely acts as a support on the clinical decision making process,
but it cannot solely achieve the goals of patient-centred care. In principle, the
role of informatics is recognised as positive, but the operational details of how to
implement it effectively are still subject to discussion. Clinicians agreed on the
strengths and limitations of existing CMR systems in providing data. There was
no agreement as to how CMRs might best improve access health information and
improve engagement in their care. There was disagreement about what limited
and how to overcome barriers to clinicians using their CMR system effectively.
The nature of the information systems, and the technical details associated with
this, are largely uncontroversial. However, there was wide disagreement regard-
ing the integration of workflows and implementation, particularly across different
contexts. It was highlighted that the level of support and training, and the inter-
operability across systems varied drastically depending on the country and the
health care setting. Moreover, clinicians and non-clinicians had differing views on
a number of statements, particularly focused on the implementation. Clinicians
had stronger views on patient engagement, as they are in direct contact with pa-
tients, and were able to assess the impact of informatics on patient engagement
more directly. Some criticisms of informatics, such as the distraction of having
to record the data, were accepted to be existing issues of medical practice, which
were actually mitigated by the ease of use of some computer systems. Overall,
it was widely accepted that informatics has a positive impact on patient-centred
care, but the implementation differs across contexts.
The positives and negatives of the CMR system to support care appeared
limited by data quality and the level of semantic interoperability between data
silos. Coordination should not necessarily be based on a single record system,
but rather a full integration of different workflows into a patient-centred frame-
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work.Clinicians may need different types of support to encourage more and better
computer use. This is highly dependent on context, particularly on the infras-
tructure and training available, and on the specialism of the clinician. Further
consultation with clinicians is needed to understand how the clinician-computer
interaction happens and where are key interventions needed to improve this pro-
cess. Quality improvement trials are needed to demonstrate how access to health
information or computer mediated consultations results in improved outcome.
The results from these trials will give a precise indication of the characteristics
of the local system, which can serve as the foundation for a strongly-evidenced
implementation strategy of informatics in the local system, with the aim of pro-
viding patient-centred quality assured care.
A systematic review about how health information technology enables patient-
centred care produced a substantial evidence base confirming health information
technology applications across a series of components, ranging from health care
processes to patient satisfaction [Finkelstein et al., 2012]. Another review on the
role of informatics in patient centred care identified cost, access to and comfort
with technology, privacy and security, health literacy, feasibility, and social in-
equality as the key barriers of facilitating better interactions between health care
providers and patients [Snyder et al., 2011]. In addition to these, there are a num-
ber of reviews which are focused on specific themes of patient-centred care. A
systematic review on patients’ online access to their electronic health records and
linked online services suggested business processes to be redesigned to effectively
engage health professionals with patients through the online services [de Lusignan
et al., 2014]. However, there is no clear evidence that indicates improvement of
the quality of medical reports due to patient access [Davis Giardina et al., 2014].
The disagreements might have reflected the different health systems that the
contributors worked in, rather than fundamental disagreements on the state-
ments. Contributors highlighted that two-part statements may have generated
equivocal responses.
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6.5 Publications associated with the chapter
This results of the study described in this chapter has been submitted as the IMIA
Primary Care Informatics Working Group to the Yearbook of Medical Informatics
2015 as “Liyanage H, Correa A, Liaw ST, Kuziemsky CE, Terry A, Lusignan
S. Does informatics enable or inhibit the delivery of patient-centred
coordinated quality assured care?.2015”. I facilitated the concensus process
involving the expert panel and contributed to the analysis of results. I also drafted
the manuscript for publication.
6.6 Summary
The consensus exercise and the literature review demonstrated that the context of
implementation is essential in answering the research question. In principle, there
appears to be a good understanding of the technical limitations and advantages
of informatics within patient-centred care, but there is much disagreement and
lack of understanding on the clinician-computer interaction, and how this can
enable or inhibit patient-centred care.
The health care system, the profession or specialism of the clinician, the level
of engagement of the patients, among others, are factors which can heavily impact
on the effective implementation of informatics, with the purpose of providing
patient-centred quality assured care. Informatics on its own does not necessarily
enable or inhibit care, but with the correct implementation it can serve as an
essential support to the delivery of patient-centred quality assured coordinated
care.
6.6.1 Clinical perspective
Patient participation to manage medical records and their health care will help to
validate the data collected and provide additional safety measures. Such mech-
anisms will result in more complete and better quality data. This increased the
research readiness of patients to participate in research. Though the informat-
ics factors facilitate better engagement of patients, the business processes that
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govern the clinicians’ work flows may not be able to make maximum use of the
circumstances that arise due to increased patient participation.
6.6.2 Informatics perspective
Advances in technology have provided many ways for patients to engage proac-
tively in managing their health care and in research studies. Wearable devices
continuously provides sensor measurement to facilitate a continuous health care
experience. The data generated provides better insights in to the bodily functions
of the patient and in some cases provide early warnings for impending adverse
health conditions. The data structures use for capturing such data is not stan-
dardised. Use of ontologies for standardising representation of collected data will
enhance readiness of the captured patient data to participate in more extensive
research programmes.
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Part II
Boundary spanning ontologies
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Chapter 7
The Ontology toolkit
7.1 Introduction
Part-I of this thesis presented the evidence base for the broadened use of ontolo-
gies in health care research. The evidence was organised according to various
dimensions of a research readiness model introduced in chapter 2.
We define “Boundary spanning ontologies” as a type of ontologies that
will allow involve different stake holders having various levels of technical ap-
titude. In the context of health care, we anticipate that boundary spanning
ontologies will maximise the engagement of clinical professionals who are not
ontology experts.
We begin this chapter by exploring applications of ontologies and semantic
integration methods in the context of chronic disease management. This was a
research output of a study conducted with the association of the Primary Health
Care Informatics Group of the IMIA. These findings motivated the development
of the ontology toolkit presented in the latter part of this chapter. This is the
foundation of the extended ontology toolkit which a key output of this PhD.
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7.2 Semantic interoperability to support chronic
disease management
Chronic non-communicable disease is rising and is a global priority, with much of
that disease managed or capable of being managed in primary care [De Maeseneer
et al., 2012; Morabia & Abel, 2006]. The chronic care model (CCM) provides a
holistic care model, in contrast to much chronic disease management (CDM),
which is carried out as if chronic diseases are mutually exclusive [Lalonde et al.,
2012]. The CCM suggests that a wide range of community, technological, care
team and patient factors contribute to CDM [Bodenheimer et al., 2002a,b]; ef-
fective care pathway management is complex and best run by integrated teams
working in partnership with patients and their communities [Cramm & Nieboer,
2012a].
The data and information sharing required to support the implementation
of the CCM are complex; and gaps in information system (IS) provision are a
limitation on delivering effective care. Whilst the CCM provides many opportu-
nities to apply technology [Siminerio, 2010], including the use of social media for
patients to interact and provide support [Roblin, 2011], and data collected from
multiple monitoring devices, so called ubiquitous computing [Bott et al., 2005];
it is challenging to link these disparate systems. In several disease areas, includ-
ing cardiovascular disease [Siminerio, 2010], cancer [Campbell et al., 2011], and
diabetes [MacLean et al., 2004] IS development is suboptimal and fails to provide
timely information required for care. Further, for many nations there is almost a
complete absence of effective information and other systems [Mendis et al., 2012].
It has been recognised that to provide more personalised health care we need
active knowledge management, reasoning systems, and semantic interoperability
with ontology based models [Hwang et al., 2010]. New information and commu-
nication technology (ICT) tools such as ontologies are needed to build federated
information infrastructures [Uhlir, 2000]. However, such approaches have hith-
erto largely limited themselves to the scope of the data within the computerised
record, often defined by archetypes and represented within standard terminolo-
123
gies such as the systematised nomenclature of medicine, clinical terms (SNOMED
CT) [Cimino, 2007; Garde et al., 2009]. Similarly, approaches to messaging have
not focused on considerable challenges of achieving semantic interoperability be-
tween data held in separate clinical data silos [Dolin et al., 2006]. Whilst we
fully support the importance of existing work, we see the data requirements for
implementing effective CDM, using the CCM, as much broader.
Ontologies and other semantic integration methods
Ontologies and other semantic integration methods have the capability to link
heterogeneous data sources that might be required to support effective CDM. An
exemplar of who might hold relevant data about a person with diabetes is show
in Figure 7.1; data relevant to health can be held by a wide range of agencies.
There is a challenge in balancing the usability of a coding system, particularly
inclusion of diverse synonymous terms, with the need for accurate capture of
discrete concepts. Classifications may be less flexible in daily use, but allow
for more accurate capture and categorization of unique concepts, allowing for
improved interoperability of information. Accurate mapping of ontologies, with
their often ambiguous concepts, to classifications is often a challenge and may
require a second step [Benedetti et al., 2004] Ontological approaches are used to
address semantic interoperability issues, flexibility of information management
and integration, and complexity of information models [Liaw et al., 2013]. In
practical terms, an ontology defines the concepts and their relationships within
a given domain, in our case CDM, allowing their specification [Gruber, 1993].
Semantic integration methods enable seamless interchange of information across
the health enterprise to achieving effective CDM, as set out in the CCM. The
semantic web forms a common approach to this challenge Medical semantics are
important because they stress the importance of preserving meaning as data are
passed between different parts of the health enterprise [Groen & Wine, 2009].
7.2.1 Conducting a realist review
The process of a realistic review is to determine what mechanism acts within a
particular context to produce an outcome [?]. The realist evaluation is a theory-
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Figure 7.1: Heterogeneous data sources relevant to the management of a person
with diabetes
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Figure 7.2: The elements of the chronic care model
driven method which is frequently used for evaluating social programmes [Marchal
et al., 2012].
Context + Mechanism = Outcome
For the purpose of this review we have looked at the context of research
identified; and identified a mechanism, either an ontology or sematic integration
methodology that produces an outcome. We have carried this out for the six
elements of the CCM as illustrated in Figure 7.2.
7.2.1.1 Search strategy
We searched PubMed, Science Direct, and Scopus databases using the terms
Chronic disease and ontolog* - the wild card capturing ontology or ontologies or
semantic integration repeating the same searches substituting each element of the
CCM. The six elements of the CCM are:
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Table 7.1: Search results from selected bibliographic databases
PubMed ScienceDirect Scopus
Areas of chronic care model All Since 2009 All Since 2009 All Since 2009
1. Community resources 3 1 167 81 2 2
2. Health system 14 8 983 521 18 1
3. Self-management support 16 9 124 86 2 2
4. Delivery system design 7 3 72 45 0 0
5. Decision support 26 16 493 265 49 32
6. Clinical information system 2 2 197 83 6 2
1. Community resources
2. Health system
3. Self-management support
4. Delivery system design
5. Decision support and
6. Clinical IS.
The results, numbers of papers identified, obtained from the searches are
shown in Table 7.2 , with duplicate results removed.
Context: We report the context in terms of the health system within which
the relevant implementation took place; this is either reported in the text or can
be identified from the relevant reference.
Mechanism: The mechanisms we describe are either the use of ontologies or
of some form of semantic integration. We include within semantic integration:
• Semantic interoperability, the ability of computer systems to exchange data
with unambiguous, shared meaning.
• Knowledge management, processes to accelerate learning and improve de-
cision making [de Lusignan et al., 2002]
• Other re-use methodologies which cant be readily classified in one of the
other categories.
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Figure 7.3: Literature search results analysis
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Outcome: We used the Donnabedian evaluative hierarchy to look at out-
comes in terms of creation of structures/IT or informatics infrastructure, pro-
cesses and true outcomes [Donabedian & Donabedian, 2005]. Ideally, we would
have liked to have found implementation of ontologies and other semantic inte-
gration tools that resulted in hard outcomes, for example classifiable using the
Cochrane Effective Practice and Organisation of Care (EPOC) Group taxonomy
of outcomes [EPOC, 2014]. Likewise with strength of evidence and recommen-
dations using commonly accepted evidence-based medicine tools [Atkins et al.,
2004]. However, the level of maturity of ontological development is such that we
had more modest expectations [Gruber, 1993]. We therefore included outcomes
where the structures/infrastructure to support ontologies and semantic integra-
tion tools are in place; and also where there are processes involving their use.
The results are presented reporting the use of ontologies in the six domains of
the chronic are model described previously. Each element identified which might
contribute to care (Figure 7.2) belongs to one or more of these six categories. The
literature on ontologies seemed to sit firmly within the medical model. There was
very little literature about how the factors such as limitations on driving, poten-
tially high insurance premiums, diabetes charities, policy makers, and professions
allied to medicine, podiatrists, optometrists, and ambulance services, might inte-
grate their information into broader patient care.
Community resources
We found little evidence of the use of ontologies to support this element of the
CCM. Community support is important in CDM but there is little evidence of
the use of ontologies or semantic integration methods; current systems require
reworking [Plumb et al., 2012] and there are prototypes [Paganelli & Giuli, 2011]
and a pan-European project in progress [Rosso et al., 2010]. The disparate na-
ture of IS in the community is highlighted in a study of the risks associated with
older people transitioning between health providers and settings [Enderlin et al.,
2013], and descriptions of very different implementations of integrated care in the
Netherlands [van der Linden et al., 2001]. Telemonitoring is increasingly proposed
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as a way for monitoring people with chronic disease and optimising therapy in
the community. There are however proposals as to how ontologies might be used
to harness these data [Mart´ınez-Lo´pez et al., 2008].
The health system
We found little evidence of a health system implementing a systematic approach
to ontologies or semantic integration processes as part of health system redesign
from a structural perspective. One exception is the NHS (National Health Ser-
vice) Data Model and Dictionary, which whilst firmly rooted in clinical practice
is an attempt to codify multiple concepts [NHSDDS, 2014]. This provides an on-
tological mechanism for providing data to support business decisions about which
services should be provided to a community (called commissioning health care) in
the English NHS. The NHS Data Model the elements are divided into data collec-
tions, classes and attributes. Its principal objective is to support usable commis-
sioning datasets. For example, enabling national definitions of care-groups that
might be hard to consistently identify from complex data; for instance the use
of readily reproducible methods for identifying emergency admissions and what
constitutes an admission of a person with chronic obstructive pulmonary disease
(COPD) [Agboado & Donkin, 2012; Gunther et al., 2013]. The Australian GP
Data Model and Core Data Set was started with similar goals but not maintained.
The majority of ontology and semantic integrative initiatives are for support-
ing processes of specific diseases. Across health systems proactive teams appeared
to be empowered by simple well established processes include the use of the plan-
do-study-act (PDSA) cycle [Berwick, 1998] and joining innovators together into
collaboratives [Kilo, 1998]. Patient empowered care is being promoted through
personal health records (PHR) and through electronic patient record access; again
we found little use of ontologies. When implemented in the context of an appro-
priate business model this has led to a decrease in face-to-face consulting and
more Virtual visits [Baer, 2011]. However, without this stimulus these initiatives
may fail [de Lusignan & Seroussi, 2013]. There is emergent use of ontologies in
PHR [Kokkinaki et al., 2008]. Outcome related initiatives include the UK health
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system interoperable pathology, prescribing and primary care data to underpin
the implementation of pay-for-performance (P4P) in the quality and outcomes
framework (QOF) [de Lusignan & Mimnagh, 2006]. The use of these have been
illustrated in chronic kidney disease (CKD), where recognition and management
of the condition has been enabled through these mechanisms [Stevens et al., 2012].
Within this P4P scheme pragmatic ontologies (though not referred to as such)
are created for what represents a case (to be included in the disease register),
and what represents good care [de Lusignan, 2013]. An ecological study, suggests
an association between improved primary care disease management and variation
in incidence of transplant and dialysis [Dhoul et al., 2012]. Registration based
systems with an accurate denominator facilitate the development of ontologies
to define cases, prevalence and quality of care. Similar levels of interoperability
have been achieved in Denmark, Netherlands, Australia and New Zealand [Protti
et al., 2009]; providing a data environment which should facilitate the develop-
ment of data driven ontological approaches. The patient-centred medical home,
as proposed in the USA, will generate more data in and out of the hospital set-
ting but a strategy to integrate these data is not apparent; an ontologically rich
approach could be effective [Tufano et al., 2010].
Self-management support
Self-management support is a broad concept stretching well beyond the medical
domain, to a range of community resources (Fig 1, Supplementary data file Table
S1); and broader partnerships providing input may for example improve care in
diabetes [Lee et al., 2011]. Such multi-faceted data sources may lend themselves
well to ontological exploration.
In hypertension an ontology has been developed to improve hypertension pre-
scribing [Mabotuwana & Warren, 2009a], patient information requirements in
COPD [Borycki & Kushniruk, 2007], and continuity of care in heart failure [Ec-
cher et al., 2006]. Ontologies have also been developed to help improve the quality
of decision making about progression from CKD to renal replacement [Harwood
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& Clark, 2012]. The ontology acts in these cases as a mechanism for tying to-
gether complex datasets to measure the quality of care, progression of disease or
health outcomes.
Self-management support has also shown benefit in a number of studies,
though ontologies and other semantic integration technologies do not appear to
have underpinned these training of professionals in shared decision making, to
improve patient self-management support. Self-management support has been
shown to be effective; for example a randomised trial tested this in COPD, di-
abetes, and irritable bowel syndrome (IBS) [Fullwood et al., 2013]; and a sys-
tematic review has found evidence of improved outcomes in diabetes and hy-
pertension, with some evidence for arthritis and less clear evidence for asthma
and COPD [Dennis et al., 2008]. Interventions in self-management support are
diverse, with little evaluation of their effectiveness [Johnston et al., 2012]; circum-
stances which may lend themselves to an ontological approach. Again there is
only emergent recognition that ontological approaches might form an appropriate
method to link complex relevant data [Protheroe et al., 2008].
Delivery system design
Ontologies have been developed to support computerised cognitive behavioural
therapy (CBT) [Lenert et al., 2005]. A systematic review has described how
delivery-system design interventions including multidisciplinary team care have
positive effects on both provider behaviour and some patient outcomes, partic-
ularly for diabetes, hypertension and lipid disorders [Dennis et al., 2008]. This
includes demonstrating the value of practice nurses in European primary care
[Ahgren, 2003; Vrijhoef et al., 2001] and of case management [Gravelle et al.,
2007]. There are few methods used to assess the effectiveness of the delivery sys-
tem. Patient Assessment of Chronic Illness Care (PACIC) demonstrates that it is
possible to assess patients quality of life, and the range of factors that contribute
also lend themselves to an ontological approach [Schmittdiel et al., 2008]; though
improving completion rates and linking it to health outcomes remain limitations
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[Rick et al., 2012].
Decision support
Computing methodologies used for implementing decision support systems in-
clude Bayesian networks, neural networks, rule-based systems, heuristics, and
fuzzy systems [Wagholikar et al., 2012]. Recently there has been a shift in the
methodologies used for developing such systems: moving from more traditional
rule-based systems to semantically-rich knowledge based systems taking advan-
tage of the connected nature of modern health IS. Ontologies have been viewed
as more effective way of representing the clinical knowledge used for the decision
making process. However, the methodologies used for emulating the decision
making process are those listed above. Ontological reasoners are being used to
add deduction capabilities to these systems [Abidi, 2009]. The commonest use of
decision support is the diagnosis of disease decision support is increasingly used
for detecting the risk of disease, prescribing or other intervention decisions and
prevention [Rodr´ıguez-Gonza´lez et al., 2010; Verma et al., 2009, 2011].
Clinical information system (CIS)
At a structural level, one of the most common objectives of ontology and seman-
tic integration initiatives has been to improve data quality of CISs in order to
facilitate effective sharing and data reuse. Improved data through ontology me-
diated data dictionaries and datasets have enabled better care management and
quality improvement initiatives [de Lusignan et al., 2011e]. High-quality data has
also enabled primary care providers to monitor the quality of their care and the
longitudinal impact of policy [Campbell et al., 2005; Murray et al., 2010]. One
of the main contributions from ontology facilitated CIS has been improved data
coding. For example, the US Veterans Administrations use a lexicon, a subset of
terms, within a defined set of terminologies [Lincoln et al., 1994]. All the unre-
solved terms (i.e. clinical record entries that could not be coded) terms in their
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Table 7.3: Emerging themes on how ontologies and semantic integration can act
as a mechanism to improve chronic disease management
Areas of CCM Main Mechanisms
1. Community
Supporting complex care in the community,
Linking services that affect outcomes (e.g. Social
care with medical care)
2. Health System Measures to support interoperability and integration
3. Self-management support
Self-management tools (though due to their diversity
it is hard to identify the mechanism)
4. Delivery system design
Shared data registries, Health behaviour modelling,
Knowledge discovery, Patient assessment of care
5. Decision support
Computer-assisted medical diagnosis,
Care pathway planning/allocation
6. Clinical information
system (CIS)
Integrated health information systems,
Interoperability of data, Consistent clinical coding
of key data, Data quality
Decentralized Hospital Computer Program (DHCP) are sent to a central registry
[Eagon et al., 1996]. SNOMED CT provides a comprehensive coverage of these
unresolved clinical expressions [Penz et al., 2004]. This improved process of data
management should enable more effective disease management.
Processes improvements from ontology designed CISs have been at many lev-
els. First has been the improvement of specific clinical processes such as decision
support for chronic disease such as diabetes [MacLean et al., 2006]. Second has
been the use of ontologies for the development of disease registries which have
improved care delivery as well as facilitating research in children with arthritis
[Natter et al., 2013].
Outcomes from ontology based CISs have included improved care in diabetes
[Benedetti et al., 2004] as well as better access and adherence to evidence-based
guidelines and educational training for health professionals.
This literature review demonstrates that ontologies and semantic integration
can act as mechanisms for improving CDM; this emerging phenomenon is sum-
marised in Table 7.3.
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Table 7.4: Gaps in the current evidence-base for ontologies and semantic integra-
tion technologies that need to be filled
Areas of CCM Gaps in using ontologies and semantic methodologies
1.Community
Concepts related to mobilising resources are,not defined.
Many community resources do not integrate with other health data
2. Health System
Little evidence of any systematic approach,for implementing
ontologies with provision for integration. Best examples at
national or integrated,care provider level.
3. Self-management support
How to achieve better continuity of care by synchronised
information flow across the health enterprise
4. Delivery system design
Lack of leveraging semantically integrated,information
for managing care pathways.
5. Decision support
Data-driven enrichment of clinical knowledge for
improved decision support.
6. Clinical information
system (CIS)
Semantic integration of clinical concepts between,
clinical information systems, and across the health enterprise,
beyond, sharing imaging and pathology data
7.2.2 Discussion
Principal findings
Ontologies and semantic integration methods underpin much of what has been
achieved to develop more integrated care. However, very often these approaches
are not directly recognised as such. The mechanism by which they appears to act
is at the level of providing a better integrated primary or ambulatory care record,
that supports more holistic care. This better integrated record not only allows
the health care professional access to the required data at the point of care, it
also enables clinical audit and other mechanisms to benefit care. However, the
level of sophistication of such approaches has been limited. There are no reports
of problems with patient safety and more ontologically rich records. However,
there are also important gaps in the use of ontologies and semantic integration
methods that required further research (Table 7.4). These gaps might be present
because linking these datasets is considered too hard. Our assertion is that data
driven ontological or semantic integration methods might enable more selective
linkage of data that is important for patient care.
Until more sophisticated methods of semantic integration are piloted and
tested for their effects on health outcomes the evidence base for these technolo-
gies will remain limited. Consequently, the evidence for the use of ontologies and
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semantic integration methods is limited by current CIS. Better use of ontologies
and semantic integration has the potential to support the CCM and improve
CDM. It could be that progress could be made using the Donnabedian approach;
with initial emphasis on creating the right informatics infrastructure; then build-
ing processes that fill in the gaps, for example in the areas of community support
and delivery system design; with finally empirical studies conducted to see if this
infrastructure and processes improved health outcomes.
Others have grappled with the difficulty of modelling holistic health [Rossi Mori
et al., 2013]. Although the scope of the CCM is community wide, we recognise
there are challenges in coding data, to make them more readily interoperable.
Coding can be challenging in itself [de Lusignan et al., 2003; Soler et al., 2008],
some systems do not routinely record reason for encounter [Soler & Okkes, 2012],
and other factors can distort coding. Coordination between professionals is also
thought important in delivering effective CDM [Cramm & Nieboer, 2012b], and
again the creation of richer records might help underpin this process. Whilst we
could not find literature about the use of ontologies and semantic integration for
optometry or podiatry, other literature points towards the value of linking data
they hold. Eye disease can be associated with worse blood pressure control in di-
abetes [Styles & Timlin, 2007], and lower limb complications are often associated
with problems with other areas of diabetes control [Brem et al., 2006].
Restricting our search to ontologies implemented in more than one system
may mean we failed to consider ontologies implemented in a single computerised
medical record system. Possibly excluding pilot studies that might have added to
our understanding in this area; for example we excluded some studies of the use
of ontologies in decision support, which might have broadened our perceptions of
their role [Corrigan et al., 2013; Kawazoe & Ohe, 2008]
Interoperability of data and information has been achieved in many primary
and ambulatory care settings; particularly to enhance self-management support.
However, the benefits have largely been achieved for single conditions, and largely
in a medical context. Further development of ontologies should start to enhance
sematic interoperability within the health enterprise. Ontologies should enable
more robust integration of data, including patients reasons for encounter, and
hence improved potential to manage chronic disease.
137
7.3 Ontology toolkit
Ontologies offer a useful approach for representing the knowledge, processes and
actors that comprise CDM. It is particularly useful for people with CNCD whose
health data is often distributed among a number of different health and social
care providers and in different formats. The ontology can then be formalized and
translated into software to automate the data and data quality management. In
addition, the ontological approach can potentially also be used to capture the
essence of CDM and the CCM in primary care.
The term ontology is used with different meanings in different communities.
Our preferred definition of an ontology is a specification of a conceptualization
[Gruber, 1993]. An ontology defines concepts and their relationships within a
domain and is amenable to machine processing [Horridge et al., 2004]. It does not
assume that all individuals have a single disease label mulitmorbidity and coding
errors are common. Ontologies also describe properties (binary relationships)
between indi-viduals which can have an inverse (e.g. people can either have,
or not have a maximum plasma glucose >11.0mmol/L). Classes in ontologies
contain individuals, are concrete or definable concepts, and can be organised
into hierarchies. For example, diabetes mellitus is a super-class, with Type 1,
Type 2, etc. classes within it. The classes are built up of descriptions that must
be satisfied to be a member of that class (e.g. people with Type 1 diabetes
require insulin for survival) [de Lusignan et al., 2012b; Hassan Sadek et al., 2012;
Rollason et al., 2009; Stone et al., 2010]. However there is a lack of formal
protocols as to how to develop and incorporate ontologies in practice to support
CDM research and QI. Ontologies are not meant to be one off models but should
enable us to learn about a domain area. We therefore explored the extent to
which ontologies and ontological approaches could improve informatics-enhanced
clinical and research decisions about people with CNCD.
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7.3.1 Methods
7.3.1.1 Literature Review
We carried out a realist review of the use of ontologies to im-prove data quality
in CDM [Liaw et al., 2013]. We explored ontologies as a mechanism that in the
context of CDM enables an outcome; in this case improved capability to conduct
research and QI projects. The scope of this work is limited to patient-centred
ontologies (i.e. the patient is in the centre of our ontological framework) in
primary and integrated care. Though we would eventually like to broaden this
work in this first step we wanted to restrict our ontologies to those relevant to
chronic disease management, and, where greater specificity is needed, we used
diabetes as an exemplar.
7.3.1.2 Workshop at MIE 2012
We extended the work through the Primary Care Informatics Working Group
of the European Federation of Medical Informatics (EFMI) by conducting a
workshop at Medical Informatics Europe (MIE2012). The participants of the
workshop included health informaticians, clinicians and researchers actively en-
gaged in data quality and CDM. Workshop participants agreed that ontologies
and ontological approaches to data quality and research in CDM were a useful
and worthwhile research and development program. It was also proposed that a
toolkit was needed to promote and support the development of an “ontological
culture” [EFMI, 2014].
The toolkit development process included (1) consensus among experts in the
field as to what should be in an ontology toolkit, and (2) develop the toolkit
building on an established method [Kuziemsky & Lau, 2010]. This development
process comprised of:
1. Capturing context by defining the domain ontology and a reference termi-
nology
2. Modelling data and metadata mechanisms, and framing the domain and
data quality ontology
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3. Formalisation and ontology development tools
4. Validation of domain and data quality ontology.
Consensus development involved two rounds: (1) an inclusive round seeking
to identify elements of the toolkit, and (2) a focused round to achieve consensus
on necessary tools.
7.3.1.3 Round 1 Consensus: inclusive list of Toolkit elements
The objective of Round 1 was to identify an inclusive list of elements of a toolkit.
The guiding framework comprised informational and clinical approaches to using
ontologies. While both are formal and emphasise an ontological world view,
they were also different. The informational methods were executable, without
losing patient preference or autonomy (i.e. pathways and mappings must be
patient-enabling not prescriptive). The clinical methods consisted of a conceptual
framework or taxonomy, a controlled or reference terminology, and some form of
critical appraisal or validation (e.g. using reasoners).
The toolkit had three main conceptual areas and a focus on delivering patient-
centred integrated care:
1. To integrate data from multiple sources, recognising the different levels of
granularity,
2. To describe the coordination of care provided by the multidisciplinary team,
and
3. To describe the health outcomes and evaluative framework.
7.3.1.4 Clinical approaches to the Ontology Toolkit
(a) Clinical approaches to the Ontology Toolkit
(b) Controlled or reference terminology
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Table 7.5: Conceptualisation
Classes /
Concepts
Concepts (either
physical/specific or
abstract/conceptual
Concepts i.e. classes
Relations
Association between
concepts (usually binary)
Relations,among the classes
Attributes
/Properties
/Slots
Describe the features
of the concepts.
Attributes,and which values
they can take
Taxonomies
Classes,are organized
into taxonomies, defining
superclass- subclass hierarchy
Classes,organized into a taxonomy
, preferably patient-centered
We used SNOMED CT; recognising that, although often used as a controlled
vocabulary, it may not meet all the requirements for data in CDM, or for the
components of a research or QI project [de Lusignan et al., 2011b; Heja et al.,
2008].
(c) Validation/critical appraisal/pilot study
We conducted a critical appraisal to ensure that the ontology meets the re-
quirements of the domain being modelled. Automatic validation by reasoners
using ontologies over data helps in determining defects in data when its features
do not agree with the domain ontology declares (e.g. relations and possible values)
[Horridge et al., 2004]. The power of ontologies could be extended if associating
probability distributions also referred to as fuzzy ontologies. A class A may
have an attribute with the possible values V1, V2 and V3. A domain ontology
should check whether a test value fulfills this constraint, however, calculating the
probability that each possible value may be an alternative. This univariate ex-
ample could be extended to multivariate cases (probability of a value given two
or more items), not only to attribute values but to relations, and to numerical
data including Bayesian methods. We emphasise these aspects because quality of
data for research, especially for building predictive models for decision support
systems, is also sensitive to noise, which is more difficult to detect than simple
domain constraints. Additionally this may provide estimates of the statistical
predictive value of key variables.
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7.3.1.5 Round 2 Consensus: essential elements of Toolkit
Round 2 aimed to achieve consensus, around the essential elements of the toolkit.
We asked about the appropriateness of each component identified in Round 1
using the RAND/UCLA Appropriateness Method (2001) [Fitch et al., 2001].
The statements are available online at: http://clininf.eu/images/stories /ontolo-
gy/round2.pdf with the online questionnaire available at:
http://www.surveymonkey.com/s/DT5 WNGM/.
Statements for concensus
1. The context of clinical interactions is easily recorded in and accessed from
computerised medical records (CMR) systems for use in QI research.
2. The roles/actions of health care providers are easily recorded in CMR sys-
tems.
3. There are reliable and valid tools/methods for conceptualizing,how good or
poor care is represented in CMR systems.
4. There are no standard,tools for combining semantic meaning between CMR
systems with different data models (e.g. episode base hospital data with
encounter based primary care data)
5. The context of data recording in CMR systems can only be understood
in detail by clinicians,and coding staff responsible for the records and how
they are coded.
6. Current methods for conducting research based on heterogeneous data sources
are adequate.
7. Ontologies can be used to conceptualise clinical interventions and derive/de-
fine outcome/impact variables.
8. CIS use a single data coding system (reference/ clinical terminology) across
the health enterprise.
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9. Different codes are used to describe a patient with the same clinical condi-
tion (e.g. Tension headache, depressed, situational crisis).
10. The same codes can have different meanings in the same health system (e.g.
Asthma, Raised cholesterol).
11. Ontologies can be,successfully implemented in CIS to support clinical work.
12. Ontologies can be,successfully implemented in CIS to support QI and re-
search.
Validation statement: Validation of ontologies is impossible.
7.3.2 Results
7.3.2.1 Outputs from the workshop and questionnaires
In round 2 we explored the degrees of consensus [Fitch et al., 2001]. We had
12 responses (92%) to round 1, and 8 (65.2%) response to round 2. There was
consensus about statements 5, 7, 9, 10, 11, 12, and the validation statement; and
there was broad agreement that we lacked methods of objectively defining clin-
ical context and linking heterogeneous data. Respondents were equivocal about
statements 2, 3, and 4 which asked if there were sufficient tools to assess health
care providers, measuring the quality of care and for semantic interoperability
respectively. There was disagreement about whether data are easily recorded in
computerised medical record systems, whether they used a single coding system
and there was marked variation in coding practice. This might have reflected
different clinical backgrounds of the respondents.
7.3.2.2 Recommended tools in the Ontology Toolkit
We considered the following tools and technologies that should be included in a
toolkit, whilst recognising that other technologies may be required.
DOLCE (Descriptive Ontology for Linguistic and Cognitive Engi-
neering): This is a high level conceptual tool, a descriptive upper-level ontology
designed for automatic reasoning and interoperability. DOLCE has a cognitive
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bias; it aims to capture the ontological categories underlying natural language
and human common sense [Heja et al., 2008; Masolo et al., 2003]. DOLCE de-
scribes human use of concepts, without revising them; incorporating a distinction
between entities which extend through time (endurants) and those that happen
in time (perdurants). DOLCE distinguishes between several entities co-locating
in the same space and time (e.g. Type 1 diabetes and insulin needed for treat-
ment). It has included some concepts from OntoClean. Ontological analysis
using DOLCE has been conducted using SNOMED CT [Masolo et al., 2003].
We recommend this tool during the initial two stages of the toolkit development
process.
OntoClean Methodology: This is a methodology based on formal nota-
tions, which are general enough to be used in any ontology, independently of
domain. We suggest its use to define a set of meta-properties which, in turn, are
used to characterise relevant aspects of the intended meaning of the properties,
classes, and relations that make up an ontology. The meta-properties impose
constraints on the taxonomic structure of an ontology, which help in evaluation
[Guarino & Welty, 2009]. We consider this methodology to be useful during the
second stage of our proposed ontology development process.
OWL (Web ontology language): OWL allows description of knowledge in
a machine-accessible way. It builds upon RDF (Resource Description Framework)
and RDF schema and uses RDFs XML syntax. OWL is mapped on to logic to
provide support for formal semantics and reasoning. In formal semantics “Pre-
cisely” excludes any subjective thinking, intuition or different interpretations by
different people or machines [McGuinness et al., 2004]. This ontology has been
applied to research into improve quality in hypertension management in primary
care [Mabotuwana & Warren, 2009b].
PROTEGE: We recommend this as the principal authoring tool. It is a
graphical tool for ontology editing and knowledge acquisition that can be adapted
to enable conceptual modelling of semantic web languages such as OWL. There
are many add-ins available for this tool and potential ways it might be used.
The latter two tools are recommended for the implementation of the ontolo-
gies.
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7.3.2.3 A four step method
We propose a four step method of re-usable components that is applicable across
many studies:
1. Identification and specification by expert users of the potentially het-
erogeneous data sources and dataset needed to identify cases, interventions,
outcomes measures and any comparator group. These experts might be
drawn from primary and secondary care, informatics, social care, workforce
planning and other branches of management, academia and guideline devel-
opers; ideally with access to or knowledge of relevant routine data in their
domain.
2. Conceptualisation of semantic meaning; how they can be used as a mea-
sure of the process or outcome of care. The contributing experts separately
apply the ontology to their dataset to enable cases, interventions, outcomes
and comparator data to be identified.
3. Formalisation reflecting complexity of the project, and the use of Prote´ge´.
A semantic mapping will combine the domain experts data source specific
ontologies into a core ontology. The study outcomes would be derived from
the relationships within this ontology. We will define a reference terminol-
ogy for the final analysis [Smith et al., 2006].
4. Validation by domain experts to test the validity of the combined model
using a three step process:
• Data flows (for key inclusion, exclusion and outcome variables).
• Process use-case models (interaction of key actors impact on outcome
variables).
• Business process models (affecting outcome varia-bles).
7.3.2.4 Reference Model for Toolkit Implementation
We developed a reference model for applying the toolkit in a health care environ-
ment (Figure 7.4). Its elements are:
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1. Health Information System (HSn): These are candidate systems that will
represent the root level of this information hierarchy being represented by
the model. They will most commonly be CIS, but might include social care
systems.
2. Semantic Data Dictionary (SDn): This is built using a template specified in
the toolkit to capture the data description (including the semantic meaning)
and be vital to resolve any ambiguity in data within the model.
3. System-specific Ontology (ONTn): This is developed by an expert user of
the candidate system based on the instructions given in the toolkit.
4. Ontology Mapping: ONTn will be mapped to a Core Ontology using SDn
to resolve any conflicts. This will be developed by the party that will be
utilizing the final product, the core ontology.
5. Core Ontology (ONT): The primary output of the process; iteratively vali-
dated using expert knowledge.
6. Expert Knowledge: A domain expert who will be able to validate the Core
Ontology and the mapping.
This model is a development of a previous approach [Kuziemsky & Lau,
2010]; but adding the dimension of complex data, often aggregated from different
sources. This added complexity is handled by introducing semantic mapping to
generalise ontologies across the systems considered for the ontology developed.
This extended approach is needed when integrating data from systems with a
wide scope across the health ecosystem.
7.3.3 Discussion
There was a consensus among participants in the workshop that formalised cap-
ture of context is needed, and that complex multi-morbidity and the elements
of care delivery cannot readily be coded and made interoperable with a single
terminology. Likewise, it is not feasible to create models and handcraft linkages
and logic for each chronic disease.
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Figure 7.4: Reference model for an ontology
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The study builds on previous reviews of ontologies which were oriented to-
wards standards and terminologies [Cimino & Zhu, 2006; Kuziemsky & Lau,
2010]. We propose a practical toolkit to provide a process and the com-ponents
needed to develop a practical ontology to support CDM. This again adds to a
recent review of the evidence-base for using ontologies in CDM [Liaw et al., 2013].
The toolkit proposes tools, a four step method, and provides a reference model
of how the process might be broken down into manageable bite-size chunks from
which a final ontology is developed.
There are two challenges in ontology design. One is agreeing upon the method
of development and the terminology that is used to build the ontology. Scalability
between high level ontologies like BFO or SNOMED in health care and front-line
health care is often a problem. Second is the role that ontologies play. Some
regard ontologies as high level representations and others detailed representations.
Ontologies are tools to link the micro and macro but first they must be designed
using good engineering principles. Too many ontologies are created as a one off
solution to a problem and that limits generalisability. Therefore the ontology
toolkit provides a common mind-set for ontology design.
There are a range of other coding systems that we might have considered as
well as SNOMED-CT as a reference terminology. Whilst we acknowledge their
limitations other terminologies are used more [Heja et al., 2008; ?]. The Interna-
tional Classification of Disease (ICD) is probably the most used internationally,
with the International Classification for Primary Care (ICPC) used widely in pri-
mary care [de Lusignan, 2005]. ICD often has to be extend-ed through the use of a
clinical modification [de Lusignan & van Weel, 2006]. The Unified Modeling Lan-
guage System (UMLS) enables library classifications and clinical terminologies to
be linked and may aid knowledge representation [Robinson et al., 2006].
7.4 Publications associated with this chapter
Sections in this chapter discussing the ontology toolkit were published as “Liyan-
age H, Liaw ST, Kuziemsky C, de Lusignan S. Ontologies to improve chronic
disease management research and quality improvement studies - a
conceptual framework. Stud Health Technol Inform. 2013;192:180-4”.
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7.5 Summary
Ontologies are the best approach available to combine data of different granu-
larity needed to provide integrated care to patients with chronic diseases [Chan-
drasekaran et al., 1999]. This toolkit provides an emergent method for using
ontologies to support CDM and the Chronic Care Model.
In this chapter we reported how a conceptual ontology toolkit was extended
to support development of light-weight (non-standardised) ontologies that can be
used for semantic mapping and decision making in projects using routine data.
We label these ontologies as “boundary spanning” since they can be utilised by
clinicians who engage in researching routine data who do not have extensive
technical knowledge of ontology development. Furthermore, the toolkit provides
provision to handle data originating from different health care settings.
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Chapter 8
The Extended Ontology toolkit
8.1 Introduction
This chapter builds on the initial development of the ontology toolkit featured
in the previous chapter. The original ontology toolkit was used in practice by
several clinicians working in the clinical informatics groups and their feedback
suggested that standard ontology development tools had a considerable learning
curve to build robust ontologies. As a result, several elements discussed in this
chapter were developed with the aim of developing a pragmatic toolkit that can be
utilised by clinicians. Among the elements, we present a generic health ontology,
an ontology template that can be used for modeling concepts commonly associate
with quality improvement studies. This ontology has been mapped to widely used
clinical terminologies to ensure that coding hierarchies used in these projects are
built consistently. Finally, we present a case study of using ontologies to map
across different terminologies within the context of the vaccine safety.
8.2 Generic Health Care Concept Ontology
Ontologies built using bio-medical ontology standards ensure interoperability of
datasets and continuity of modeling complex concepts in associated to health
care. For routine data projects that require semantic modelling of a narrow set
of clinical concepts the standardised ontologies become too complicated to work
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Figure 8.1: Levels of the health care concept ontology
with. As a result there have been instances of incorporate ontological elements
(that have not being built based on bio-medical standards) have been integrated
to merely enable improved decision making at semantic level [de Lusignan et al.,
2011d].
As an extension to the ontology toolkit presented earlier, we have developed
a generic health care concept ontology which is mapped to several widely used
clinical terminologies including SNOMED-CT, 5-Byte Read ver2, CTv3, ICD-
9-CM and ICD-10. The mappings are helpful for developing data requirements
for studies that use integrated datasets that originate from different health care
settings (i.e. primary care, secondary care, surveillance databases etc.). We have
also mapped the ontology to elements of the MeSH (Medical Subject Headings)
terms to provide a link between clinical knowledge and clinical records. The
generic ontology can be used to maintain consistency when defining study specific
research requirements across multiple studies (Figure 8.1. The use of this ontology
will also promote reuse of requirements in similar types of studies (for example,
different studies related to type-2 diabetes will have similar information needs).
At the root of the concept hierarchy we find three main high-level concepts:
Non-clinical data, coded clinical data and other clinical data 8.2.
When developing the ontology mappings, we observed the varying degree of
coverage across the generic ontology. For example, terminologies that have a
clinical focus such as ICD-9-CM and ICD-10 were mainly mapped to the clinical
data branch of the generic ontology where as large complex terminologies such
as SNOMED-CT has a good level of coverage across the concepts of the generic
ontology.
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Figure 8.2: Health care concept ontology - Level 1
While performing the mapping we analysed if associated concepts in the clin-
ical terminologies had a:
1. Direct mapping;
2. Partial mapping; or
3. No clear mapping.
When indicate the degree of mapping, if there is are elements that are di-
rectly associated, we have given the relevant chapter headings or concepts of the
terminology. However, if we found that concepts have only some relevance we
have indicated the chapter heading or concept name and also indicated that it is
a partial mapping. If we have not been able to find a corresponding concept in
the terminology we have indicated that there is not clear mapping.
To demonstrate the nature of the mappings, we have given a complete listing of
concept mappings for SNOMED-CT within the chapter. In Appendix-C, we have
given further mappings corresponding to Read ver2, CTv3, ICD-9-CM, ICD-10
and MeSH.
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Figure 8.3: Non-clinical data in the ontology - Level 2
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Figure 8.4: Coded-clincal data in the ontology
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Figure 8.5: Other clinical data in the ontology
Table 8.1: Mapping SNOMED-CT to HCC->Non-Clinical->population data
branch
Level 3 Level 4 Mapping to SNOMED-CT
Aggregated Hospital
Hospital (environment)
[22232009]
Practice
Medical practice (qualifier value)
[408443003]
Cases Age
Age values (qualifier value)
[272130008]
Ethnicity
Ethnic group finding
(finding) [397731000]
Deprivation Clinical Finding (Partial mapping)
Gender Observable entity(Partial mapping)
Occupation Social Context(Partial mapping)
Location
Environment or geographical
location(Partial mapping)
155
Table 8.2: Mapping SNOMED-CT to HCC->Non-Clinical->General informa-
tion/ Service information/ Consumer information branches
Level 3 Level 4 Mapping to SNOMED-CT
Geographical
information
Territory
Environment or geographical
location (Partial mapping)
Localities
Environment or geographical
location (Partial mapping)
Output area
Environment or geographical
location (Partial mapping)
Service
information
Regional
Environment or geographical
location (Partial mapping)
Ministry Agencies (Partial mapping)
Commissioner No clear mapping
Provider Qualifier value
Consumer
information
Staging and scales/
Consumer satisfaction/
Social context/
Person in health care
environment (Partial mapping)
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Table 8.3: Mapping SNOMED-CT to HCC->Coded-clinical data->clinical con-
cepts branch
Level 3 Level 4 Mapping to SNOMED-CT
Clinical
Management
Diagnosis
Diagnosis (observable entity)
[439401001]
Condition
Patient condition finding
(finding) [418138009]
Symptom
Finding reported by subject or
history provider (finding)[418799008]
Finding Clinical Finding (finding) [404684003]
Determinants
and security
Causes of
disease
Clinical Finding (finding) [404684003]
(Partial mapping)
Severity Severity (attribute) [246112005]
Risk factor Risk factor (observable entity)[80943009]
Social
History
Social/personal history NOS
(observable entity) [138418006]
Interventions Prevention
Preventive procedure
(procedure)[169443000]
Therapy Therapy (regime/therapy) [276239002]
Procedure Procedure (procedure) [71388002]
Table 8.4: Mapping SNOMED-CT to HCC->Coded Clinical Data >Descriptors
Qualifiers branch
Level 3 Level 4 Mapping to SNOMED-CT
Linkage
concepts
Data quality No mapping
Classification Linkage concept
Error No mapping
Data relationship No mapping
Linkage concept
(other)
Linkage concept
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Table 8.5: Mapping SNOMED-CT to HCC->Other clinical data branch
Level 2 Level 3 Mapping to SNOMED-CT
Free text
clinical data
Direct access
to read
No mapping
Machine processed No mapping
Special field No mapping
Structured data
Locally defined
field
No mapping
Immunisation
registers
No mapping
Other structured No mapping
8.3 The extended ontology toolkit
In this section, we have brought together the ontology toolkit described in the
previous chapter and the additional elements presented in the initial part of this
chapter, to form an extended ontology toolkit that supports boundary span-
ning ontology development (Figure 8.6). The elements of the toolkit are organised
around the clinician’s role and the informatician’s role as the process requires col-
laborative effort from both parties.
The extended ontology toolkit allows to rapidly build ontologies through pre-
built ontological elements. The elements of the toolkit are listed in Table 8.6.
Table 8.6: Roles of elements of the toolkit
Toolkit Element Role
1. Data source ontology Capture semantics of metadata from data sources
2. Study requirement ontology Model study data requirements and semantics
3. Generic health care ontology Generic ontology that can be extended
4. Ontology mappings Map ontologies to clinical coding systems
The data source ontologies will ensure that the semantic relationships between
the data items in a data source is captured such that the data can be interpreted
in meaningful way during analysis. On the other hand capturing requirements of
studies that could potentially use the data will allow the better matching of data
sources in situations where multiple data sources are at disposal. The generic
ontologies will ensure that clinical ontologies will not require to be developed
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Figure 8.6: The Boundary Spanning Ontology Toolkit
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from scratch. They will guide the clinician’s (i.e the domain experts) to focus on
modeling the information related to the ontology rather than dealing with the
finer technical details. The ontology mappings have will also result in a more
effective data capturing and analysis workflow. The mapping to frequently used
clinical terminologies such as ICD-10, SNOMED-CT and Read will reduce the
time for data (from data sources) to be converted in to a dataset can be used by
a data analyst.
8.4 Ontologies for mapping AEFI concepts across
multiple terminologies
Monitoring burden of vaccine preventable disease and vaccines benefits and risk
are essential elements of modern public health surveillance. Investigators are
moving towards using big data [Hay et al., 2013]. International surveillance is
likely to become more important with increased globalisation [Kramarz et al.,
2014]. Building a common data model is important for international surveillance
[ECDC, 2009]. However, we also need automated methods that understand the
semantics of these data [Seth, 2008]; ontologies formally define the semantic rela-
tionships between data items and offer the allure of enabling machine processing
[Liyanage et al., 2013a]. Detection of Adverse Events Following Immunization
(AEFIs) is vital if we are to quantify the benefits of vaccination. The Vaccine
Adverse Event Reporting System (VAERS) is an example of a national passive
surveillance method used for detecting adverse events in USA. VAERS allows
direct reporting by members of the public and utilised automated methods for
classifying adverse events reported to it [Botsis et al., 2013]. However, such re-
porting systems vary between countries, collecting data in non-standard ways.
Vaccine informatics focuses on development and use of bio-informatics methods
during preclinical, clinical and post-licensing stages of vaccine development and
deployment[He et al., 2010] [Sejvar et al., 2011]. This branch of informatics has
largely focussed on the digitalisation of a well regulated process and ensuring
complete datasets are collected and extracted from data sources. Whilst use-
ful, we propose a much more agile approach. The Brighton Collaboration has
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developed case definitions required to define AEFI; these include Guillain-Barre
syndrome (GBS) [Sejvar et al., 2011]. GBS is rare, and very large datasets are
needed to detect it [Fokke et al., 2014]; a further challenge is that GBS is a clini-
cally heterogeneous disorder. We use GBS as an AEFI to illustrate our method;
and the Brighton collaborations definition of GBS as the gold standard (Table
8.4). Our ontology might be used to detect the signals associated with definite
or possible cases of GBS.
1. Vaccine related ontology development Vaccination programmes are gener-
ally implemented in a global scale; while data related to vaccine coverage, benefits
and risks are generated and managed at national level. This introduces a diver-
sity of data, which is a challenge for global vaccination monitoring [Lopalco &
Carrillo Santisteve, 2014]. Ontologies developed to detect AEFI must cope with
this complexity. Vaccine Ontology (VO) is a community based biomedical ontol-
ogy in this domain. It contains more than 5000 vaccine-specific ontological terms
[He et al., 2009]. The introduction of the Vaccine Ontology has been followed by
efforts to develop ontologies to conceptualise adverse events. Ontology of Adverse
Events (OAE) and Ontology of Vaccine Adverse Events (OVAE), an extension
of OAE, has been developed to formally represent and analyse AEFI [He et al.,
2011; Marcos et al., 2013]. The Adverse Event Reporting Ontology (AERO) has
been introduced to standardise reporting of AEFI [Courtot et al., 2014]. VO has
largely been used to ensure the completeness of data capture about AEFI rather
than, as we propose to systematically identify cases from clinical databases. They
take little account about the granularity of the coding system, the nature of data
recording, including free-text records when searching for signals of possible AEFI
[Liyanage et al., 2013b]. 2. An AEFI ontology to detect GBS signals across mul-
tiple coding systems We propose an ontology which will be useful for formally
integrating adverse event data from computerised medical records (CMR). This
process takes into account the degree of specificity with which the clinical concept
can be represented within the extractable CMR data; at present largely coded
data [Botsis et al., 2013]. The ontology will detect signals of varying specificity
and sensitivity depending on the data available. We can classify the outputs as
having complete, partial or no clear mapping (Table 8.4).
Class 0 will indicate no clear mapping but one or more possible symptoms or
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Table 8.7: Class of mapping possible from the ontology
Class Mapping Interpretation
Class 0 No clear mapping Possible case
Class 1-3 Partial mapping Possible/ probable case
Class 4 Complete mapping Definite case
Table 8.8: Representation of GBS in different coding systems
Clinical Concept Read2 ICD-9 ICD-10 ICPC
Guillain-Barre´
syndrome
F370.00,F370000,
F370100
357.0 G61.0 N94.1
data suggestive of a possible case are present. Class 1 will be given when there
is a diagnosis or a compatible diagnosis only, there are different codes available
in the common coding systems used (Table 8.8).
Class 2 will be assigned when there is additional supporting administrative
evidence (e.g. period of admission), Class 3 will be given if the supporting clinical
evidence is present. (e.g. immunoglobulin therapy) which is part of the Brighton
case definition. Finally, Class 4 is a definite case with all aspects of mapping
complete. We may be able to compare reported levels of partially mapped with
completely mapped.
The proposed ontology has been developed (Figure 8.7) using the ontology
modelling tool, Prote´ge´ (http://protege.stanford.edu) [Knublauch et al., 2005].
The semantics of the ontology has been described according to the OWL (Web
Ontology Language) specification by the W3 Consortium [McGuinness et al.,
2004].
An AEFI mapping ontology has been developed based on Brighton Case Def-
initions for adverse events (Figure 8.8). This supports annotating code from
multiple coding systems. Annotated AEFI ontologies can then be used for gener-
ating queries for extracting AEFI related data from various health data sources;
the associated AEFI parser can be used to parse the data and analyse a health
data set (Figure 8.9).
Ontologies can be constructed that enable the consistent and reliable iden-
tification of AEFI, where there is both a complete set of coded data that map
to a defined AEFI and the sematic relationships. The ontology will also identify
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Figure 8.7: Representation codes for GBS in multiple coding systems
Figure 8.8: Representation of Brighton collaboration case definitions as ontology
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Figure 8.9: Parsing/extracting data from multiple coding systems using AEFI
ontologies
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possible and probable cases, which cant be directly mapped to AEFI, but can be
investigated further. Developing ontologies that define the relationship between
clinical concept and coded health data is a small step towards the automated
detection of AEFI from heterogeneous data sources.
8.5 Publications associated with this chapter
The exploration of the use of ontologies and semantic integration methods given
at the beginning of this chapter has been published as “Liyanage H, Liaw ST,
Kuziemsky C, Terry AL, Jones S, Soler JK, de Lusignan S. The Evidence-
base for Using Ontologies and Semantic Integration Methodologies to
Support Integrated Chronic Disease Management in Primary and Am-
bulatory Care: Realist Review. Contribution of the IMIA Primary Health
Care Informatics WG. 8 Edition. Yearbook of Medical Informatics. 2013:1:147-
54.” In this study I conducted the literature review and conducted the results
analysis. I also drafted the manuscript for publication.
The consensus process for developing the ontology toolkit was published as
“Liyanage H, Liaw ST, Kuziemsky C, de Lusignan S. Ontologies to improve
chronic disease management research and quality improvement studies
- a conceptual framework. Stud Health Technol Inform. 2013;192:180-4.” In
this study coordinating the consensus process and analysed the outcomes of the
process. Additionally, I drafted the manuscript for publication.
The application of the ontology toolkit in the context of vaccine adverse events
was published as “Liyanage H, de Lusignan S. Ontologies to capture adverse
events following immunisation (AEFI) from real world health data.
Stud Health Technol Inform. 2014;197:15-19.” I developed the conceptual archi-
tecture that can utilise the ontologies representing adverse events and drafted the
manuscript for publication.
8.6 Summary
In this chapter reported how a conceptual ontology toolkit was extended to sup-
port development of light-weight (non-standardised) ontologies that can be used
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for semantic mapping and decision making in projects using routine data. We
label these ontologies as “boundary spanning” since they can be utilised by clini-
cians who engage in researching routine data who do not have extensive technical
knowledge of ontology development. Furthermore, the toolkit provides provision
to handle data originating from different health care settings.
166
Chapter 9
Conclusion
9.1 Introduction
The first part of the thesis presented a conceptual model for assessing readiness
to participate in research across various dimensions in health care. We explored,
across a number of dimensions of the model, for evidence of using semantic inter-
operability and ontological approaches to increase research readiness. We com-
bined data and records system readiness as both these dimensions addressing
were addressing similar issues within a wider context. Similarly, we combined
exploration of organisational and governance readiness as they were mainly fo-
cusing on resolving barriers related to access to data, preserving the privacy of
data and ethical issues related to how data is being used in research projects.
After conducting initial assessments across the different dimensions, we proposed
a series of ontological elements that would increase the readiness to participate in
research in the respective dimensions. While developing ontological approaches
we ensured that the methods used are equally understandable by both clinical
and informatics professionals. This boundary spanning approach allowed us to
validate the elements developed within real-world health care research projects.
The second part of the thesis presented a toolkit that guided development of
boundary spanning ontologies discussed in part one. We explored the require-
ments of such ontologies, and then followed a process from starting from con-
ceptual ontology models to practical implementations that processes data coded
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using multiple clinical terminologies. The extended ontology toolkit that sup-
ports boundary spanning ontology development was developed to support the
clinician’s and the informatician’s as the process requires collaborative effort from
both parties.
9.2 Principal Findings
The research readiness model which was initially proposed as five dimensions was
extended by adding three dimensions additional dimensions: governance readi-
ness, business process readiness and patient readiness. Ontological support for
conducting research were assessed against six of the seven dimensions. We did not
consider the business process readiness dimension to limit the scope that could
be achieved during the period of PhD study.
We assessed data and record system together as the readiness of these two
dimensions are related to each other. Several survey instruments that assess the
readiness of databases to participate in research were evaluated. While evidence
for ontological representation of clinical data was abundant there was no evidence
for ontologies that represent the source of the data. To fill this void, a data source
ontology that model the semantics of the data source was proposed in this thesis.
Subsequently, the factors affecting organisational and governance readiness
and any ontological support was examined. Key challenges that affected organ-
isation and governance readiness were explored with a particular emphasis on
challenges introduced through the emergence of Big data were discussed. Three
commonly occurring big data use cases in health care were identified. To resolve
the challenges identified, a conceptual entity known as the Intermediate Proces-
sor of Health Information was proposed. The IPHIs were designed to address
organisational and governance challenges related to processing large volumes of
health data.
Study readiness for partaking in effective research flows were assesses through
the development of use cases that elicit study requirements. Typical use case
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engineering methodologies were adapted to as a form which is more user friendly
to clinicians. These narrative use cases were robust as they created by general-
ising the evidence found in literature. The usefulness of the narrative use cases
were illustrated through the implementation of vaccine use cases. Additionally, a
critical appraisal tool that assesses the validity of the use cases was introduced.
As there were limited evidence for modeling study requirements, a study require-
ments ontology was proposed.
The readiness for patients to participate in research was examined through a
UCLA/RAND consensus study involving a panel of international experts. During
the study various informatics factors that affect patient readiness were identified.
There was limited evidence for ontological approaches for increasing patient readi-
ness to participate in research.
Overall, although there was no evidence for the extensive use of ontologies
across the different dimensions (i.e. except the data and record system readiness
which includes clinical data ontologies), we were able to conclude that there is
clearly scope for broadened use of ontologies. The result of broadening the use
of ontologies is the formation of semantic layer across many significant areas of
health care research project. In a typical health care research projects, in addition
to modelling the semantics of clinical data, it is useful to represent data sources,
requirements of the study that would lead to the expected outcomes, privacy and
ethical information pertaining data access etc..
The ontology toolkit’s featured in PART-II of the thesis explored efficient
methods for building ontologies. The toolkit provides various building blocks for
rapidly building ontologies for health care projects. It has been built particularly
to ease ontology development for clinicians who have limited exposure to techni-
calities of ontology development. The toolkit provides generic ontologies to get
started with developin an ontology and also mappings to the generic ontology to
assist the code identification process during the process of capturing data from
health data sources.
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9.3 Implications of findings
The implications of the research findings in this project are mainly related to
expanding the use of semantic interoperability using ontological methods as a
key driver. As the ontological processes developed are boundary spanning, they
can be effortlessly integrated in to multi-disciplinary research projects in order
to promote semantic interoperability through the use of ontologies.
9.4 Limitations
During the initial part of the thesis, we did not assess factors related to busi-
ness process readiness which supports semantic interoperability and ontological
approaches. There is a significant evidence base for this dimension of readiness
produced so far. However, this was not considered in order to narrow the scope
of the PhD study.
While developing ontologies for this project we recommended the use of se-
mantic queries for combining merging and analysing ontologies developed in the
different readiness dimensions. However, implementation of the queries was not
carried out during the course of the project. As the data source ontologies and
the study-requirement ontologies have been developed within the context of the
vaccine benefit risk monitoring, we aim to complete this part of the process at a
latter stage of the ADVANCE project in order to make the maximum use of the
ontologies developed.
9.5 Comparison with literature
There are only a limited number of instances where boundary spanning ap-
proaches have been directly suggested in the context of health care informatics.
Most of the research conducted are in relation to boundary spanning roles and
responsibilities in management studies [Aldrich & Herker, 1977; Ansett, 2005;
Leifer & Delbecq, 1978].
There is evidence for utilising a multidimensional approach in the context of
architectural approach for modelling a generic component model [Blobel et al.,
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Figure 9.1: An Architectural Approach to Ontology Systems from [Blobel et al.,
2011]
2011]. This architectural approach used for modelling ontology systems is illus-
trated in Figure 9.1.
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9.6 Call for further research
Understanding the challenges of large complex data sets, particularly “big data”
has been a focus of this research. We have accommodated these issues in most of
the conceptual work presented in the thesis. Industry standard big data technol-
ogy stacks approach data processing in a different way and there is opportunity
to link these big data processing methods to ontological approaches. We sug-
gest that the ad-hoc nature of certain big data applications can be handled, at
a semantic level, by machine processing of ontology artifacts. We also, suggest
that further studies are conducted to assess ontological approaches used with re-
spect to business processes in health care research projects. This will be useful
to extend the boundary spanning ontologies and to have an end-to-end stack of
ontologies that supports the research readiness model presented in this thesis.
Finally, we recommend further research on how to extend the boundary spanning
ontologies to conform to existing biomedical ontology standards. This will be
useful for gaining wider acceptance of this work in ontological communities.
9.7 Conclusions
Having access to data covering a wide range of disease areas suggest working
with large complex datasets. The bigger data needs increase the emphasis on on-
tologies for harmonising boundary spanning processes within research projects.
Use of semantic interoperability for these data that fit this approach does not
ensure that the the semantic meaning are also resolved during information ex-
change. Ontological approaches can better serve these limiting factors and bound-
ary spanning methods can lead to efficient building of domain ontologies within
interdisciplinary research projects.
Whilst it is desirable to achieve end-to-end semantic interoperability; the lim-
itations of the current focus on data means that the practicalities of organisations
and their governance approaches are not yet widely incorporated into standards.
We conclude this thesis by emphasising the fact that boundary spanning on-
tologies are needed to maximise the potential of semantic interoperability to re-
alise the value of routine health data.
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Appendix A - Schema for
TIRRE2 Instrument
Micro level
Data Source Level
A. Genetic Databases or other (e.g. hospital, social care, cohorts):
• Focus (general database/ specific disease)
• Demographics definition (national representative population/ inclusion and
exclusion criteria)
• Only for genetic databases:
– Links to complete primary care records
– Phenotype information
– Links to routine health records of patients
B. Primary Care Databases or Disease Registries:
• Central or distributed data store network
• Links to genetic databases
• Single or multiple EPR vendors (and which)
C. For all types of resources:
• Potential to support studies
– Cross-sectional study
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– Capability to follow cohorts
– Cause of death information
• Methods of collection
– Upload types
– Critical trial forms
• Aims and Publications (information about studies published)
• Data Source History
– Age, updates and accuracy
– Historical data availability
• Ethics (specific protocols, duration of approval process, duration of approval
process, restrictions)
• Representativeness
– Age-sex profiles
– Ethnicity information
– Deprivation indices
– Additional consents
Data Interoperability Level
A. Unique identifiers and pseudonymisation
B. Links to primary care data, national health identifies
C. Data Types
• Coding systems (ICD, ICPC, SNOMED, CTv3/ Read)
• Mental health, nursing diagnosis
• Classification systems (procedures, genetic information etc.)
• Episode and free-text input
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• Guidance between diagnosis and therapy
D. Metadata
• Structure
• Association of data with clinicians and practices
• Data quality
Meso Level
Record System Level
A.Record System
• Recognisable formats
• Archetype
• Extraction API
• EPR interface
• Hardware
B. Software
• Network connection
• Local/ remote query execution
• Efficiency and backups
C. Team and Users
• Collection process
• Training
• Team size
D. Data Modelling and Size
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• Extract type
• Statistical analysis
• Audit trails
• Patient number and recordings
Macro Level
Health System Organisational Level
Organisational Structure
• State financed health system
• Private insurance
• GP referrals
• Multi-practice registration
• Emergency treatment
• Childcare, maternity, dental, mental and sexual health as primary health
care
• National associations for primary care practitioners
Socio-cultural Level
A. Social and cultural restrictions
• Legal, ethical, social, economical, political, religious factors
B.Other factors
• Factors able to affect data quality
C. Languages
• Primary and Secondary language being used
• English as accepted language for ethical bodies
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Study
Study Use-case specific
A. Data quality & improvement relevant to use-cases
• Plans for improving the data (extending coverage, improving completeness
and reducing bias)
B. Demographics and other data
• Age, gender, ethnicity, country of birth
• Physical examinations (e.g. weight, blood pressure, etc.)
• Medical history (e.g. smoking habits, activity, family history, etc)
• Access to laboratory and imagin results
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Appendix B - AIRR Survey
Instrument
AIRR Survey- A (For Database Users)
The ADVANCE International Research Readiness (AIRR) Instrument aims to
collect information about databases that contain data about vaccines and vaccine
preventable diseases.
Using this survey, we intend to map various data sources that are capable of
participating in rapid assessment of vaccine benefit-risk.
For more information about the ADVANCE project, please visit:
http://www.advance-vaccines.eu
We are using this part of the AIRR instrument to collect contact information
about databases that could potential take part in vaccine benefit risk studies. If
you have used such databases, please share this information with the ADVANCE
project. We will contact the data custodians to obtain further information.
In one attempt, you can use this survey to provide details of up to five
database. If you would like to share information about additional databases,
please attempt the survey again by clicking again on the link provided in the
invitation email.
Please do not use your browser’s Back button. If you wish to move back to a
previous page and change a response, use the ’Prev’ and ’Next’ buttons.
Please email any queries to wp3 survey@advance-vaccines.eu
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Database information entry of database users
Please provide details about the database that you would like to describe. We
would like to contact the custodian to get more information about this database.
enumerate
Database Information
• Database name:
• Database website:
• Contact person first name:
• Contact person last name:
• Job title:
• Affiliation:
• Contact address:
• Phone number (inc. international code):
• Contact email:
Brief description of the database
Comments (please add comments or questions on this survey, or additional infor-
mation on your database)
Please provide respondent details
• Respondent name:
• Organisation:
• Email address:
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AIRR Survey- B (For Database Custodians)
The ADVANCE International Research Readiness (AIRR) Instrument aims
to collect information about databases that contain data about vaccines and vac-
cine preventable diseases.
Using this survey, we intend to map various data sources that are capable of
participating in rapid assessment of vaccine benefit-risk.
For more information about the ADVANCE project, please visit:
http://www.advance-vaccines.eu
This part of the AIRR survey intends to collection information about the
database that is managed/owned by you/your organisation.The details provided
will be used to build a catalogue of databases that are suitable for participating
in vaccine benefit risk studies.
The information provided will be shared only within the ADVANCE project.
Data custodians will be informed if the information and results of the analysis
are disseminated in any other way.
Please do not use your browser’s Back button. If you wish to move back to a
previous page and change a response, use the ’Prev’ and ’Next’ buttons.
Please email any queries to wp3survey@advance− vaccines.eu
Main Database Information
The section is to be completed by the data custodian.
1. Name of the database/register?
2. Database/register website(URL):
3. Who can authorise access to the database?
• Title:
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• First name:
• Last Name:
• Organisation:
• Job Title:
• Affiliation:
• Address:
• City:
• Postcode:
• Country:
• Phone number (inc. international code):
• Alternative phone no:
• Email address:
4. Scientific contact person
(a) Title:
(b) First name:
(c) Last Name:
(d) Organisation:
(e) Job Title:
(f) Affiliation:
(g) Address:
(h) City:
(i) Postcode:
(j) Country:
(k) Phone number (inc. international code):
(l) Alternative phone no:
(m) Email address:
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5. Brief description of database:
6. Brief description about data custodian:
7. How would you characterise your database ?(select all that apply)
• Primary health care
• Outpatient Electronic medical records, Community /ambulatory
• Inpatient electronic medical records / Hospital
• Healthcare reimbursement claims, including date and place of service,
patient, diagnoses, treatment.
• Communicable / infectious disease surveillance
• Vaccination / immunization registry or coverage data
• Population data (census and demographic)
• Vital records (birth and death registries)
• Pharmacy dispensing records
• Specialized care consultations
• Drug / vaccine adverse event reporting systems
• Specific registry (inc. chronic or rare disease, cancer registries)
• Population health surveys
• National health surveys
• Healthcare costs
• Biobank (e.g. genetics data)
• Pharmacovigilance systems
• Other (please specify)
8. Which of the following best characterises your database ?(select one only)
• Primary health care
• Outpatient Electronic medical records, Community /ambulatory
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• Inpatient electronic medical records / Hospital
• Healthcare reimbursement claims, including date and place of service,
patient, diagnoses, treatment.
• Communicable / infectious disease surveillance
• Vaccination / immunization registry or coverage data
• Population data (census and demographic)
• Vital records (birth and death registries)
• Pharmacy dispensing records
• Specialized care consultations
• Drug / vaccine adverse event reporting systems
• Specific registry (inc. chronic or rare disease, cancer registries)
• Population health surveys
• National health surveys
• Healthcare costs
• Biobank (e.g. genetics data)
• Pharmacovigilance systems
• Other (please specify)
General Characteristics
9. Start date of data collection (i.e. the date from which high quality data is
available):
10. Please select how frequently your database is updated
• Daily
• Weekly
• Monthly
• 3 Monthly
• 6 Monthly
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• Annually
• Not updated
We would like to know the time lag/ delay between data collection and the
data being available for a researcher. The time lag would be an estimate
between the date of the last clinical record and the date on which the data
is available for a researcher for analysis.
11. Please provide an estimate of the time delay for the data being available
for research?
For the following questions 12 - 14, please provide the number if patients
active for research (i.e. having high quality data)
12. Total number of registered subjects, including adults (please provide de-
nominator data as well)
13. Total number of registered children available for studies (0-18 years of age)
14. Population size (active) in the latest data collection
Geographical Coverage
15. Please specify the geographical coverage of the database
• Subnational
• National
• Multinational
• Other/Additional details about coverage:
16. If your database coverage is national or multinational, please select the
relevant country/countries:
Austria/ Belgium/ Bulgaria/ Croatia/ Cyprus/ Czech Republic/ Denmark/
Estonia/ Finland/ France/ Germany/ Greece/ Hungary/ Ireland/ Italy/
Latvia/ Lithuania/ Luxembourg/ Malta/ Netherlands/ Poland/ Portugal/
Romania/ Slovakia/ Slovenia/ Spain/ Sweden/ United Kingdom
17. Does your database/register contain inpatient or outpatient data? Yes/No
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18. Which of the following data does your database capture?
• Outpatient (through insurance claims)
• Outpatient (through medical records)
• Inpatient (through insurance claims)
• Inpatient (through medical records)
Patient-based linkage
19. Is patient-based linkage of clinical data to follow-up time (population file)
possible? Yes/No
20. Is the patient-based linkage of clinical data to follow-up time (population)
possible through
• Probabilistic linkage: Yes/No
• Deterministic linkage (with unique identifier): Yes/No
21. Is patient-based linkage between drug prescriptions and clinical data possi-
ble? Yes/No
22. The patient-based linkage between drug prescriptions and clinical data pos-
sible is through
• Probabilistic linkage: Yes/No
• Deterministic linkage (with unique identifier): Yes/No
23. If your database contains vaccine data, please indicate the completeness of
recording in the target population with respect to each vaccine
• BCG: None/Partially Complete/Complete/Don’t Know
• Diphteria: None/Partially Complete/Complete/Don’t Know
• Haemophilus influenzae: None/Partially Complete/Complete/Don’t
Know
• Hepatitis A: None/Partially Complete/Complete/Don’t Know
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• Hepatitis B: None/Partially Complete/Complete/Don’t Know
• HPV: None/Partially Complete/Complete/Don’t Know
• Influenza: None/Partially Complete/Complete/Don’t Know
• Measles: None/Partially Complete/Complete/Don’t Know
• Mumps: None/Partially Complete/Complete/Don’t Know
• Pertussis: None/Partially Complete/Complete/Don’t Know
• Polimyelitis: None/Partially Complete/Complete/Don’t Know
• Rabies: None/Partially Complete/Complete/Don’t Know
• Rotavirus: None/Partially Complete/Complete/Don’t Know
• Rubella: None/Partially Complete/Complete/Don’t Know
• Shingles: None/Partially Complete/Complete/Don’t Know
• Tetanus: None/Partially Complete/Complete/Don’t Know
• Tick born encephalitis: None/Partially Complete/Complete/Don’t Know
• Typhoid: None/Partially Complete/Complete/Don’t Know
• Varicella: None/Partially Complete/Complete/Don’t Know
24. Does the data contain any of the following vaccine related information?
• Date of vaccination
• Batch number
• Lot number
• Type of vaccine (ATC level)
• Brand (commercial name)
• Manufacturer
• Body site of vaccination (arm (left/right), leg (right/left), oral)
• Facility where vaccine was administered (eg. GP office, health agency,
...)
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Data Access
25. Is there a written policy governing data access? Yes/No
26. Do the database have a data governance committee to evaluate requests for
data access? Yes/No
27. Does the database have an ethics committee to evaluate requests for data
access? Yes/No
28. Is a charge made for data access? Yes/No
29. How many industry sponsored studies has the database been involved with
during the last 5 years?
30. Would external parties be allowed to audit the database?
• Yes to regulators
• Yes to companies for whom studies are done
• No
Publications Please list the 5 most relevant publications using your data
for the last five calendar years? (If there are studies related to vaccine stud-
ies, please include first)(Use Vancouver reference format where possible)
31. List of recent relevant publications
Comments
32. Comments (please add comments or questions on this survey, or additional
information on your database)
Respondent details
33. Please provide respondent details
• Respondent name
• Organisation:
• Email address:
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Thank your for using the ADVANCE International Research Readiness instru-
ment!
If you experienced any difficulties responding to the survey or would like to
have a copy of your responses please email wp3 survey@advance-vaccines.eu.
Note: The online version of this survey is available at:
https://www.surveymonkey.com/r/AIRR V1B
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Appendix C - Generic Health
Ontology Mappings
This appendix contains the mappings created between the generic health ontol-
ogy (chapter 7) to several widely used clinical terminologies. It also contains a
mapping of the ontology to MeSH terms.
• Mappings for Read2 coding system (Table 1 - Table 4)
• Mappings for CTv3 coding system (Table 5 - Table 8)
• Mappings for ICD-9-CM coding system (Table 9)
• Mappings for ICD-10 coding system (Table 10)
• Mappings for Mesh terms (Table 11 - Table 13)
Table 1: Mapping of Read2 to non-clinical concepts (1)
Level 3 Level 4 Mapping to Read2
Aggregated Hospital Hospital reference number (9R6..)
Practice No clear mapping
Cases Age No clear mapping
Ethnicity Ethnicity and other related nationality data (9T...)
Deprivation No clear mapping
Gender Gender(1K...)
Occupation Occupations(0....)
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Table 2: Mapping of Read2 to non-clinical concepts (2)
Level 3 Level 4 Mapping to Read2
Geographical
information
Territory No clear mapping
Localities
Patient in local study (9Q2)
(Partial mapping)
Output area No clear mapping
Service
information
Regional No clear mapping
Ministry No clear mapping
Commissioner
Practice based commissioning
administration (022..)(Partial mapping)
Provider No clear mapping
Consumer
information
No clear mapping
Table 3: Mapping of Read2 to clinical concepts
Level 3 Level 4 Mapping to Read2
Clinical
Management
Diagnosis
Read Chapters A... to Z....
(Partial mapping)
Condition
Patient examined (212..)
(Partial mapping)
Symptom
Symptoms, signs and ill-defined
conditions (R..) (Partial mapping)
Finding
Symptoms, signs and ill-defined
conditions (R..) (Partial mapping)
Determinants
and security
Causes of
disease
No clear mapping
Severity No clear mapping
Risk factor No clear mapping
Social
History
Social History (13...)
Interventions Prevention Preventive procedures (6....)
Therapy Other therapeutic procedures (8....)
Procedure Operations, procedures, sites (7....)
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Table 4: Mapping of Read2 to linkage concepts
Level 3 Level 4 Mapping to Read2
Linkage
concepts
Data quality No clear mapping
Classification No clear mapping
Error
Error entry deleted (9R9..)
(Partial mapping)
Data relationship No clear mapping
Linkage concept
(other)
No clear mapping
Table 5: Mapping of CTv3 to non-clinical concepts (1)
Level 3 Level 4 Mapping to CTv3
Aggregated Hospital Hospital reference number (9R6..)
Practice No clear mapping
Cases Age DOB- Date of Birth (9155.)
Ethnicity Ethnicity and other related nationality data (9T...)
Deprivation No clear mapping
Gender Gender(XC00J)
Occupation Occupations(0....)
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Table 6: Mapping of CTv3 to non-clinical concepts (2)
Level 3 Level 4 Mapping to CTv3
Geographical
information
Territory
Country of Birth (XaG2A)/
Country of origin (XSCj5)
(Partial mapping)
Localities No clear mapping
Output area No clear mapping
Service
information
Regional No clear mapping
Ministry No clear mapping
Commissioner No clear mapping
Provider
Administration (9....)
(Partial mapping)
Consumer
information
No clear mapping
Table 7: Mapping of CTv3 to clinical concepts
Level 3 Level 4 Mapping to CTv3
Clinical
Management
Diagnosis Diseases (X0003)
Condition No clear mapping
Symptom
Symptoms, signs and ill-defined
conditions (R..) (Partial mapping)
Finding
Clinical observation: symptoms
and signs (XM06O)
Determinants
and security
Causes of
disease
No clear mapping
Severity No clear mapping
Risk factor No clear mapping
Social
History
Social History (13...)
Interventions Prevention Preventive procedures (6....)
Therapy Other therapeutic procedures (8....)
Procedure
Operations, procedures sites
(X0001)
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Table 8: Mapping of CTv3 to linkage concepts
Level 3 Level 4 Mapping to CTv3
Linkage
concepts
Data quality No clear mapping
Classification No clear mapping
Error
Amended record entry to correct message
mapping error (XaJ5G), Error entry deleted
(9R9..,)(Partial mapping)
Data relationship No clear mapping
Linkage concept
(other)
No clear mapping
Table 9: Mapping of ICD-9-CM to clinical concepts
Level 3 Level 4 Mapping to ICD-9-CM
Clinical
Management
Diagnosis
Miscellaneous diagnostic and
therapeutic procedures (Partial mapping)
Condition
ICD-9-CM Diseases (001-629),
(680-739)
Symptom General symptoms (780-789)
Finding
Interview, evaluation, consultation
and examination (89)
Determinants
and security
Causes of
disease
Defined and Unknown Causes of
Morbidity and Mortality (797-799)
Severity No clear mapping
Risk factor No clear mapping
Social
History
Situation with explicit context
(Partial mapping)
Interventions Prevention No clear mapping
Therapy
Miscellaneous diagnostic and
therapeutic procedures (8799)
Procedure No clear mapping
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Table 10: Mapping of ICD-10 to clinical concepts
Level 3 Level 4 Mapping to ICD-10
Clinical
Management
Diagnosis
Diseases (Chapter 1-14)
(Partial mapping)
Condition
Diseases (Chapter 1-17)
(Partial mapping)
Symptom
Symptoms, signs and abnormal clinical
and laboratory findings, not elsewhere
classified (18) (Partial mapping)
Finding
Symptoms, signs and abnormal clinical
and laboratory findings, not elsewhere
classified (18) (Partial mapping)
Determinants
and security
Causes of
disease
External causes of morbidity and
mortality (20) (Partial mapping)
Severity No clear mapping
Risk factor No clear mapping
Social
History
No clear mapping
Interventions Prevention No clear mapping
Therapy
Care involving use of rehabilitation
procedures (Z50)
Procedure
Complications of medical and surgical
care (Y40-Y84), Persons encountering
health services for specific procedures
and health care (Z40-Z54) (Partial mapping)
Table 11: Mapping of MeSH terms to non-clinical concepts (1)
Level 3 Level 4 Mapping to MeSH Terms
Aggregated Hospital Hospitals
Practice Professional Practice
Cases Age
Age
Factors (Partial mapping)
Ethnicity Ethnic Groups
Deprivation
Socioeconomic Factors
(Partial
mapping)
Gender Sex
Occupation Social Context(Partial mapping)
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Table 12: Mapping of MeSH terms to non-clinical concepts (2)
Level 3 Level 4 Mapping to MeSH
Geographical
information
Territory Geographic Locations
Localities No clear mapping
Output area No clear mapping
Service
information
Regional No clear mapping
Ministry No clear mapping
Commissioner No clear mapping
Provider No clear mapping
Consumer
information
No clear mapping
Table 13: Mapping of MeSH terms to clinical concepts
Level 3 Level 4 Mapping to MeSH
Clinical
Management
Diagnosis Diagnosis
Condition Diseases
Symptom Signs and Symptoms
Finding Signs and Symptoms
Determinants
and security
Causes of
disease
Causality
Severity Severity of illness index
Risk factor Risk factors
Social
History
Life change events
Interventions Prevention Prevention and control
Therapy Therapeutic
Procedure Methods
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